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Abstract 
 
Prostate cell lines were derived from two regions of prostate tissue from the same patient. The 
objective was to produce cell lines (as a useful in vitro model) from these two different regions 
which exhibit different properties for carcinoma development. The tissue was obtained from 
patients suffering from benign prostate hyperplasia undergoing trans-urethral resection. Tissue 
was taken from the deep (peripheral) and superficial (peri-urethral) areas. The cells were 
immortalised by transduction with constructs over expressing the cdk4 and hTERT genes. These 
cell lines were then characterised for their cellular phenotypes utilized for radiation transformation 
studies and utilized to investigate the role of plant derived polyphenols on normal and tumour 
cells. 
 
The cell line from the superficial region (P21s) was treated to fractionated doses of gamma 
radiation and a transformed cloned cell line was derived (P21s 40Gy (clone-a)). The cell line from 
the deep region (P21d) was found to consist of a mixed population of abnormal cells and a 
transformed cloned cell line was derived from it (P21d 0Gy (clone-a). In an attempt to obtain a 
normal P21d cell line cloned cell lines from early passage P21d cells were established. All seven 
cloned lines were abnormal with an average of 80 chromosomes per cell, invasive using a 
Matrigel assay and produced anchorage independent colonies. All cell lines were fully 
characterised with immunocytochemistry, chromosome analysis, invasion assays, and anchorage 
independent colony formation. P21s expressed basal cell markers (cytokeratin 5 (CK5) and 14), 
were positive for stem cell markers (prostate specific stem cell antigen PSCA, CK6), positive for 
p16, p63 and telomerase expression and negative for c-Myc expression. P21s was not invasive in 
a Matrigel assay and did not produce anchorage independent colony formation. P21d and P21d 
0Gy (clone-a) also expressed CK5, CK14, PSCA, CK6, and telomerase but not p16 or p63 and 
showed an increase in expression of nuclear c-Myc, highly invasive and produced anchorage 
independent colonies. P21s 40Gy (clone-a) expressed CK5, CK14, PSCA, CK6, telomerase and 
p63, produced anchorage independent colonies, and was weakly positive for c-Myc expression. 
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Spectral karyotyping analysis (SKY) showed P21s had a normal chromosome complement 
except an additional chromosome 20 whereas the P21s 40Gy (clone-a), P21d and P21d 0Gy 
(clone-a) cell lines had an abnormal chromosome complement with P21d and P21d 0Gy (clone-a) 
cell lines expressing multiple copies of every chromosome including loss of the Y chromosome. 
These results were echoed in the single nucleotide polymorphism chip (SNP) results which 
showed P21s as normal but P21d and P21d 0Gy (clone-a) to have large deletion and 
amplification regions that correlated with the SKY analysis.  
 
No differential cytotoxic response was noted between normal and abnormal cell lines including 
prostatic carcinoma cell lines LNCaP and PC-3 following treatment with strawberry polyphenol 
compounds. Most reports of a cytotoxic response to tumour cells in the literature did not compare 
the response to normal cells and used established cell lines. Human lymphocytes were also 
tested and all compounds were toxic in high doses. Polyphenol and ellagitannin rich polyphenol 
fractions were very cytotoxic and the anthocyanin rich fraction less toxic. In contrast to the lack of 
a direct differential cytotoxic effect, plant polyphenols did produce a protective effect to a 
carcinogenic insult. However a protective effect was noted via micronucleus assay with 3 hour 
incubation with the polyphenol rich fraction prior to radiation treatment. 
 
Finally, the expression and association of metabolic enzymes within the cells cytosol were 
investigated. The P21s cells were found to express both isoforms of LDH and so thought to be 
able to metabolise anaerobically and aerobically. P21d and P21d 0Gy (clone-a) cells were found 
to only express one isoform in the complex and so it was assumed that these cells favoured 
anaerobic metabolism of ATP in correlation to the Warburg effect. c-Myc association with 
compounds in the cell cytosol of P21s cells existed whereas, abnormal cells lost this association 
along with up-regulation of c-Myc expression and down stream targets of c-Myc in the nuclei.  
 
Thus these newly established human prostate cell lines provide a useful model system for 
investigating the biology of the prostate and prostate cancer. 
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1.1 The prostate 
The prostate is a male reproductive secretory gland located under the bladder and behind the 
pubic bone, Figure 1.1. A healthy prostate is about the size of a horse chestnut and weighs about 
twenty grams (Ross, et al., 1989). Its function is to secrete an acidic fluid into semen which aids 
the liquefaction of the semen during ejaculation. The prostate also constricts urine flow as the 
gland is wrapped around the urethra and can contract to slow urine flow, Figure 1.1 (Ross, et al., 
1989). 
 
Figure 1.1 - Location of the prostate gland in humans (Homo sapiens) 
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The prostate is composed of mainly two types of tissue, fibromuscular and glandular tissue, which 
are surrounded by a vascular capsule. The two tissue types are not site specific and are 
intercalated in the gland (Ross, et al., 1989), Figure 1.2. The prostate is comprised of five lobes; 
anterior, median, posterior, and right and left lobes. It is oxygenated by the pelvic internal iliac 
arteries, Figure 1.3. 
 
The glandular epithelium is embedded in a fibromuscular stroma (Long, et al., 2005). The 
epithelium has a luminal layer made up of tall columnar cells which are secretory and are 
responsible for the production of Prostate Specific Antigen (PSA), Prostatic Acid Phosphatase 
(PAP), and human Kallikrein-2 which is secreted as part of the seminal fluid (Long, et al., 2005). 
A basal layer of cuboidal epithelial cells lies underneath the secretory layer on a basement 
membrane separating the glandular epithelium from the fibromuscular stroma (Long, et al., 2005), 
Figure 1.2. 
 
 
 
 
 
 
Figure 1.2 - Prostatic tissue acini and epithelial cell layer arrangement 
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Tumours are found throughout the prostate but interestingly the area where they are found is 
related to whether the cancer is benign or malignant. Benign prostate cancer, also known as 
benign prostatic hyperplasia (BPH), is found in peri-urethral tissue whereas malignant cancers 
develop from the glandular epithelium from the peripheral zones and the posterior lobe (Long, et 
al., 2005). Interestingly, over 90% of tumours found in the prostate are malignant and arise from 
the glandular epithelium in the peripheral zone (Long, et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 - The 5 main prostate lobes including zones where superficial and deep cell lines were 
derived from 
 
In BPH the prostate becomes enlarged and occurs in men over the age of forty years. Symptoms 
include more frequent urination to incontinence and can be very painful. It can be diagnosed by 
painful urination or blood in the urine. The symptoms can be relieved by removing part of the 
prostate by Trans-Urethral Resection (TUR). Tissue for this study was obtained from this 
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operation from patients in Ninewells Hospital in Dundee. Tissue from the superficial peri-urethral 
zones and the deep peripheral zones were collected. Epithelial cells were cultured from the tissue 
samples.  
 
It is still not known what the causes of prostate cancer are. It is also unclear why the probability of 
men developing the disease increases over the age of fifty. However, certain factors can increase 
the probability of developing the disease. These include a family history of the disease and there 
is some speculation that a fatty diet and obesity in men can increase the risk, although this has 
yet to be proven (Habuchi, et al., 2000). Evidence to suggest this is derived from epidemiological 
studies which show change in incidence with country of origin and ethnicity (Habuchi, et al., 2000; 
Gronberg, H., 2003). This is illustrated by African Americans and American whites who have a 
ten times and five times higher incidence respectively than the Japanese. Interestingly, Japanese 
immigrants to America have an increased incidence also though not to the extent of the local 
inhabitants (Habuchi, et al., 2000). 
 
The occurrence of prostate cancer has been steadily on the increase (Long, et al., 2005) and in 
2000 the number of new cases estimated at 513,000 worldwide (Gronberg, H., 2003). It is the 
third most common cancer in men worldwide, and the most common cancer in men in Europe, 
North America and some parts of Africa (Gronberg, H., 2003).  
 
In 2004 prostate cancer was the third most common cancer causing death in men in Scotland 
(NHS Scottish Health Stats, 2004). Almost 15,000 people died of cancer in Scotland in 2004 and 
prostate cancer accounted for 10.5% of cancer deaths in males (NHS Scottish Health Stats, 
2004). Colorectal (11%) and lung cancer (28%) were second and first common cancer causing 
death in males respectively (NHS Scottish Health Stats, 2004). 
 
Treatment for prostate cancer involves either surgery which can leave men incontinent and 
impotent, or radiation therapy which can also lead to unfavourable side effects. Therefore 
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research into prostate carcinogenesis is desirable and will hopefully lead to an increase in 
understanding of the causes and development of the disease. This will possibly help enable new 
drugs to be developed in a rational way.  
 
Localised disease can be cured by surgery and radiation therapy (Miki, et al., 2007). However 
advanced disease is treated by androgen ablation which initially gives good results. But over time 
the cancer can turn androgen independent, become non-responsive to the treatment and develop 
into metastatic cancer (Miki, et al., 2007). There is no cure for advanced disease and so in vitro 
models are desperately required to study prostate cell differentiation and malignant 
transformation (Kogan, et al., 2006).  
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1.2 Cell cycle 
To create cell lines the normal cell cycle has to be controlled so that the cells will not go into 
senescence after a few passages in vitro.  
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Figure 1.4 - The eukaryotic cell cycle 
 
Cells are commonly maintained in vitro in non-physiological conditions i.e. the oxygen 
concentration is significantly higher than levels in vivo. Thus, primary cultures of cells are under 
stress and a checkpoint in the cell cycle occurs and the cells don‟t progress to the next stage, 
Figure 1.4.  
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1.3 Cyclin dependent kinases 
Cyclin dependent kinases also known as cell cycle dependent protein kinases, are a family of 
proteins which regulate cell cycle checkpoints (Kim, et al., 2003). Each cyclin dependent kinase 
(cdk) has a respective cyclin protein and each cyclin appears at a specific cell cycle phase and 
thus activates its cdk partner (Kim, et al., 2003). 
 
cdk4 and cyclin D1 operate in G1 phase of the cell cycle and if cdk4 forms a complex with cyclin 
D1 the cell can progress into S phase (Kim, et al., 2003). When cells are grown in vitro they can 
become stressed, as the oxygen concentration in vitro is significantly higher than in vivo 
conditions, and can undergo telomere independent, p16
INK4a 
premature growth arrest (Ramirez, et 
al., 2003). Oxidative stress causes the cell to go into early senescence by up regulation of the 
p16
INK4a
 gene (Ramirez, et al., 2003). p16 protein binds to cdk4 and prevents cdk4 from forming a 
complex with cyclin D1 and the cell cycle checkpoint does not occur and thus the cell does not 
progress to S phase and undergoes senescence (Ramirez, et al., 2003). 
 
Oxidative stress is the cause of the first crisis stage for cells grown in vitro (Ramirez, et al., 2003). 
Work has been undertaken to over express cdk4 in cell lines to overcome the crisis stage 
(Ramirez, et al., 2003; Morris, et al., 2002). These cell lines, human fibroblasts and human 
keratinocytes, grew in atmospheric oxygen concentration and their lifespan was significantly 
extended (Ramirez, et al., 2003; Morris, et al., 2002). 
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1.4 Telomeres and telomerase 
At the end of mammalian chromosomes are structures called telomeres, which contain long 
stretches of repetitive deoxyribonucleic acid (DNA) sequences TTAGGG (Shay, et al., 2001). The 
function of telomeres is to cap eukaryotic chromosome ends and protect chromosomes from 
degradation, fusions and instability (Ju, et al., 2006). However, during every cell division and 
hence each time the chromosomes are copied, a little bit of each telomere is lost, due to the 
inefficiency of the ribosome complex. Hence every cell has a limited number of times it can divide 
and thus telomere shortening limits the proliferative capacity of the cells. In embryonic cells an 
enzyme telomerase is up-regulated and prevents telomere shortening so the cells can divide an 
infinite number of times. Telomerase consists of two essential components: the telomerase 
reverse transcriptase (TERT), which is the main protein complex, and a RNA sequence serving 
as a template for the sequence synthesis (Ju, et al., 2006). The human form is therefore referred 
to as hTERT.  
 
Every time a telomerase negative cell divides some telomeric sequences are lost and when the 
telomeres get to a critical length the cells enter an irreversible growth arrest state called 
replicative senescence (Shay, et al., 2001). Bearing in mind every time a cell‟s DNA is copied 
mistakes are made, the cells become senescent before they are transformed into tumour cells, 
thus short telomere induced growth arrest is an anticancer mechanism (Shay, et al., 2001). 
Introduction of telomerase into telomerase silent cells is sufficient to restore telomerase activity 
and extend cellular lifespan. Even though cancer cells usually have telomerase activity, these 
telomerase activated cells are not cancer cells since they have not accumulated the other 
changes needed to become malignant (Shay, et al., 2001). A study into hTERT immortalised 
human fibroblasts in vitro proved that telomerase expression alone was not sufficient to transform 
the cells into tumour cells. They did not exhibit the characteristics of cancer cells (Morales, et al., 
1999). An hTERT immortalised human oesophageal cell line was fully characterised and shown 
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to be non-tumourigenic (Morales, et al., 2003). A prostate hTERT immortalised cell line also 
showed no tumour characteristics (Kogan, et al., 2006).  
 
1.5 Immortalisation of prostate cell lines 
1.5.1 Culture of prostate cell lines 
1.5.1.1 Creating a cell line from prostate carcinomas 
There are three human prostate carcinoma cell lines readily available and well studied, DU145, 
LNCaP and PC-3 (Ko, et al., 2003). These cell lines were not derived from primary cancer tissue 
but were isolated from sites where the cancer had spread, metastatic lesions. DU145 was 
originally isolated from a lesion in the brain of a patient with widespread prostate carcinoma in 
1978 (Xu, et al., 2001). A portion of tumour tissue was scraped with a scalpel to loosen the cells 
from the bulk of the tumour (spill out method) (Stone, et al., 1978). The cells were then grown up 
in growth medium on collagen coated Petri dishes, characterised and were found not to be 
hormone sensitive or hormone dependent (Stone, et al., 1978).  
 
The LNCaP cell line was developed from a needle aspiration biopsy of the left supraclavicular 
lymph node of a patient with metastatic prostate carcinoma in 1977 (Xu, et al., 2001). These cells 
were found to be androgen sensitive and if injected into athymic nude mice formed tumours 
(Horoszewicz, et al., 1983).  
 
PC-3 cell line was developed from a grade IV prostate adenocarcinoma in 1978 (Xu, et al., 2001). 
The cell line is androgen independent and forms subcutaneous tumours in nude mice (Kaighn, et 
al., 1979).  
 
A novel human prostate carcinoma cell line called 22Rv1 was derived from a human prostate 
carcinoma xenograft (Sramkoski, et al., 1999). The xenograft, CWR22R was serially propagated 
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in mice and was derived from a parental xenograft CWR22 which after castration of the mouse 
resulted in regression (Sramkoski, et al., 1999). In nude mice the line 22Rv1 forms tumours and 
is morphologically similar to the CWR22R and CWR22 xenografts (Sramkoski, et al., 1999).  
 
1.5.1.2 Creating a cell line from normal prostate tissue 
1.5.1.2.1 Primary cultures 
There is a benefit of creating a cell line from normal prostate tissue. These cell models can then 
be used for drug testing and monitoring the effects of androgens. They can also be used to 
induce prostate cancer in vitro. Epithelial and fibroblastic cell lines were created from normal 
canine prostate (Eaton, et al., 1982). These were primary cell cultures and were used for 
investigating the effects of steroid hormone treatment on cell proliferation. The problem with 
primary cultures is that they only proliferate for a finite number of divisions. 
 
Primary cultures of human prostate were established and the population ratios of sub-types of cell 
with increased passage numbers was investigated (Uzgare, et al., 2004). They found that at a 
early passage they composed of transit amplifying cells, and with increased passage the cells 
matured into intermediate cells, until passage 7-10 where they lost their proliferative capability 
(Uzgare, et al., 2004).  
 
1.5.1.2.2 Viral oncogenic expression  
Human prostate epithelial cells were first immortalised and the corresponding cell lines created 
26 years ago (Ohnuki, et al., 1982). They utilised the Simian virus 40 (SV40) constructs and 
derivatives and developed human prostate epithelial cell lines. These cell lines could grow for an 
infinite number of divisions but there were major chromosomal abnormalities in the cells including 
loss of one or both copies of chromosome 18 and numerous translocations (Ohnuki, et al., 1982). 
They concluded that transformation of prostatic epithelial cells by SV40 may bring about site-
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specific, as well as random, chromosomal changes resulting in hypo- and pseudodiploidy. This 
shows that it would not be a very good in vitro model for normal prostate. 
 
Human neonatal prostate epithelial cells were immortalised by strontium phosphate transfection 
with a plasmid containing SV40 early region genes (Kaighn, et al., 1989). This cell line was 
created from normal neonatal prostate tissue and did not form tumours when injected into nude 
mice therefore was not neoplastic. The cell lines chromosomal karyotype was mostly normal at 
early passages including presence of a Y chromosome. However by the 53
rd
 population doubling 
24% of the cells were tetraploid and had a significantly higher proportion of abnormal 
metaphases, monosomy, trisomy, and rearrangements (Kaighn, et al., 1989).  
 
Normal adult human prostate epithelial cells were transfected with a plasmid containing the large 
T SV40 gene with a defective origin encapsulated into liposomes (Cussenot, et al., 1991). The 
cells, labelled PNT1 expressed the large T antigen, presented the phenotype of differentiated 
luminal prostatic cells, were androgen dependent, and expressed cytokeratin 18 and 19 markers 
(Cussenot, et al., 1991).  
 
Rat ventral prostate epithelial cells were immortalised with a plasmid containing the SV40 large T 
antigen (Rundlett, et al., 1992). They were attempting to create different cell lines containing 
different prostate cell types. Since the cell types are dramatically affected by androgen withdrawal 
and replacement they took cells from normal, castrated and castrated but with regular injections 
of testosterone, rats (Rundlett, et al., 1992). However, after characterisation all the cell lines 
turned out to have been derived from basal prostate epithelial cells (Rundlett, et al., 1992). 
 
A year later Shay et al. report that for successful immortalisation of cells with the SV40 large T 
antigen, the T antigen must be expressed during the cells continued proliferation after the crisis 
stage (Shay, et al., 1993). The SV40 T antigen expressing cells have an extension of lifespan 
until a period called “Crisis” begins (Berger, et al., 2004). If a clone of cells arises during crisis 
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and they continue to grow they will grow on to give rise to an immortalised cell line (Berger, et al., 
2004). This paper goes on to look at the frequency of this in mammary epithelial cells and lung 
fibroblasts and finds that this escape from crisis occurs much more frequently in mammary 
epithelial cells (10
-5
) than in fibroblasts (3 x 10
-7
) (Shay, et al., 1993). 
 
Even though the SV40 T method of immortalisation was hit and miss to see if the cells could 
escape crisis, the method of immortalisation was successfully reported for human prostate 
epithelial cells (Bae, et al., 1994) and human prostate stromal myofibroblast cells (Webber, et al., 
1999). Bae et al. (1994) created a human prostate epithelial cell line and used it to look at 
epidermal growth factor (EGF) and the epidermal growth factor receptor (EGFR) pathway for 
prostate tumour progression. The cells were immortalised by transfection with the SV40 T antigen 
gene and injected into nude mice. The cells grew tumours after a 6 month latency period and the 
tumours were taken out of the mice and the cells recovered from the tumours injected again. The 
latency period was reduced to 12-25 days and the cells were characterised and found to be of 
human origin, pseudodiploid, and retained the Y chromosome. EGF stimulated proliferation in 
tumour and parent cells, and tumour lines expressed less EGFR protein than the parental line. 
With decreased expression of EGFR in tumour lines there was a corresponding increase in 
expression of transforming growth factor alpha (TGF-α) precursor. The growth of the parental and 
tumour lines was inhibited by a neutralizing antibody to TGF-alpha under serum-free defined 
conditions.They concluded that increased tumourigenicity and decreased latent interval observed 
among the human prostate tumour cells is partially due to activation of the TGF-α/EGFR 
autocrine network. 
 
A human prostatic stromal myofibroblast cell line WPMY-1 was used to look at stromal-epithelial 
interactions (Webber, et al., 1999). The cell line showed positive staining for androgen receptor, 
large-T antigen, and positive but heterogeneous staining for p53 and pRb (Webber, et al., 1999).  
EGF stimulated cell growth where as transforming growth factor beta (TFG-β) inhibited the cell 
line growth in serum free media. 
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In 2007 Daly-Burns et al. created human prostate epithelial and stromal cell lines from the same 
patient using the SV40 large T gene from TUR chips from patients with BPH (Daly-Burns, et al., 
2007). They demonstrated that if the stromal and epithelial cell lines were mixed together and 
incubated in three dimensional (3D) Matrigel matrix small spheroid structures would form after 6 
days, and after 14 days become linked by duct-like structures. Spheroid structures showed 
keratin 14 (K14) expression in basal cells and K17 and K8 in luminal cells, with the androgen 
receptor being expressed in spheroids cytoplasm and nuclei. These cell lines are differentiation 
temperature dependent and provide a useful model for looking at the process of prostate 
epithelial differentiation and stromal-epithelial interactions (Daly-Burns, et al., 2007). 
 
With the knowledge of the difficulties with SV40 immortalisation, another viral oncogenic method 
to transfect human prostate cells was perfected (Rhim, et al., 1994). The presence of oncogenes 
in prostate carcinomas was researched and found that the presence of ras gene mutations and 
human papillomavirus (HPV) DNA was prevalent in prostate carcinomas (Rhim, et al., 1994). 
They investigated transfecting prostate epithelial cells with the entire HPV-18 genome which 
resulted in immortal cells that didn‟t undergo malignant conversion (Rhim, et al., 1994). The 
activated Ki-ras oncogene was introduced to the cells via the Kirsten murine sarcoma virus which 
led to the malignant transformation of the cells (Rhim, et al., 1994). This led to a very useful  
human prostate model as there was increasing evidence to support the idea that ras oncogene 
activation and HPV infection may be involved in prostate carcinogenesis at that time (Anwar, et 
al., 1992). The HPV-18 immortalised non-tumourigenic human prostate epithelial cell line (RWPE-
1) and the further transformed (by v-Ki-ras) human prostate epithelial cell line (RWPE-2) were 
further characterised and found to coexpress luminal cytokeratin 8 (CK8) and 18 (CK18) and 
basal markers (Bello, et al., 1997). The RWPE-1 did not invade through a matrigel porous 
membrane or form tumours in nude mice whereas the RWPE-2 did invade and form tumours 
(Bello, et al., 1997). Nuclear expression of p53 and Rb proteins were detectable and the cell lines 
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are considered good models and are now available from the American Type Culture Collection 
(ATCC). 
 
The same year another group was working on immortalisation of prostate epithelial cells with 
HPV-18 (Weijerman, et al., 1994). They obtained cells from both normal and tumour tissue and 
successfully transformed the cell lines using a lipofection mediated method (Weijerman, et al., 
1994). Both cell lines formed small tumour nodules when injected in to nude mice but they did not 
enlarge progressively and were composed of squamous cells (Weijerman, et al., 1994).  The 
similar pattern of non-progressive small tumours were also seen when SV40-transformed 
neonatal prostate cells were injected into mice (Kaighn, et al., 1989).  
 
Human prostatic tumour cell lines were transformed by HPV-18 infection from primary prostate 
cultures, and the cytokine regulation of the matrix metalloproteinases were investigated (Wang, et 
al., 1996). They deduced that cytokines may play a role in controlling the metalloproteinases and 
influence the invasive behavior of the malignant cells in vivo (Wang, et al., 1996). The same 
group also investigated the influence of interleukin-10, follistatin, activin-A and 
dihydrotestosterone (DHT) on the growth of these cells (Wang, et al., 1999). They found that DHT 
stimulated cell proliferation and colony forming ability and stimulated prostate specific antigen 
(PSA) production, whereas activin-A blocked DHT stimulated growth and PSA production. 
 
Fourteen immortal benign or malignant prostate epithelial cell cultures from primary prostate 
adenocarcinomas were immortalised using the E6 and E7 genes from the HPV-16 genome 
(Bright, et al., 1997). Tissue was taken from patients undergoing radical prostatectomies 
(Gleason score 6-8) and tissue was dissected into normal, cancer, or seminal vesicle specimens. 
To fully characterise the cell lines they screened for Loss of Heterozygosity (LOH) at the 8p loci, 
as >85% of prostate cancer foci exhibit LOH on chromosome 8p (Bright, et al., 1997). Their 
results showed LOH at multiple loci on chromosome 8p, as assessed by polymerase chain 
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reaction (PCR), which correlated with the original tumours and demonstrated that the cell lines 
were direct derivatives of the patients‟ tumours.  
 
A human prostate stromal cell line was immortalised using E6 and E7 genes from the HPV-16 
genome (Price, et al., 2000). The cell line was characterised and found to express stromal cell 
markers including expressing alpha-smooth muscle actin. The cell line did not express neoplastic 
properties and fully expressed the E6 and E7 genes, as demonstrated with reverse transcriptase 
polymerase chain reaction (RT-PCR) (Price, et al., 2000). 
 
Human prostate cells were immortalised with the HPV-16 E6 gene (Maitland, et al., 2004). The 
report describes the protocol for using E6 gene only via a retroviral transfer vector, pLXSN, and 
the murine packaging cell line, PA317. Use of the E6 and E7 genes together resulted in cells with 
an increased proliferative index so E6 was used alone which had the dual effect of inactivating 
p53 and activating telomerase to give cells with a prolonged life span (Maitland, et al., 2004). The 
successfully E6 expressing cells grew for 25 passages but then entered a stage of G0 for 
approximately 6 weeks. If cells are consistently fed fresh medium then it increases the chances of 
the cells surviving through the crisis phase resulting in immortal cultures being established. 
 
A human neoplastic prostate epithelial cell line was created by using tissue from a primary tumour 
and then immortalising the cells with E6 and E7 genes from the HPV-16 genome, to create a cell 
line that represented a primary tumour (Ko, et al., 2003). The cells exhibited high telomerase 
activity, produced tumours when injected into severe combined immunodeficient (SCID) mice, 
and were androgen responsive. The cells exhibited extensive loss of chromosomes including 2p, 
3p, 8p, 13, 14, 16, 17, 18, 21 and the gain of 7 and including a trisomy 20 (Ko, et al., 2003). 
 
Human prostate epithelial cells were successfully immortalised by insertion of one gene only (Gil, 
et al., 2005). The c-Myc gene is amplified in many prostate tumours but why this occurs is not 
fully understood (Gil, et al., 2005). The immortalised cells over expressed the c-Myc oncogene 
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and although the cells showed many normal cell characteristics, like an intact p53 response and a 
senescence-like growth arrest in response to the Ras gene, the cells transformed in culture 
without any additional genetic input (Gil, et al., 2005).  
 
 
1.5.1.2.3 Telomerase expression 
Cell lines have been created by immortalising the primary cells with the over expression of 
hTERT, the active subunit of the telomerase enzyme. Telomerase is a cellular reverse 
transcriptase that adds new DNA to the telomeres that are at the very ends of chromosomes 
(Shay, et al., 2008). The telomeres are looped structures that prevent the ends of the 
chromosome being detected as doubles strand breaks. They are naturally eroded every time a 
cell divides and therefore each cell has a finite number of divisions it can perform before the 
telomeres reach a critical length and the cell senescences (Shay, et al., 2008).  
 
Telomerase is switched on in 90% of all malignant tumours, stem cells, and embryonic cells 
(Shay, et al., 2008). Certain cell lines have been immortalised by over expressing the hTERT 
subunit without neoplastic effects. Human cell lines that have been immortalised using hTERT 
include retinal pigment cells (RPE) (Bodnar, et al., 1998) foreskin fibroblasts (Bodnar, et al., 
1998), urothelial cells (Chapman, et al., 2006), esophageal keratinocytes (Harada, et al., 2003) 
oesophageal squamous cells (Morales, et al., 2008), myometrial cells (Condon et al., 2002), and 
corneal epithelial cells (Robertson, et al., 2005). 
 
Berger et al. (2004) initially transduced primary human prostate epithelial cells with hTERT. The 
cells had detectable up regulation of hTERT levels but the hTERT expressing cells senesced at 
the same time as the control cell line which was transduced with a control vector (Berger, et al., 
2004).  
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A human prostate epithelial cell line was immortalised from tissue from primary tumours of familial 
prostate cancer patients with the gene telomerase (Yasunaga, et al., 2001). As these cell lines 
are derived from carcinomas they are models for prostate carcinoma. Carcinoma tissue was 
taken from the patients and established in culture. The 957E/hTERT cells were immortalised at 
passage 5 and the control cells 957E senesced at passage 4. The cell lines were transduced 
through infection with a retrovirus expressing hTERT and the successful transduction enabled the 
prostate carcinoma cells to grow to passage 40. The cell line 957E/hTERT line was fully 
characterised and found to express p16, prostate stem cell antigen (PSCA), cytokeratin 8, but not 
androgen receptor (AR).  The chromosome complement was near diploid but there were random 
losses of chromosome 8, 13, X, and Y. Other alterations included an alteration on 4q and a 
trisomy 20. This cancer cell line, established from a primary tumour, is a useful tool for 
researching into prostate carcinoma but researchers have been attempting to create “normal” 
human prostate cell lines from normal prostate tissue. 
 
Human prostate cells from a primary tumour of patients with prostate cancer were immortalised 
by transduction with a retroviral vector which contained the hTERT gene five months later by the 
same group (Yasunaga, et al., 2001). The cell line was called RC-58T/hTERT and was not only 
immortalised but exhibited tumourigenic characteristics after hTERT over expression (Yasunaga, 
et al., 2001). The cells propagated colonies when grown in agar, expressed cytokeratin 8, p16 
and PSCA, but not PSA or AR. The cells exhibited a number of chromosome alterations including 
loss of Y, 3p, 10p, 17p, and 18q and the gain of chromosome 16 and 20 (trisomy 20). The cell 
line RC-58T/hTERT was characterised and a clonal line called RC-58T/hTERT SA#4 was created 
by picking an anchorage independent clone (Gu, et al., 2004). The clonal line called RC-
58T/hTERT SA#4 produced adenocarcinomas when transplanted into SCID mice (Gu, et al., 
2004).  
 
Cell lines ideal for the study of human primary prostate tumours would be those derived from 
spontaneously immortalised tumour cells (Gu, et al., 2006). However, this occurrence is very rare 
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and to make an authentic model human prostate cells derived from benign and malignant 
prostate carcinoma and immortalised with over expression of hTERT provide a suitable model. 
The cell lines derived from malignant tissue, immortalised with over expression of hTERT, were 
reported to retain original phenotypes and express some of their prostatic markers but all cell 
lines (malignant and benign tissue derived) showed chromosomal abnormalities including often 
loss of the Y chromosome and loss of 8 and 13 chromosomes. They also all were positive for 
Alpha-methylacyl-CoA racemase (AMACR), also known as p504S, which is a biomarker which 
distinguish cells from benign cancer and normal tissue (Gu, et al., 2004). Therefore these cell 
lines derived from benign tissue are useful models of benign cancer as they express numerous 
chromosomal abnormalities and all express AMACR which shows that they are benign cancer 
cell lines. One of these hTERT immortalised cell lines (RC-170N/h) from benign tissue was 
cloned and a clone line (RC-170N/h/clone 7) was derived from single cell cultures and found to 
retain properties of multipotent stem cells (Li, et al., 2008). They were found to express stem cell 
markers CD133, CD44, integrin α2, integrin β1, and differentiate into multi-tissues when 
transplanted into the sub-renal capsule of non-obese diabetic severe combined immunodeficient 
(NOD-SCID) mice (Li, et al., 2008). 
 
In the same year human prostate epithelial and stromal cells were immortalised with telomerase 
(Kogan, et al., 2006). Tissue was taken from human patients with progressive prostate tumours 
(Gleason Score 5 and 7 where the tumour had extended beyond the prostate capsule) and 
established in primary culture first, then immortalised with hTERT (Kogan, et al., 2006). Only one 
of the four cell lines immortalised could be propagated in culture for ~200 population doublings.  
Their results showed that hTERT alone was not sufficient to cause immortalisation as the cultures 
that did not survive were successfully expressing the hTERT gene and thus suggests the cell line 
that survived up to 200 population doublings was immortalised due to another factor as well as 
hTERT (Kogan, et al., 2006). These cell lines were further characterised and found to express 
stem cell markers CD133 and CXCR4 (Miki, et al., 2007). 
 
Jennifer Weaver 
  20 
1.5.2 Radiation and chemical neoplastic transformation  
1.5.2.1 Radiation 
1.5.2.1.1 Cell lines 
The theory of radiation induced neoplastic transformation of human prostate cells was discussed 
almost forty years ago (Rhim, et al., 1989). Since then SV40 immortalised keratinocytes, HPV 
immortalised human bronchial epithelial cells, and SV40 immortalised human thyroid epithelial 
cells have been transformed by gamma radiation or radon or plutonium alpha-particles (Thaves, 
et al., 1990; Hei, et al., 1994; Riches, et al., 1994; Riches, et al., 1997). However cell lines that 
are immortalised with viral genes then transformed by radiation are unstable and exhibit 
chromosomal aberrations and mainly polyploid karyotypes (Zitzelsberger, et al., 2004). To 
address this complication a telomerase immortalised retinal pigment cell line (RPE) (Bodner, 
1998) was transformed by fractionated doses of gamma radiation and cloned lines were 
propagated (Riches, et al., 2001). The parent line maintained a stable diploid karyotype whereas 
the cells exposed to 2 x 15 Gy were near tetraploid which were fully characterised with spectral 
karyotyping (SKY) analysis (Riches, et al., 2001). 
 
1.5.2.1.2 Prostate cell lines 
The human neonatal prostate cell line called 267B1 was initially immortalised with SV40 T 
antigen in 1989 (Kaighn, et al., 1989; Kuettel, et al., 1996). In 1996 research was carried out on 
the ability of ionising radiation to transform this cell line and was successful. This produced the 
first evidence that human prostate epithelial cells can be malignantly transformed by exposing 
them to small, fractionated doses of ionising radiation (Kuettel, et al., 1996). The cells were 
exposed to up to 30 Gy in cumulative doses of X-rays and then screened for anchorage 
independent growth in soft agar (Kuettel, et al., 1996). No p53 or ras mutations were observed 
but numerous chromosomal defects were noted in the karyotypes after exposure (Kuettel, et al., 
1996). 267B1 before irradiation exhibited a diploid normal chromosome complement but after 
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irradiation the tumour cell line expressed duplication of one allele of chromosome 8 and loss of 8p 
in the other allele and a translocation of chromosome 3 were seen in the majority of karyotypes. 
This suggests that both chromosome 3 and 8 may be important in the transformation process 
(Kuettel, et al., 1996). These findings were the first evidence of malignant transformation of 
human prostate epithelial cells exposed to ionising radiation. 
 
The cytoskeletal changes of human prostate epithelial cell line 267B1 during radiation induced 
neoplastic transformation were investigated (Prasad, et al., 1996). They noted before irradiation 
the cells exhibited numerous, well organised and evenly distributed stress fibres (Prasad, et al., 
1996). After cumulative 30 Gy exposure the cells expressed disorganised actin microfilaments 
(Prasad, et al., 1996). This along with changes of expression of selective tropomyosin isoforms in 
the tumour cell lines which coincide with the cells becoming tumourigenic and could be an 
important marker of early prostate cancer. Further work revealed progressive loss of expression 
of tropomyosin isoforms (TM-1 and TM-3) and myosin light chain-2 (MLC-2) in the irradiated 
267B1 cells which contributed to the changes in actin stress fibre formation in tumourigenic cells 
(Prasad, et al., 1997). 
 
1.5.2.2 Organic carcinogens 
The radiation induced transformation was successful but the mechanisms involved were not fully 
understood. Other more effective and direct ways of neoplastic transformation of cells were thus 
investigated. Human prostate epithelial cells were successfully transformed by treatment with a 
chemical carcinogen N-nitroso-N-methylurea (Rhim, et al., 1997). The cells expressed no p53 or 
ras mutations but did exhibit losses in the p arms of chromosome 8 (further support cells need to 
do this to transform) and 10 and exhibited anchorage independent growth in agar and induced 
carcinomas when transplanted in nude mice (Rhim, et al., 1997). This was the first evidence of 
malignant transformation of human prostate cells when they are exposed to a chemical 
carcinogen.  
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1.5.2.3 Inorganic carcinogens 
Cadmium induced carcinogenesis is reported for the first time in human prostate epithelial cells in 
2001 (Achanzar, et al., 2001). The cells acquire apoptotic resistance and disruption of the c-Jun 
NH2-terminal kinase (JNK) pathway and Bcl-2 over expression have important roles in this 
resistance (Qu, et al., 2007). This is because stress signals activate the JNK pathway and cause 
apoptosis and Bcl-2 inhibits apoptosis (Qu, et al., 2007). 
 
Arsenic induced transformation of human prostate epithelial cells was reported in 2002 
(Achanzar, et al., 2002). This study was reported after several epidemiological studies showed an 
association between arsenic exposure and prostate cancer (Achanzar, et al., 2002; Chen, et al., 
1990; Wu, et al., 1989). The arsenic transformed cells grew aggressive undifferentiated malignant 
epithelial tumours in nude mice (Achanzar, et al., 2002). 
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1.6 Stem cells and cancer stem cells 
Stem cells are defined as “cells that have the ability to perpetuate themselves through self-
renewal and to generate mature cells of a particular tissue through differentiation” (Foster, et al., 
2002). Until recently cancer stem cells were a theory (Maitland, et al., 2005).  Cancer stem cells 
have a similar portrayal but they are found deep in tumours and their progeny are tumour 
initiating cells (Kasper, et al., 2008). 
 
Prostate stem cells have been identified and isolated by the markers CD133 and α2β1
hi
 
population (Richardson, et al., 2004). They reside in the prostate basal cell population and 
account for about 1% of the basal population (Richardson, et al., 2004). This population of cells, if 
isolated, have a high in vitro proliferative potential and, if injected into immunocompromised nude 
mice, give rise to prostatic-like acini (Richardson, et al., 2004).  
 
CD133 antigen, also know as AC133, is a five-transmembrane glycoprotein localised to human 
membrane protrusions or microvilli (Richardson, et al., 2004). It is found in epithelia that are 
constantly regenerating. It is believed to be the human orthologue of mouse Prominin which is 
expressed in embryonic epithelia (Richardson, et al., 2004).  
 
Prostate cancer stem cells have also been identified and exhibit a CD44
+
/ α2β1
hi
/CD133
+
 cell 
surface marker phenotype (Collins, et al., 2005). Approximately 0.1% of cells in any prostate 
tumour exhibited this phenotype independently of tumour Gleason Grade (Collins, et al., 2005). 
The CD44
+
/ α2β1
hi
/CD133
+
 cell population was shown to be of cancer origin by characterising the 
malignant properties of the cells. This included growing the cells in semi-solid medium and noting 
anchorage independent colony formation, and submitting the cells to a Matrigel invasion assay 
and noting the highly invasiveness nature of the cells through the Matrigel porous membrane.  
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It is noted that normal epithelial stem cells can be isolated using similar markers to prostate 
cancer stem cells (Collins, et al., 2005). The prostate cancer stem cells are proved to be different 
to normal stem cells in their properties to self-renew. The prostate cancer stem cells can 
proliferate and differentiate to recapitulate the phenotype of the tumour from which they were 
derived (Collins, et al., 2005). CD133 has been used to identify normal and/or cancer stem cells 
in other tissues also (Miki, et al., 2008). 
 
Human prostate epithelial stem cells that express cell markers CD133
+
/integrin α2β1
hi
 / p63
-
 / 
PSCA 
- 
/ AR
 -
 / PSA
 -
 can self renew and generate two distinct cell lineages (neuroendocrine and 
transit amplifying cells) but can not differentiate into luminal-secretory cells in vitro (Miki, et al., 
2008). As prostate tissue is composed of basal and luminal layers comprised of basal, secretory 
and neuroendocrine cells this tends to argue that these are not the correct markers for the stem 
cell progeny or that it is the in vitro culturing conditions that are limiting.  
 
CD133
+
 cells from hTERT immortalised non-tumourigenic RC-165N/hTERT cells and from 
hTERT immortalised malignant tumour derived RC-92a/hTERT cells were grown in Matrigel 3 
dimensional (3D) culture (Gu, et al., 2006). It was noted that CD133
+ 
cells from non-tumourigenic 
cells grew organised branched structures whereas, the CD133
+
 cells from the tumour derived cell 
line grew irregular large spheroids with fewer branched structures (Miki, et al., 2008). This is 
further evidence that even though stem cells and cancer stem cells share similar cell surface 
markers they have very different cultural properties. Therefore, if the prospective stem cells and 
cancer stem cells can be differentiated in either in vitro Matrigel 3D culture or injection into 
immunocompromised mice, it would be possible to identify if they were cancer or normal stem 
cells from the sub-culture of the structures that grew.  
 
Prostate carcinomas initially shrink after androgen deprivation which suggests that the bulk of the 
tumour is made up of androgen sensitive cells (Berry, et al., 2008). However, after the therapy the 
tumour regrows and is resistant to androgen deprivation treatment and consists of androgen 
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insensitive cells. This suggests that an androgen insensitive population of cells (not affected by 
previous therapy) stems a new androgen-independent tumour (Collins, et al., 2006). Prostate 
cancer is slow growing and has a lot of cells in G0 which are often inherently resistant to 
chemotherapy (Maitland, et al., 2005). Therefore it would be advantageous to fully characterise 
these tumour initiating cells so that they can be targeted and a drug resistant prostate cancer will 
not occur. 
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1.7 Polyphenols 
Part of this study was to develop prostate cell lines and one role of interest was to investigate if 
there was a differential cytotoxic effect of fruit polyphenols on the normal and cancer cell lines 
and see if there were any protective effects in the event of a DNA damaging agent.  
 
1.7.1 Human cancer cell line studies and epidemiological evidence  
A diet rich in fruits and vegetables is well known to provide essential nutrients but they also 
contain dietary antioxidants such as phenols and flavonoids, which have been shown to induce 
apoptosis in cancer cells such as a human hepatoma cell line HepG2 (Ramos, et al., 2005), 
human colon cancer Caco-2 cells (Yi, et al., 2005), and human breast carcinoma (Agarwal, et al., 
2000).  
 
Epidemiological evidence has pointed to diet being an active factor in modifying cancer incidence 
around the world (Simopoulos, 2001; Norman, et al., 2004). This led to more extensive 
investigations into the specific elements of the diet that is high in antioxidants and polyphenols 
(Simopoulos, 2001). Countries that consume a lot of green tea, which is high in polyphenols, 
have a lower incidence of bladder cancer compared to countries that don‟t drink green tea which 
have significantly higher bladder cancer incidences (Leppert, et al., 2006). Interestingly if people 
from a high green tea consumption country such as Japan emigrate to the United States of 
America, which is a low green tea consumption country, the bladder cancer incidence increases 
by two fold after as little as two generations (Leppert, et al., 2006). This suggests food high in 
polyphenols is protective.  
 
There is a substantial body of scientific evidence that polyphenols are protective from 
carcinogens inducing colon, mammary, and brain cancer in rat studies (Fermia, et al., 2005; Kim, 
et al., 2004; Kim, 2005). This could be a direct effect of the polyphenols being there before and 
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during the carcinogen and also a more long term effect as seen by the epidemiological studies 
where the polyphenol diet as a long term protective effect from cancer development.  
 
1.7.2 Strawberries and other berry extract studies 
Strawberries are consumed in high quantities in the developed world in juice, jams and as fresh 
fruit, thus being an easy method of receiving natural healthy compounds (Aaby, et al., 2007). The 
strawberry polyphenol content is made up of a mixture of anthocyanins and ellagitannins, Figure 
1.5. 
 
General structure of Anthocyanidins 
 
General structure of Ellagitannins 
Figure 1.5 - Chemical structure of polyphenols in strawberries. (Aaby, et al., 2007) 
Anthocyanins are what give strawberries the deep, rich, red colouring. The most abundant 
polyphenol is ellagic acid, in the ellagitannin fraction, in strawberries (Hannum, 2004). 
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Polyphenols are antioxidants as they can easily donate hydrogens to neutralise reactive oxidising 
species (ROS), as they can distribute the spare electron from the donating oxygen to the high 
aromatic phenyl rings, Figure 1.5, (Hannum, 2004; Jones, 2007) 
 
Whole fruit extracts and the extract constituents have been applied to a range of cancer cell lines 
and results showed that they had a negative effect on cell growth (Seeram, et al., 2004; Yi, et al., 
2005; Yi, et al., 2005 2; Schaefer, et al., 2006). The fruit extracts affected the in vitro cancer cells 
by having antiproliferative, apoptotic and antioxidant effects that lead to the cells reduced ability 
to survive in vitro (Seeram, et al., 2005).  
 
Investigation into the effects of phytochemicals on prostate and breast cell lines so far has been 
quite limited. Grape seed extract has been tested on human prostate cancer cell lines DU145 and 
LNCaP and human breast cancer cell lines MCF-7 and MDA-MB468 in vitro (Agarwal, et al., 
2000; Ye, et al., 1999; Agarwal, et al., 2000). The extract had irreversible growth inhibitory effects 
on all cell lines and caused this effect via mitogenic signalling and induction of cell cycle G1 
arrest. A multitude of berry extracts were tested on LNCaP and MCF-7 lines and were found to all 
inhibit cell proliferation (Seeram, et al., 2006). Further research looked at the effect of the 
polyphenolic compounds on human cancerous prostate cells in an environment mimicking the 
body. Pomegranate juice extracts were reported to inhibit the invasion of human prostate cancer 
cell line PC-3 in vitro across a Matrigel 
TM
 membrane but the mechanism is unknown (Lansky, et 
al., 2005). 
 
Agarwal, et al., (2006), investigated the mechanisms by which the growth of prostate cancer cells 
were inhibited by polyphenols (Veluri, et al., 2006; Kaur, et al., 2006; Agarwal, et al., 2006). 
DU145 and LNCaP cell lines were treated with grape seed extract. The breakdown product 
ellagitannin and gallic acid was found to induce DNA damage and resulted in the cells undergoing 
cell cycle arrest and apoptosis. 
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Zhang et al., (2008), isolated ten polyphenolic compounds in strawberry extracts and tested them 
on human oral, prostate, and colon cancer cell lines. They found that crude anthocyanin and 
tannin rich extracts inhibited the oral cancer cell lines growth by over 50% at 250 ppm with the 
tannin rich fraction being the most cytotoxic (Zhang, et al., 2008). The crude anthocyanin and 
tannin extracts inhibited the prostate cancer cell line DU145 growth by about 50% at 250ppm. 
Whereas, the crude anthocyanin and tannin extracts inhibited the prostate cancer cell line LNCaP 
by 80% growth inhibition. Kaempferol (compound 5) and quercetin (compound 6) polyphenols 
isolated from the strawberry extracts were the most cytotoxic to the oral and colon cancer cell 
lines but they did not have the same extent of effect on the prostate cancer cells. Quercetin 
(compound 6) and ellagic acid (compound 10) were the most cytotoxic of all the strawberry 
polyphenols on the prostate cancer cells. All cell lines were cultured in medium containing 10% 
fetal calf serum (FCS). This is important as the polyphenols will bind to the serum and become 
unavailable to the cells (Ross, et al., 2007). 
 
The majority of studies have investigated the effect of polyphenol extract on cancer cell lines and 
have reported that the polyphenols were inhibiting the cancer cells growth. However they have 
not used a control normal cell line of the same tissue origin and therefore their claims that the 
polyphenol compounds have a differential effect needs more investigation. 
 
1.7.3 Studies that used controls  
The only work that has used polyphenol extracts with normal and cancer cells were studies on 
colon, breast, oral, prostate and leukemic and progenitor cells. 
 
1.7.3.1 Anthocyanin extracts on colon cells 
Zhao (2004) investigated berry anthocyanin extracts on the HT-29 colon carcinoma cells and 
non-tumourigenic colonic NCM460 cells. They found that at low concentrations (10 μg / mL) the 
normal cells growth was not inhibited whereas the tumour derived cells growth was inhibited by 
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~50% after 48 hour exposure to 25 μg / mL of extract. This suggested that berry anthocyanin 
extracts have the ability to inhibit growth of cancer cells compared to normal cells but it is not 
clear if this is a differential effect.  
 
1.7.3.2 Proanthocyanidin extract on variety of cancer cells and normal mucosal cells 
Ye, et al., (1999) looked at grape seed proanthocyanidin extract in many cancer cell lines and 
used normal human gastric mucosal cells from endoscopic biopsies as a control and found that 
the grape seed extract exhibited cytotoxic effects on breast, lung, and gastric adenocarcinoma 
cells but it enhanced the growth and viability of the normal gastric mucosal cells. However, the 
results from the normal gastric mucosal cells cannot be compared to cells of other tissue origin. 
 
1.7.3.3 Gallotannin polyphenol on human colon cells 
Studies have shown that gallotannin, a plant polyphenol, has anticarcinogenic activities in animal 
models so further investigation on human cell lines was undertaken (Al-Ayyoubi, et al., 2007). 
They discovered that the gallotannin had a differential effect on HCT-116 and HT-29 colon cancer 
cells than normal human intestinal epithelial cells (FHs 74Int) at doses of 60 μg / mL for 72 hours 
exposure (Al-Ayyoubi, et al., 2007). The cancer cell lines were much more sensitive to the 
polyphenol and concentrations of 30-45 μg / mL gave a 50% reduction in cell survival. The 
extracts were dissolved in ethanol and controls of only ethanol were run. The ethanol 
concentration did not exceed 0.1% in control and test samples. Two isogenic HCT-116 cell lines 
(p53+/+, p53(-/-) were also tested and it was found that the cytoxicity of the polyphenol was not 
p53 dependent but the p53-/- cells were more sensitive to the extract (Al-Ayyoubi, et al., 2007).  
 
1.7.3.4 Polyphenol extract on human breast cells 
Hakimuddin, et al., (2006) investigated red wine polyphenol extract on MCF-7 breast cancer cells 
and MCF-10A breast epithelial cells, a spontaneously immortalised cell line that did not form 
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tumours in athymic animals. They reported that the red wine polyphenol extract had selective 
cytotoxicity towards the MCF-7 cells and did not affect the MCF-10A cells at all.  
 
1.7.3.5 Cocoa extracts on human prostate cells 
This study looked at polyphenol extracts from cocoa beans and tested their effect on prostate 
cancer 22Rv1 (nonmetastatic, androgen responsive) and DU145 (metastatic, androgen non-
responsive) cell lines and normal RWEP-1 prostate cell lines (Jourdain, et al., 2006). They looked 
at cocoa polyphenols supplements with β-sitosterol at varying doses and looked at cell inhibition. 
Their results showed that all extracts supplemented with β-sitosterol inhibited the cancer cell lines 
growth at 0.01% extract doses. The control cell line growth was not inhibited at low (0.01%) or 
high (>0.1%) doses but 70% growth inhibition was seen at doses in between (Jourdain, et al., 
2006). The extract was applied to the cells for 48 hours and was initially dissolved in ethanol then 
diluted in medium. In conclusion, the cancer cell lines were more susceptible to the extracts at 
higher doses (1% extract) than the normal cells and the metastatic DU145 cells were more 
resistant than the non-metastatic 22Rv1 cells.  
 
1.7.3.6 Black raspberry phytochemicals on human oral cells 
Cell lines used were normal (TE1177), premalignant (SCC-83-01-82), and malignant (83-01-
82CA) human oral epithelial cells (Han, et al., 2005). Black raspberry fractions and known 
polyphenol compounds were tested on the cell lines. The results showed that the ethanol fraction 
(RO-ET) had inhibited the pre and malignant cell lines at 200 μg / mL by 45% and 27% 
respectively but did not inhibit the growth of the normal cells at the same dose. At lower doses it 
inhibited the premalignant cells by 23% and malignant cells by 5% and normal cells by 3%. The 
cells were treated twice with extract over 6 days. The dichloromethane fraction (RO-DM) inhibited 
all cells and was more toxic to the normal cells. The compounds in the fractions were not 
discussed but the RO-ET fractions effects on cell cycle proteins were measured after 3 days 
treatment. The RO-ET fraction reduced levels of cyclin A, cell division cycle gene 2 (cdc2) in 
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premalignant cells, and reduced levels of cyclin B1, cyclin D1 and cdc2 in malignant cell lines, but 
did not affect the cell cycle distribution of the cells (Han, et al., 2005). They concluded that the 
RO-ET fraction was having a distinct differential effects on the cells at high doses (100-200 μg / 
mL) and affecting the cancer cells cell cycle protein levels but not significantly to perturb the 
distribution of the cells in the cell cycle.  
 
1.7.3.7 Flavonoid commercial chemicals on progenitor cells and leukemic cells 
Quercetin and flavopiridol were tested on various acute myeloid leukemic cells obtained from cell 
lines (ATCC), and CD34+ progenitor cells separated from normal marrow donors (Liesveld, et al., 
2003). The flavonoid chemicals were tested at doses ranging 0-100 μM for 72 hours. No 
differential effects were found between the normal CD34+ progenitor cells and the leukemic cells. 
Flavopiridol was more cytotoxic with 1 μM causing 50% reduction in viable cells after 24 hours 
incubation (leukemic) and 1 μM causing 50% reduction in viable normal cells in 18 hours 
(Liesveld, et al., 2003). Quercetin was less cytotoxic but affected the leukemic cells with a dose of 
50 μM after 72 hours incubation giving 50% reduction in viable cells and the normal cells with a 
dose of 50 μM after 46 hours incubation (Liesveld, et al., 2003). This shows that there was no 
differential effect between the cancer cells and the normal cells. 
 
1.7.4 Conclusions 
However with only a handful of papers comparing polyphenol extract on normal and cancer cells 
to the many publications reporting that polyphenol extracts kill cancer cells but with no controls, it 
is essential to evaluate whether polyphenol compounds have any differential effect. With the 
generation of a normal and cancer cell lines from the same tissue origin and same patient it 
would be interesting to see if the polyphenolic compounds really do affect normal cells and if their 
prevention in cell growth is cancer specific alone. In light of the epidemiological evidence it would 
also be attractive to see if the polyphenol chemicals have a protective effect from carcinogens or 
other DNA damaging agents that could cause cancer in a more direct way. Studies to look at 
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longer term prevention could also be investigated with long term feeding of the cells at a low dose 
of polyphenols then testing their response to carcinogens or other DNA damaging agents.  
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1.8 Metabolic enzymes in cell cytosol 
1.8.1 Nucleoside diphosphate kinases 
Nucleoside diphosphate kinases (NDPKs) are a family of highly conserved proteins that have 
multifunctional purpose in mammalian cells. There are nine human NDPK isoforms, which are 
transcribed from different nm23 genes. The most widely expressed isoforms are NDPK-A and 
NDPK-B. These isoforms act as cellular nucleotide converters and regulate the energy currency 
in the cells, adenosine triphosphate (ATP) (Jovanovich, et al., 2007). 
 
 
  ATP + GDP     ADP + GTP 
 
 
NDPK-A catalyses the production of ATP in mammalian cells via gamma-phosphate transfer 
between nucleoside diphosphates to nucleoside triphosphates. However NDPK-A does not work 
alone. The adenosine monophosphate (AMP) – activated protein kinase (AMPK) is a 
heterotrimeric protein complex that responds to cellular energy status (Hardie, et al., 1999). If 
ATP becomes scarce in the cell, the resulting rise in cellular AMP levels activates AMPK (Hardie, 
et al., 1997). AMPK phosphorylates downstream substrates and has a net effect of switching off 
ATP-utilising pathways such as fatty acid synthesis, and cholesterol synthesis, and turns on ATP-
generating pathways such as fatty acid oxidation and glycolysis (Dr Elaine Campbell, Bute 
Medical School, personal communication). 
 
It has been reported that NDPK-A only (not NDPK-B) selectively regulates the alpha 1 isoform of 
AMPK independently of AMP concentration (Hardie, et al., 1999). AMPK alpha 1 uses the ATP 
generated by NDPK-A to phosphorylate a recognised downstream in vivo target, acetyl 
coenzyme A carboxylase (ACC).Once ACC is phosphorylated it promotes ATP conservation by 
NDPK-B 
NDPK-A 
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inhibition of fatty acid synthesis and encourages ATP-generating pathways such as fatty acid 
oxidation (Campbell, personal communication). 
 
The other side of the coin, NDPK-B equilibrium favours using ATP to generate guanosine 
triphosphate (GTP) to supply heterotrimeric G-protein functions (Hippe, et al., 2006). This process 
of ATP production and conservation via NDPK-A and NDPK-B is regulated by Protein Kinase 
CK2 formally known as Casein Kinase 2 (CK2), (Jovanovich, et al., 2007). CK2 is a constitutively 
active two alpha and two beta heterodimer and has been found to have an essential role in 
almost every process in mammalian cells (Jovanovich, et al., 2007).  
 
1.8.2 Casein kinase 2 (CK2) 
When cells are unstressed, CK2 alpha is bound to NDPK-A and AMPK and has an inhibitory 
effect on NDPK-A so that it does not generate ATP local to AMPK and therefore ACC is active 
and ATP consuming pathways are switched on e.g. fatty acid synthesis. As a result, CK2 is not 
bound to NDPK-B which functions as normal with ATP being used to generate GTP and G-
protein pathways are active (Jovanovich, et al., 2007; Campbell, personal communication). 
 
Oxygen tension or stress can affect this process and causes CK2 to translocate to NDPK-B. This 
results in NDPK-A being free to supply AMPK with ATP which results in ATP generating 
pathways being switched on via AMPK phosphorylation (Campbell, personal communication). 
NDPK-B is thus inhibited by CK2 and no longer uses ATP to generate GTP and hence G-protein 
pathways are repressed.  
 
1.8.3 Lactate dehydrogenase (LDH) 
It has been reported that lactate dehydrogenase (LDH) is a key regulatory subunit of this energy 
pathway and may regulate the CK2 alpha effect on NDPK-A/B (Jovanovich, et al., 2007; 
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Campbell, personal communication). LDH is a tetramer composed of two isoforms A or B and 
there are five human isoenzymes (Kaplan, 1963). LDH-1 is found in the heart and is composed of 
4 B subunits and is known as LDH-B. LDH-2 is located in reticuloendothelial system cells. LDH-3 
is expressed in the lungs, and LDH-4 has been discovered in the kidneys. LDH-5 is located in the 
liver and striated muscle and is composed of 4 A subunits and named LDH-A. LDH-A has the 
highest efficiency to catalyse pyruvate to lactate, particularly under hypoxic conditions (Goldman, 
et al., 1964).  
 
Under normal conditions, LDH-B is bound to NDPK-B which functions normally as discussed. 
However if LDH-A is bound to NDPK-B it augments CK2s inhibitory effect as described. Thus, 
LDH-A acts as a regulatory subunit of NDPK-B s GTP output and ATP generation (Jovanovich, et 
al., 2007). 
 
Glycolysis is sensitive to the oxidative stress of the cells. In aerobic conditions, pyruvate and 
nicotinamide adenine dinucleotide in its reduced form (NADH) are used via oxidative 
phosphorylation. In hypoxic conditions lactate and nicotinamide adenine dinucleotide oxidised 
form (NAD
+
) are used via continuous anaerobic glycolysis.  
 
  Pyruvate + NADH   Lactate + NAD
+
 
 
 
 
 
 
Therefore, if oxygen is in plentiful supply, LDH-B is expressed in the cells and is bound to NDPK-
B. However if oxygen is scarce, LDH-A preferentially binds to NDPK-B, augmenting CK2 alpha 
which has an inhibitory effect on NDPK-Bs ability to make GTP from ATP and G-protein 
processes are depressed to conserve ATP. 
LDH-A 
LDH-B 
Aerobic 
Hypoxic 
Oxidative 
phosphorylation 
Continuous anaerobic 
glycolysis 
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Cancer cells express LDH-A independent of the oxygen concentration available to the cell and 
produces energy via continuous anaerobic glycolysis. This is known as the Warburg Effect 
(Warburg, 1956).  
 
1.8.4 c-Myc 
A novel sting in the tail is the proto- oncogene c-Myc. It has been shown that c-Myc is bound to 
the NDPK-B complex in the cytoplasm of cells under normal conditions. When it is bound it is 
inactive, however when cells get stressed and LDH-A /CK2 alpha binds to NDPK-B, c-Myc is 
ejected from the complex, (Campbell, personal communication). It may translocate to the nucleus 
as nuclear downstream targets of c-Myc are noted to be up regulated, (Campbell, personal 
communication).  
 
c-Myc is a transcription factor and has three closely related members in its family; c-Myc, L-Myc, 
and N-Myc (Williams, et al., 2005). They each have very distinct patterns of expression but can 
compensate if one of the isoforms is lost (Williams, et al., 2005). Myc forms a heterodimeric 
transcription factor with its partner Max (Blackwood, et al., 1991). Myc expression regulates cell 
proliferation (by activating cyclins), differentiation, and apoptosis (Williams, et al., 2005). Myc 
controls various cell cycle activities including regulating cell cycle checkpoints by binding to and 
activating cyclins. This includes cyclin D2 in which activation corresponds to pushing the cell into 
S phase. Myc is also indirectly involved in reducing expression of protein pathways, such a 
p21
WARF1
 and p15
INK4b
 which are involved in cell cycle arrest (Williams, et al., 2005). 
 
Over expression of c-Myc has been observed in prostate cancer and is directly related to 
amplification in the 8q24 region as this leads to an increase in copy number of the c-Myc gene 
(Williams, et al., 2005; Yang, et al., 2005). This suggests that c-Myc in involved with the 
progression of prostate cancer. Interestingly, also over expression of c-Myc in transgenic mice 
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models resulted in prostate carcinogenesis (Williams, et al., 2005). The mice models also 
exhibited a decreased expression of PTEN, a tumour suppressor gene (Williams, et al., 2005). 
 
Epidemiological evidence shows that human prostate cancer is associated with genetic variation 
at chromosome 8q24 in African-American men (Sole, et al., 2008), where it is associated with 
increase risk of contracting the disease (Freedman, et al., 2006). Mutations which disrupt the 
regulation or expression levels of c-Myc gene are among the most common found in human and 
animal cancer (Cole, et al., 1999). Studies have shown transgenic mice with unregulated c-Myc 
gene developing prostate neoplasia (Zhang, et al., 2000) and shown that these mice tumours 
share molecular features with human prostate tumours (Ellwood-Yen, et al., 2003). 
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1.9 Tumour suppressor genes 
The most common chromosomal abnormalities in prostate cancer cells include losses of 8p, 10q 
and 13q (Isaacs, et al., 2001; Brookman-Amissah, et al., 2007).  
 
1.9.1 Chromosome 8p 
On 8p the most frequent regions that are deleted in prostate cancer are 8p23 and 8p12-p22 and 
these deletions appear to be an early event in cancer development (Isaacs, et al., 2001). The 
evidence for tumour suppressor genes at 8p is well supported by many somatic deletion studies 
and genetic linkage studies (Chang, et al., 2007). 
 
1.9.1.1 NKX3.1 
The NKX3.1 tumour suppressor gene is located at 8p21.2 and has been found to encode a 
transcription factor (Guan, et al., 2008). NKX3.1 is expressed throughout prostate development 
and is thought to be involved in growth control as nkx3.1 knockout mice show a delay in cells 
from being exited from the cell cycle, which results in a sharp increase in cell number (Lei, et al., 
2006; Li, et al., 2006).  Diminished NKX3.1 protein expression has been observed in many 
prostate cancers (Guan, et al., 2008) and has been demonstrated that NKX3.1 reduced 
expression is directly caused by PTEN loss in human prostate cancer (Lei, et al., 2006). Normal 
expression of NKX3.1 results in stabilizing p53, and inhibiting AKT activation and blocking 
prostate cancer initiation caused by PTEN loss. Therefore the current stream of thought is that up 
regulation of NKX3.1 in prostate carcinomas could be a possible therapy (Guan, et al., 2008). 
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1.9.2 Chromosome 10 
Deletions of 10q are one of the many most frequent deletions in prostate cancer which indicates 
that this is a region for candidate tumour suppressor genes (Nupponen, et al., 2000). Deletions in 
10p are also common in prostate cancers (Bar-Shira, et al., 2006).  
 
1.9.2.1 Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) 
PTEN is located on chromosome 10q23 and is a known tumour suppressor gene in prostate that 
is found to be inactivated in ~ 50% of advanced prostate tumours (Lin, et al., 2004; Wu, et al., 
2006; Bertram, et al., 2006). PTEN is a liquid phosphatase that dephosphorylates the D3 position 
of phosphatidylinositol (3, 4, 5)- triphosphate (PtdIns-3, 4, 5-P3) and phosphatidylinositol (3, 4)- 
biphosphate (PtdIns-3, 4-P2), the products of phosphoinositol-3‟ – kinase (PI3K) (Wu, et al., 
2006). This is important because PtdIns-3, 4, 5-P3 and PtdIns-3, 4-P2 are essential for 
phosphorylation and activation of the Akt protein kinase which is a downstream target of PI3K 
(Wu, et al., 2006). Once activated, Akt stimulates cell cycle progression and inhibits apoptosis. 
Thus if PTEN is deleted there is no Akt regulation. Hence the cell cycle and apoptosis processes 
are uncontrolled (Bertram, et al., 2006). PTEN deletion also leads to expansion of a prostatic 
stem/progenitor cell subpopulation and leads to initiation of tumour cells (Wang, et al., 2006). 
 
It has been shown that PTEN expression is associated with androgen responsiveness in prostate 
cancer cells (Wu, et al., 2006). Especially a loss of PTEN is associated with progression to 
androgen independence and this helps make clear why prostate cancer cells become androgen 
independent and that PTEN inactivation may play a role in progression to androgen 
independence (Bertram, et al., 2006). This is of particular interest as after androgen ablation 
therapy androgen independent prostate cancers often occur and are notoriously hard to treat and 
cure. However, it must be noted that PTEN inactivation alone was not sufficient to create an 
androgen independent phenotype and additional alterations are required to achieve complete 
androgen independent growth (Bertram, et al., 2006).  
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PTEN also plays a role in tumour metastasis in prostate and breast cancer (Bandyopadhyay, et 
al., 2004). Drg1 (Differentiation related gene) gene has been shown to suppress tumour 
metastasis in animal models of prostate cancer and expression of the gene is significantly 
reduced with advancement of prostate cancers clinically (Bandyopadhyay, et al., 2004). Results 
showed that Drg1 gene was controlled by PTEN and over expression of PTEN significantly 
augments the endogenous expression of Drg1 protein (Bandyopadhyay, et al., 2004). Clinically, 
the combination of the 2 markers PTEN and Drg1 were a better predictor of prostate and breast 
cancer patient survival than either marker alone (Bandyopadhyay, et al., 2004).  
 
1.9.2.2 KLF6 
KLF6 has also been implicated as a candidate susceptibility gene for prostate tumourigenesis 
(Narla, et al., 2001). KLF6 is a Kruppel-like transcription factor and maps to 10p15, a region 
frequently deleted in prostate carcinomas (Bar-Shira, et al., 2006). Wild type KLF6 suppresses 
cell growth through a p53-independent transactivation of p21 (Narla, et al., 2005). Deletions and 
mutations in this gene result in lack of suppression of cell growth and hence has been 
characterised as a tumour suppressor gene (Narla, et al., 2005). A large scale population study of 
300 Jewish prostate cancer patients were screened for mutations in KLF6 gene and results 
showed that only 17 patients had KLF6 mutations (Bar-Shra, et al., 2006). This indicates that 
mutations in KLF6 are associated with prostate cancer risk but in a minority of prostate 
carcinomas in Jewish men.  
 
A tri-institutional study of 3,411 men showed that a single nucleotide polymorphism in the KLF6 
region of 10p15 was significantly associated with increased risk of prostate cancer (Narla, et al., 
2005). The mutant KLF6 protein isoforms mislocalise to the cytoplasm and antagonise wild type 
KLF6 function which results in decreased p21 expression which leads to increased unregulated 
cell growth (Narla, et al., 2005). This is further evidence that KLF6 is a tumour suppressor gene, 
Jennifer Weaver 
  42 
although further study would warrant the general population frequency of KLF6 mutations and 
prostate carcinoma frequency. 
 
1.9.2.3 ANX7 
ANX7 (also known as ANXA7) gene is localised on chromosome 10q21, a region that is most 
frequently deleted in prostate cancers, and codes for a calcium ion activated GTPase (Srivastava, 
et al., 2001; Dong, 2006). DU145 and LNCaP prostate cancer cell lines show marked decrease in 
tumour cell growth and colony formation when ANX7 gene is up-regulated in these cells 
(Srivastava, et al., 2001). This along with the evidence of (ANX7+/-) mice models develop many 
cancers including prostate cancer and microarray analysis of these tumours showed a reduction 
of expression of several other tumour suppressor genes, indicates that ANX7 is a potential 
prostate tumour suppressor gene. However more investigation into ANX7 gene deletions in 
human prostate cancer would give more detailed analysis into this gene.  
 
1.9.3 Chromosome 13q 
Chromosome 13 is one of the most frequently altered chromosomes in cancer including prostate 
cancer (Hyytinen, et al., 1999). Studies have shown that the most frequently deleted regions on 
chromosomes 13 are 13q14, 13q21-22, and 13q33 in prostate cancer (Hyytinen, et al., 1999; 
Brookman-Amissah, et al., 2007; Dong, et al., 2001). 
 
1.9.3.1 BRCA2 
The tumour suppressor gene BRCA2 is located at 13q12.2 and has been shown to be deleted in 
many cancers including prostate cancer (Moro, et al., 2008) and males carrying a BRCA2 
mutation have a more aggressive prostate cancer phenotype (Mitra, et al., 2008) but this gene 
has not been found to be frequently altered in primary prostatic neoplasms (Hyytinen, et al., 
1999). This suggests that this deletion of BRCA2 is a late event in prostate carcinoma 
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development and there is a strong association with hereditary loss of BRCA2 linking to loss of 
heterozygosity of BRCA2 in men who develop hereditary prostate cancer (Willems, et al., 2008). 
 
BRCA2 plays critical roles in DNA repair, transcription, and cell proliferation (Moro et al., 2008). It 
has recently been reported that loss of BRCA2 promotes cell migration and invasion through a 
reconstructed Matrigel basement membrane and BRCA2 overexpression decreases both 
migration and invasion (Moro et al., 2008). 
 
1.9.3.2 RB1 
RB1 is involved in cell cycle arrest and like many proteins involved in inactivation of cell growth, it 
is often lost or mutated in cancer (Bettendorf et al., 2008). It is considered to play an important 
role in carcinogenesis and inactivation is one of the necessary steps to malignant transformation 
(Bettendorf, et al., 2008). RB1 is located on chromosome 13q14 and loss of heterozygosity of this 
region is reported in one of three prostate cancer cases (Cooney, et al., 1996). RB1 codes for 
retinoblastoma protein (pRB) and is so named as loss of both alleles results in cancer of the eye 
(Lai, et al., 2003). The protein binds to transcription factors during G1 of the cell cycle and 
prevents the cell from entering S phase (Lai, et al., 2003). If correct cyclin dependent kinases 
have bound their respective cyclins it is phosphorylated and deactivated (Lai, et al., 2003). 
Hence, if RB1 is not expressed there would be less pRB in the cell cycle and less regulation of 
cell growth.  
 
Studies have been undertaken to research into genes in the loci that are affected to see if 
candidate tumour suppressor genes can be discovered. This will lead to a greater understanding 
into how cells turn cancerous and will eventually lead to a mechanism or drug to reverse or 
prevent it. 
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1.10 Aim 
The aim of this study is to derive a reliable, stable, representable human cell model of prostate 
tissue. As previously discussed the current human prostate models were derived by expression of 
viral oncogenes which disrupt progression in the normal cell cycle and results in un-representable 
models.  
 
Here I report successful immortalisation of human prostate cells from two different regions of the 
prostate, superficial and deep, and are denoted S and D respectively, with over-expression of two 
human genes. 
 
Transformed clones of P21s and P21d were created so that I had available for study the 
immortalised normal cells and the transformed cancer cell lines for comparison. All cell lines were 
fully characterised with growth curves, radiation survival curves, Single Nucleotide Polymorphism 
(SNP) and Spectral Karyotyping (SKY) analysis, Matrigel invasion assays and Anchorage 
Independent colony assays.  
 
The cell lines were used to investigate their responses to strawberry polyphenols and define 
whether a differential effect on cancer as compared to normal cells exists. Further, whether 
polyphenols exerted a protective effect against radiation induced damage was also investigated.  
 
Finally, the expression and association of metabolic enzymes within the cells cytosol was 
investigated to define whether the cancer cells were potentially metabolising ATP in accordance 
to the Warburg effect. 
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Chapter 2 
 
Materials and Methods 
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2.1 Prostate tissue collection and manipulation 
2.1.1 Collection of human prostate tissue 
Tissue for this study was obtained from trans-urethral resection (TUR) from patients with benign 
prostatic hyperplasia (BPH) from Ninewells hospital in Dundee, with appropriate ethical approval. 
Tissue chips from the superficial peri-urethral zones and the deep peripheral zones were 
collected in Transport Medium (RPMI 1640 (Lonza UK, BW12-115F), 10% Fetal Calf Serum (FCS 
Globepharm, UK) and Penicillin, Streptomycin, Glutamine (PSG Sigma UK, G6784, Stock: 
Penicillin 10,000 units / mL, Streptomycin 10 mg / mL Glutamine 2 mM, 10 mL / L of stock to cell 
culture)). Epithelial cells were cultured from the tissue samples.  
 
2.1.2 Processing of prostate tissue 
TUR chips were minced into 1 mm cubes and treated with collagenase Type 1 (Sigma, UK 
C0130, 4000 units / mL), 2.5 mL per gram of tissue for 14 hours on a rotary wheel. After the 14 
hour period the tissue was centrifuged at 2000 rotations per minute (rpm) for 10 minutes. The 
supernatant was discarded and tissue resuspended in 25 mL transport medium (RPMI 1640, 10% 
FCS, PSG). This was repeated twice and then the tube was left on the bench so that cells settled 
under gravity for 15 minutes. The epithelial cells settled into a pellet and the fibroblast cells 
stayed suspended in the supernatant. The supernatant containing the fibroblasts was removed. 
The pellet of epithelial cells was resuspended in 8 mL Prostate Epithelial cell and Basal Medium 
(PREBM, Lonza, UK, CC 3166) and 2 mL was pipetted into T25 cm culture flasks and placed in 
an incubator. Flasks were left for several days in the incubator (37 °C 5% CO2) until out-growths 
of single sheets of epithelial cells were seen to be growing.  
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2.2 Immortalisation of the prostate cells  
Once primary prostate epithelial cell cultures were established and had been successfully 
passaged, they were transduced with the cdk4 gene and then subsequently with the hTERT gene 
to immortalise them. The cells were immortalised by transducing with cdk4 using supernatants 
from ψ-CRIPwtcdk4LXSNneo cells followed by hTERT using supernatants from ψ-
CRIPpBABEpurohTERT cells. The prostate cells were selected in G418 (Sigma, UK G8168, 25 
µg / mL for 4 days) and puromycin (Sigma, UK P8833, 1 µg / mL for 7 days) respectively.  
 
2.2.1 Construction of amphotrophic retrovirus expressing hTERT or cdk4 
The following vectors in the retroviral cell lines were kindly supplied by Dr Chris Jones, Dept 
Pathology, School of Medicine, University of Cardiff, and constructed in the following way. Briefly, 
the plasmid that contained the hTERT or cdk4 genes were transformed into an Escherichia coli 
(E.coli) strain. The plasmid was digested with the restriction enzymes (ECoR1) and the cDNA 
was inserted into another plasmid pBABE-puro and pLXSN-neomycin respectively. These 
plasmids were grown up in E.coli and the plasmids were purified from the bacteria and inserted 
into an ecotropic producer cell line ΩE. These cells were grown up, washed and fresh medium 
was applied. This medium was collected after 12 hours incubation then filtered (0.45 µm) and 
applied to another cell line, ΨCRIP cells, an amphotropic retroviral producer cell line that has a 
deleted ENV gene so that the cell line does not shed live virus. The ΨCRIP murine defective 
retroviral packaging cell line now contained the pBABE-puro-hTERT plasmid or pLXSN-
neomycin-cdk4.  These packaging ell lines were kindly donated by Dr Chris Jones. These cells 
were grown up in DMEM (Invitrogen, UK Gibco 10938)10% FCS PSG and the supernatants 
contained the retroviral expression vector used to transduce the target cells. 
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2.2.2 Transduction of prostate cells 
2.2.2.1 ΨCRIP murine retroviral packaging cell line 
The ΨCRIP hTERT and ΨCRIP cdk4 cells were cultured below confluencey in Dulbecco's 
Modified Eagle's Medium (DMEM) 10% FCS in the humidified incubator (37 °C 5% CO2). The 
DMEM medium 10% FCS had respective antibiotic in it to ensure that ΨCRIP cdk4 and hTERT 
specific cells grew. ΨCRIP cdk4 cells were cultured in medium containing neomycin (G418) 400 
µg / mL. ΨCRIP hTERT cells were cultured in medium containing 2.5 µg / mL puromycin.  
 
2.2.2.2 Harvesting supernatants and flash freezing 
The ΨCRIP cells were washed with sterile phosphate buffered saline (PBS) and warmed 10 mL 
prostate medium was applied to the cells. The cells were incubated for 12 hours at humidified 37 
°C 5% CO2. After 12 hours the prostate medium was removed from the ΨCRIP cells and filtered 
through a 0.45 μm (Acrodisc Syringe Filters, PALL corporation UK) and used fresh or frozen. If 
supernatant was to be frozen, once it was filtered, 5 mL per 15 mL falcon tubes was aliquoted. 
The falcon tubes were placed in liquid nitrogen for 4 minutes and then removed with forceps and 
placed in -70 °C freezer. 
 
2.2.2.3 Treatment of prostate cells with ΨCRIP supernatant 
Prostate medium containing 8 μg / mL of polybrene (Sigma UK, H9268) was prepared. Stock 
polybrene was 200 mg / mL so a 1 in 100 dilution was made up resulting in a 200 μg / mL 
concentration. 80 μL of 200 μg / mL dilution added into 20 mL medium = 8 μg / mL. 5 mL prostate 
medium containing polybrene was applied to the prostate cells in T25 cm flasks and incubated on 
the cells for 1 hour. Polybrene was added to the viral supernatant (8 μg / mL final concentration 
 20 μL of 200 μg / mL dilution was added to 5 mL supernatant).  
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After 1 hour the medium containing polybrene was removed from the prostate cells and 3 mL of 
viral supernatant was applied to the cells for 4 hours. After 4 hours, 2 mL normal prostate medium 
was added to the flasks and the cells were incubated for a further 18 hours. Medium was 
changed and after a further 24 hours respective antibiotics were added.  
 
The prostate cells were firstly treated with the ΨCRIP cdk4 cells supernatant before being treated 
with antibiotic selection then treated with the ΨCRIP hTERT supernatant.  
 
2.2.2.4 Antibiotic selection 
Antibiotic selection was undertaken to ensure the prostate cells were expressing the appropriate 
genes. For the hTERT gene the plasmid contained a puromycin resistance gene as well, 
therefore cells that take up the plasmid and express the genes within it will be expressing hTERT 
and will be immune to puromycin. For the cdk4 gene the plasmid also contained a neomyocin 
resistance gene. After the 24 hour recovery period the cells were treated with the respective 
antibiotic.  
 
The prostate cells treated with the cdk4 plasmid were treated with G418 at a concentration of 25 
μg / mL for 4 days. Stock concentration was 5 mg / mL and was diluted down to 25 μg / mL. 
Briefly, 5 mg / mL was diluted to 50 μg / mL (50 μL of stock into 4.950 mL), 2.5 mL of 50 μg / mL 
into 2.5 mL medium = 25 μg / mL). 5 mL of 25 μg / mL per T25 cm flask was incubated on the 
cells for 4 days. After 4 days the cells had a fresh 5 mL medium change.  
 
The prostate cells treated with hTERT plasmid were treated with puromycin at a final 
concentration of 1 μg / mL for 7 days. Stock concentration was 1 mg / mL which was defrosted 
and diluted to 1 μg / mL in prostate medium. 10 μL of stock 1 mg / mL was added to 10 mL 
prostate medium and 5 mL per T25 cm flask was incubated on the cells for 7 days. After 7 days 
the cells had a fresh medium change.  
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Cell lines were developed from TUR chips collected from the superficial region and also from the 
deep region. Cell lines created from tissue from the superficial region were denoted with the letter 
S after the prostate number and lines created from tissue from the deep region were denoted with 
the letter D. The cell lines were numbered P# corresponding to which cell line was generated.  
 
2.3 Prostate epithelial cell culture 
2.3.1 Prostate cell lines derived 
Prostate epithelial cells from lines we derived were cultured in PREBM (+ additives) and medium 
changed every other day. When the cells became 70% confluent they were trypsinised with 
Trypsin / ethylenediaminetetraacetic acid (EDTA) (Sigma UK, T3924, 0.5 mg / 500 mL). The 
medium was removed from the cells and the flasks were washed with 2 mL trypsin. 3 mL trypsin 
was applied to the cells and flasks were incubated for 2 minutes at 37 °C. 4 mL of PREBM + 4% 
FCS was added to the flasks to inactivate the trypsin and then gently scraped. The cell 
suspension was centrifuged at 800 rpm for 5 minutes at room temperature and the supernatant 
discarded. The cells were resuspended in 2 mL PREBM and seeded at 400,000 cells / T25 cm 
flask to continue culture. 
 
2.3.2 Human prostate carcinoma cell lines 
PC-3 and LNCaP human prostate carcinoma cell lines were grown in RPMI 1640, 10% FCS, 
PSG. The cells were passaged before they reached 90% confluency by removal of the medium 
and washing them with 2 mL trypsin then further addition of 3 mL trypsin. The flasks were 
incubated for 5 minutes at 37 °C then tapped gently. 8 mLs of RPMI 1640 10% FCS PSG was 
added and the cells were pipetted into a falcon tube and counted as described below. The cells 
were resuspended in 2 mL RPMI 1640 10% FCS PSG and seeded at 200,000 cells / T25 cm 
flask to continue culture. 
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2.3.3 Freezing cell lines 
Prostate epithelial cells were frozen approximately every 20 passages. The cells were trypsinised 
and spun as discussed above. Once the cells had been centrifuged the supernatant was 
discarded and 2 mL / T25 cm flask of Cryomedium (CRYO-SFM, Promocell Germany, C-29910) 
was added and cells resuspended gently. 1 mL of cells was added to 1.5 mL cryo vials. Vials 
were placed in a plastic holder container containing a propane-1,2-diol bath, and then put into the 
-70 °C freezer for 18 hours then transferred to the liquid Nitrogen store.  
 
All other cell lines grown in 10% FCS were frozen in complete 4.5 mL medium (RPMI 1640, 10% 
FCS, PSG) and 0.5 mL dimethyl sulfoxide (DMSO, Sigma UK, D2650). Cells once they had been 
trypsinsed were centrifuged at 800 rpm for 5 minutes at room temperature and the supernatant 
was discarded. Cells were resuspended and medium and DMSO was added and 1 mL of cells 
was added to 1.5 mL cryo vials. 
 
2.3.4 Defrosting cell lines 
In preparation for defrosting cells the appropriate medium was warmed. Cells were taken out of 
the liquid nitrogen and put into a 37 °C waterbath for 2 minutes. Cells were pipetted out drop wise 
into a fresh flask and the pre-warmed medium was added drop wise. Flasks were incubated for 
24 hours then the medium was changed.  
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2.4 Characterisation of the cell lines 
2.4.1 Growth 
2.4.1.1 MTT protocol 
The prostate cells were trypsinsed as described above. The growth of the cell lines was 
measured using the MTT protocol in 96 well plates (Riches, et al., 2001). The prostate epithelial 
cells were counted on a Coulter Z1 cell and particle counter (Beckman Coulter Inc). The Coulter 
Counter was set to measure particles above a certain volume using an aperture (100 microns) 
with a threshold setting of 275 fL for prostate epithelial cells. A blank (isoton) was run first and the 
background average was deducted from the final count. 40 μL of cell suspension was added to 
20 mL isoton and placed in the Coulter. The Coulter counts 0.5 mL of this mixture and the total 
cell concentration could be calculated. Five readings were done then the values were averaged 
and then multiplied by 1000 to give the number of cells / mL in an unknown cell concentration. 
This value was multiplied by the total volume.  
 
The cells were diluted down at doses 60,000 cells / mL in 10,000 graduations down to 5000 cells 
/ mL. 100 μL of cell suspensions were added per well in 96 well plate giving dilutions of 6000 cells 
/ well to 500 cells / well. 5 wells for each dilution were plated in 3 plates and the results were read 
at day 2, day 4 and day 6 after plating. The plates were read at absorbance of 590 nm on MRX 
Dynex plate reader after cells were incubated with MTT (Sigma UK M2003) solution (3,(4,5-
Dimethylthiazol-2-yl)-2,5– diphentyltetrazolium bromide)  for 4 hours in the absence of light. After 
4 hours the MTT solution was flicked out and 200 μL of DMSO and 50 μL of Sorensen‟s Buffer 
(0.1 M Glycine (Sigma UK, G7126), 0.1 M NaCl (BDH UK, 102415K), pH 10.5) were added and 
the plates were read at 590 nm. The optimum dose and day were recorded. Viable cells 
metabolised the yellow MTT into to a blue formazan product. 
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2.4.1.2 Dojindo assay (Cell counting Kit – 8, Dojindo technologies USA, CK04-11) 
10 μL of Dojindo assay tetrazolium salt, WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt), was added to each well, including blanks. 
WST-8 was bioreduced by cellular dehydrogenases to an orange formazan product, therefore the 
amount of formazan produced was directly proportional to the number of living cells. The plates 
are incubated for 3 hours at 37 °C 5% CO2. After 3 hour incubation the plates are read at 
absorbance 450 nm on an MRX Dynex plate reader. All plates were stained with 10% Giemsa 
and water (GURR UK ,350865T) after the assay to confirm cell numbers by eye. 
 
2.4.1.3 Anchorage independent colonies in agar 
The cell lines were screened for anchorage independent growth in Bacto-agar (DIFCO USA, 
0140-01). A layer of 5% agar and medium was prepared by adding 2 mL 5% hot liquid agar to 18 
mL warmed PREBM medium and 4 mL was added to 60 mm round dishes. The top layer was 
mixed by adding 1 mL hot liquid 3% agar to 8 mL pre-warmed PREBM medium and then 1 mL of 
cells (250,000 cells / mL) was added to the medium and agar mix. The medium cells and agar 
were mixed gently and 2 mL of the mixture was added to the top layer of the cooled 5% agar and 
medium. The medium was warmed in a waterbath set to 37 °C and the agar was heated in a 
waterbath at 100 °C. When the agar had set the plates were placed in the incubator 37 °C 5% 
CO2 and left for 3 weeks. After 3 weeks 1.5 mL of iodonitrotetrazolium chloride (p-
Iodonitrotetrazolium Violet, 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride 
(INT, Sigma UK, i8377)) was added to half of the dishes and incubated for 12-18 hours. If 
colonies were present they were picked from the unstained plates and resuspended in a 12 well 
tissue culture plate in 1 mL PREBM medium (1 colony per well) and incubated for 1-2 weeks until 
epithelial cells were seen to grow outwards from the colony. These cells are subsequently 
trypsinsed and placed in 4 mL pre-warmed PREBM medium in a T25 cm
 
culture flask.  
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2.4.2 Immunocytochemistry 
Antibodies 
 
Source Dilution 
CK14 NOVOCASTRA 1:20 
CK5 NOVOCASTRA 1:100 
CK18 NOVOCASTRA 1:60-100 
Telomerase NOVOCASTRA 1:100 
p63 NOVOCASTRA 1:25-50 
P16 NOVOCASTRA 1:20-40 
PSCA ABCAM 1:75 
CD133 ABCAM 1:11 
CK6 ABCAM 1:10 
c-Myc NOVOCASTRA 1:150 
  
Table 2.1 - Antibodies used and their source and dilution used 
 
Optimal dilutions used were chosen from previous experiments results or as specified in the 
manufactures instructions. All cells lines were screened for cell markers, including stem cell 
markers. Epithelial cells were trypsinsed and resuspended in medium to a concentration of 
400,000 cells / mL. 100 μL of cells were added to cytospin buckets and cytospined (800 rpm 10 
minutes). Slides were fixed in 100% ice cold acetone for 10 minutes. The slides were air dried 
and 100 μL of protein block (DAKO. UK, X0909) was added to the slides and left for 10 minutes. 
Antibodies were diluted according to instructions (DAKO, UK). Slides were flicked dry and 100 μL 
of antibody was added and slides were left for 1 hour, negative control was 100 μL of antibody 
dilutent in humidified chamber. Slides were washed in PBS buffer for 5 minutes and this was 
repeated twice, with fresh buffer in each dish. Secondary antibody DAB biotinylated link solution 
(DAKO UK, E0453) was added after washing and left for 10 minutes in a humidified chamber. 
The slides were washed three times, 5 minutes each, in PBS buffer. 100 μL of Streptavidin-HRP 
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(DAKO, UK K0690) was added to the slides for 10 minutes and then washed three times, 5 
minutes each, in PBS buffer. DAB chromogen (DAKO, UK K4065) was diluted to a volume 
needed (1 mL of substrate buffer and 100 μL of DAB chromogen), and 100 μL was added per 
slide and incubated in the dark for 10 minutes. The slides were then rinsed in milli Q (MQ) water 
and counterstained with Heamotoxylin (VECTOR UK, H3404) for 30 seconds. Slides are rinsed in 
tap water for 3 minutes and then left to dry. Dry slides were mounted with 100 μL of DePeX 
(GURR, UK 36125) and a cover slip and left for 24 hours to set. 
 
2.4.3 SKY analysis 
SKY analysis was kindly carried out by Dr. Horst Zitzelsberger and Dr. Ludwig Hieber at Institute 
of Molecular Radiation Biology, Cytogenetics group, GSF National Research Centre for 
Environment and Health, GmbH, Neuherberg Germany. Briefly, preparations of metaphase 
chromosome spreads were set up and slides were pre-treated with trypsin or pepsin to digest 
surrounding proteins and cytoplasm. SKY probes consist of a cocktail of chromosome painting 
probes. SKY probes were denatured and hybridised to the denatured chromosomes, and in the 
process of Watson-Crick base pairing, complementary sequences of the probes hybridised with 
the complementary sequences on the metaphase chromosomes.  Slides were then washed and 
the results visualised with an epifluorescence microscope, SKY filter cube, DAPI filter cube, and 
Sagnac interferometer (Padilla-Nash, et al., 2006).  
 
2.4.4 SNP data 
SNP data was kindly carried out in the laboratory of Prof RIchard Iggo, Biological and Medical 
Sciences Building, St Andrews. The results were visualised using CNAG software. GeneChip 
microarrays consist of small DNA fragments chemically synthesized at specific locations on a 
coated quartz surface of the Chip array. By extracting and labelling nucleic acids from 
experimental samples and hybridizing those prepared samples to the array, the amount of label 
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can be monitored at each probe, and thus detection of increased expression or deletion of 
specific areas can be recorded. Briefly, genomic DNA was extracted from cells and digested with 
restriction enzymes and labelled following the manufacturer‟s standard protocol (Affymetrix). Data 
was visualised with CNAG version 2.  
 
2.4.5 Invasion assay  
Inserts (Becton Dickinson UK, Biocoat
TM
 Matrigel
TM
 Invasion Chamber 24 well plate 8.0 micron, 
354480) were removed from the freezer and rehydrated with pre-warmed PREBM medium for 2 
hours in the incubator 37 °C 5% CO2. After the 2 hour period this medium was removed and 
discarded. Control inserts were also hydrated and moved to companion plates with sterile forceps 
 
Epithelial cells were trypsinised and resuspended in PREBM 4% FCS and centrifuged at 800 rpm 
for 5 minutes at room temperature. The supernatant was discarded and the cells were 
resuspended in PREBM without the added nutrients. Cell suspensions were prepared in culture 
medium 5 x 10
4
 cells / mL. PREBM medium containing the additives was used as a 
chemoattractant. 1 mL of the chemoattractant medium was pipetted to the bottom wells of the 
companion plate. Sterile forceps were used to transfer the chambers and control inserts to the 
wells containing the chemoattractant ensuring no air bubbles. Immediately 0.5 mL of cells was 
added to chambers and the plates were incubated for 22 hours in a humidified incubator. After 22 
hours the non-invading cells were removed by inserting a cotton swab into the chamber and 
scrubbing the filter surface gently. A second cotton swab wetted with medium was applied to the 
chamber subsequently. The control and invasion chambers were fixed in 100% methanol (VWR, 
UK, 20847-307) for 10 minutes and then stained in 10% Giemsa for 20 minutes. The chambers 
were washed in water and left to dry. The cells that had migrated through the control insert and 
invasion insert were counted using an inverted microscope under the 40X and 200X objective. 
The chambers were set up in doublet for test and control plates. Data was expressed as the 
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percent invasion through the Matrigel Matrix and membrane relative to the migration through the 
control membrane. Percent invasion was calculated as follows: 
 
% invasion = Mean # of cells invading through Matrigel insert membrane     X 100 
Mean # of cells migrating through control insert membrane 
 
 
2.4.6 Cytosolic protein extraction 
Fractionation of tissue / cells was carried out as previously reported (Jovanovich, et al., 2007). 
Briefly, homogenisation of tissue or cell extracts was achieved by using mechanical lysis into 1 
mL of ice-cold buffer (10 mM tris (hydroxymethyl) aminomethane (Tris BDH UK, 10315), 20 mM 
NaH2PO4 (BDH UK, 10249), 1 mM EDTA (Sigma UK, ED045), pH 7.8 containing a fresh protease 
inhibitor cocktail). Osmolarity was restored by adding 1 / 20 volume of 2.4 M KCl (Sigma UK, 
P5405), 1 / 40 volume of 1.2 M NaCl and 1 / 5 volume of 1.25 M sucrose (Sigma UK, S7903). 
Cell extracts were sonicated 3 x 10 second bursts using appropriate precautions of ear 
protection. Mixtures were centrifuged for 5 minutes at 500 g (3500 rpm) to extract nuclei. The 
supernatant was then spun at 30000 g (13500 rpm) for 30 minutes. The resultant pellets contain 
membrane proteins and the supernatants contain cytosolic extracted proteins. Samples were kept 
at -20 °C in labeled bags.  
 
2.4.7 Immunoprecipitation 
Prior to precipitation, dimethyl pimelimidate (DMP) linking was performed as previously described 
(Jovanovich, et al., 2007). 500 μL of standard assay buffer (50 mM NaF (BDH UK, BDH0209), 50 
mM HCl (BDH UK, BDH3028), 150 mM NaCL, 1 mM NaPPi (VWR UK, EM-SX0741-1), 1 mM 
EDTA, 1 mM ethylene glycol tetraacetic acid (EGTA VWR UK, VW8690-2), pH 6.8 at room 
temperature, pH using Tris) was added to fresh eppendorfs, 2 μL of specified antibody (NDPK-A, 
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NDPK-B, c-Myc) was added and then 300 μL (0.35 μg / μL) of sample supernatants containing 
cytosolic extracted proteins. NDPK antibodies were kindly donated by Dr Russel Crawford, Bute 
Medical School. Samples were set up for each of the P21 prostate cell lines available. All 
eppendorfs were placed in a 50 mL falcon tube and put on a shake-incubated on a rotator mixer 
for 60 minutes at room temperature. The samples were pelleted in a desktop centrifuge. The 
supernatant was aspirated using a glass Pasteur pipette and discarded. 0.5 mL of standard assay 
buffer plus 1 M NaCl was added to all eppindorphs and spun 13500 rpm 60 seconds. The 
supernatant was aspirated again and the samples were washed in 0.5 mL of standard assay 
buffer plus 1 M NaCl and spun again. The wash step was repeated two more times but with 
standard buffer (no added salt). Precipitation pellets were re-suspended in 20 μL of standard 
buffer. Samples were run on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) as described below. 
 
2.4.8 Bradford assay (Bradford, 1976) 
First a standard curve was prepared in order to determine unknown protein concentrations. A 
stock solution of 10 μg / mL bovine serum albumin (BSA Sigma UK, A8412) was used to prepare 
known solutions, Table 2.2. Dilutions from the stock were made 1 / 10 (2 μL stock and 18 μL 
sterile water) and 1 / 100 (2 μL 1 / 10 and 18 μL of water). 
 
Stock 1 / 100   1 / 10   Stock 
Conc (μg 
/ mL) 
0.1 0.3 0.5 1 2 5 10 
Add of 
conc (μL) 
1 3 5 1 2 5 1 
Water 
(μL) 
9 7 5 9 8 5 9 
 
Table 2.2 - Bradford dilution solutions for standard curve 
 
1 mL Bradford solution (Sigma UK, B6916) was added to each vial and mixed by inversion. The 
blank sample was 10 μL sterile water and 1 mL Bradford solution. Prepared standard 
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concentration samples were read at absorbance 595 nm and a standard curve was drawn. For 
unknown samples, 10 μL was added to 1 mL Bradford and the absorbance recorded and the 
values were extrapolated on the standard curve to give approximate protein concentration of 
samples.  
 
2.4.9 Western blot and two dimensional (2 D) gel analysis  
Precast and prepared gels were used. A prepared gel needed two different gels (resolving and 
stacking) to be made and is known as the Laemmli method (Laemmli, 1970) 
 
2.4.9.1 Laemmli method  
Firstly, the glass plates were assembled with black rubber spacers and clamped into setting rig. 
Glass plates were swabbed with ethanol before use. Sterile water was applied to check for a tight 
seal. The resolving gel was made first. The following was mixed in the subsequent order:- 
 7.9 mL sterile water 
 5 mL Tris (1.5 M pH 8.8) 
 200 μL sodium dodecyl sulfate (SDS) (10%) (Sigma UK, L4390) 
 6.7 mL Acrylamide (30%) (Sigma UK, A9099) 
 200 μL of ammonium persulfate (APS) (10%) (Sigma UK, A3678) 
 8 μL N,N,N′,N′-Tetramethylethylenediamine (TEMED) (Gibco UK, 540-5524UB) 
The tube was inverted quickly to mix and ~6 mL was added to the setting rig between the glass 
plates and let to set. Sterile water was added on top to seal it. The gel was left to set for 40 
minutes. Once set the water was poured off and the Stacking gel cocktail was prepared. 
Ingredients were added in the following order:- 
 4.1 mL sterile water 
 750 μL Tris (0.5 M pH 6.8) 
 60 μL SDS (10%) 
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 1 mL Acrylamide (17%) 
 60 μL APS (10%) 
 60 μL TEMED 
The ingredients were mixed by inversion then applied to the stacking gel to the top of the 
resolving gel and the comb was put in. Once the gel set, the comb was taken out and the running 
buffer was prepared.  
 
10X Running buffer recipe is as follows:- 
 30 g Tris 
 144 g Glycine 
 10 g SDS 
 pH 8.56 
The buffer was made up to 1 L with sterile water and put to one side. When needed 100 mL of 
10X stock was taken and 900 mL of sterile water was added and stirred. The gels set in the glass 
plates were removed from the setting rig and placed in the running rig. 1X running buffer was 
poured into the rig sufficient to cover the plates.  
 
2.4.9.2 Sample preparation 
Samples to be run were mixed with 5 μL loading dye and put on the heat block at 70 °C for 10 
minutes. The protein concentrations were determined by the Bradford method (See above).  
2.4.9.3 SDS PAGE of prepared gels 
4 μL of ladder was applied to the first well and samples were added to the other wells. The gel 
was run at 100 V until the dye front was running to the bottom of the gel. While the gel ran, 
blotting buffer was prepared. The 1X Transfer buffer recipe is as follows:- 
 3 g Tris 
 14.4 g Glycine  
 Made up to 100 mL with sterile water and stirred until all dissolved 
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 50 mL methanol was added and made up to 1 L with sterile water 
 pH 8.48 
 
While the gel was running, transfer paper (nitrocellulose), sponges, and filter paper was pre 
soaked in transfer buffer. Once the gel had finished running the gels were removed from the 
running rig carefully. The transfer cassette was prepared next as follows:- 
 Black Cassette 
 Sponge 
 Filter paper 
 Gel 
 Nitrocellulose 
 Filter paper 
 Sponge 
 White cassette 
The transfer rig was clipped together and put in transfer box. Transfer buffer was poured into the 
rig and box and connected to the power pack. Transfer occurred at 100 V for 1.5 hours.  
 
2.4.9.4 SDS PAGE for Precast gels  
The precast gel protocol is very different from the prepared gel protocol, including the kits coming 
with prepared 10X running and 25X transfer buffers. Novex TRIS – GLYCINE precast gels 
(Invitrogen UK, 1 mm 10 well EC6035BOX) were used with 4-12% gradient separation. The 
precast gel was removed from the plastic packet and washed with sterile water and the comb 
removed and lanes washed. It was then clipped into the rig and the running buffer was prepared 
(50 mL of 10X stock tris glycine buffer + 450 mL sterile water). The wells were loaded with 4 μL 
ladder and 20 μL sample and a well map was prepared. The gel was run at 150 V for 1.5 hours. 
While the gel ran, tris-glycine transfer buffer was prepared, (380 mL sterile water, 100 mL 
methanol, 20 mL 25X transfer buffer stock), and nitrocellulose, filter paper, and sponges were 
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pre-soaked in the buffer. Once the dye front had reached the bottom of the gel, the power was 
switched off and clipped off. The gel was unclipped from rig and cracked open with the gel knife. 
The gel was carefully extracted from the plastic casing and made into a transfer sandwich, as 
follows:- 
 3 sponges were placed in the transfer box 
 Filter paper was placed on gel and bubbles were rolled out  
 The gel was inverted so that the filter paper lay on the hand 
 Back plastic cover removed from gel with gel knife  
 Gel placed filter paper down and nitrocellulose placed on top 
 Next piece of filter paper was applied and bubbles ironed out 
 The transfer “sandwich” is placed on top of 3 sponges in transfer box 
 2 more sponges placed on top and transfer box clipped shut and placed in 
transfer rig 
 Transfer buffer was applied until it fills transfer box and surrounding rig 
 The power pack is clipped on top and ran at 25 V for 1 hour 
 
 
2.4.9.5 SDS PAGE for Precast gels for 2 D gel separation 
2 D gels were run as isoforms of LDH have the same molecular weight and the commercial 
antibody cannot differentiate between them. The two isoforms have different isoelectric points so 
can be separated by isoelectric focus first, then by molecular weight to fully characterise the 
isoform associated.  
 
The precast Novex Isoelectric focus gel (IEF) (Invitrogen UK, 1 mm thick, 10 wells EC6655A), pH 
range 3 – 10, was washed with sterile water after removing the packaging and clipped into the 
running rig. Anode and cathode buffers were made up according to manufactures instructions. 
Anode buffer was made up using 600 mL sterile water and 12 mL anode buffer stock. The 
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cathode buffer was prepared by 180 mL sterile water and 20 mL cathode stock buffer. The anode 
buffer was poured on the outside reservoir and the cathode buffer was poured into the inside 
reservoir. 4 μL of IEF ladder was applied to the first well and 20 μL of samples were applied to 
consequent wells. The gel was run at 140 V for 1.5 hours. Once complete, the gel was cracked 
out of the plastic assembly with a gel knife and placed in a tub with 10% trichloroacetic acid (TCA 
Sigma UK, T6399) for 30 minutes to fix the samples. During this time the molecular weight 
precast Novex Tris glycine 10% (wide lane) gel (Invitrogen UK, 1 mm thick 2D well EC6076) was 
removed from the plastic covering and washed with sterile water and the comb removed. Once 
the IEF gel had set, the lanes were exercised one at a time using a blade. Each exercised lane 
was placed on top of a wide well tris glycine gel and pushed down with aid of a finger and filter 
paper so that there were no bubbles. Running buffer was prepared (10 mL 10X stock and 490 mL 
sterile water) and once the gel had been clipped into running rig, was poured over the gel. The 
gel was run at 140 V for 1 hour. Transfer occurred as previously described. Briefly, buffer was 
prepared and the sponge, filter paper and nitrocellulose membrane were pre soaked in 380 ml 
water, 20 mL 10X buffer, 100 mL methanol. Once the gel was run, it was cut from the plastic 
casing using the gel knife and made into a transfer sandwich and put into the transfer box as 
described above. The gel was run at 25 V for 1 hour as previously described.  
 
2.4.9.6 Western blot analysis 
Nitrocellulose membrane was incubated in 1X TBS TWEEN. 10X stock of TBS was made:- 
 24.22 g Tris 
 116.8 g NaCl 
 Make up to 950 mL 
 pH with conc. HCL to 7.5 room temp 
 
0.5% TWEEN (Sigma UK, P5927) detergent was added to 1X stock as needed (0.5 mL to 500 
mL 1X TBS). 1X solution TBS TWEEN was prepared with 50 mL 10X stock and 450 mL sterile 
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water. The membrane is washed in 1X TBS-TWEEN to rid any non-specific proteins off the 
membrane for 5 minutes.  
 
Membranes were then blocked for 30 minutes in 1% BSA or 3% milk powder (40 mL milk powder 
dissolved in 1X TBS TWEEN) and was applied to the membrane for 30 minutes on the rocker at 
room temperature.  
 
Membranes were then subjected to 1X TBS TWEEN for 4 x 15 minute washes on the rocker at 
room temperature. 40 mL of primary antibody was added at 1 / 1000 dilution for 1.5 hours, 
agitated incubation followed by another 4 x 15 minute washes. The secondary species specific 
antibody was diluted 1:5000 in 1X TBS TWEEN and applied for 45 minutes followed by 4 x 15 
minute washes. Enhanced Chemiluminescent (ECL) reagent (GE Healthcare Ltd UK, RPN2109) 
was used for visualisation, and applied as described in manufactures instructions. The membrane 
was placed face down on cling film and was taped into the cassette membrane face side up and 
taken to the dark room for developing.  
 
2.4.9.7 Developing the film 
Under red light, 1 piece of Kodak film (Kodak UK, KODQ5-100284) was placed on top of the 
membrane and the cassette was closed and the film was exposed to the membrane for 4 minutes 
precisely. After 4 minutes, under red light, the film was removed from the cassette and placed in 
developer, for 5 minutes with agitated movement.  After 5 minutes the film was removed from the 
developer with forceps and put in methanol to fix for 5 minutes with agitated movement. Next the 
film was washed in water and then hung to drip dry. The film images, if successful, were scanned 
into the computer.  
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2.4.10 Survival assay 
Survival assays were done by two methods, MTT protocol measuring 3-7 days growth after 
radiation, and colony assay plating cells in 90 mm dishes, measuring growth after 3 weeks. This 
looked at the short and long term effect on growth of the cells after exposing them to various 
doses of radiation.  
 
2.4.11 Colony assay 
Cells were trypsinised and single cell suspensions prepared and counted as previously 
described. 1 mL of cells was added to 90 mm plates in the middle and 9 mL medium was pipetted 
around the cells. The plates were then swirled to distribute the cells and all plates were incubated 
for 2-3 weeks at 37 °C 5% CO2. After the incubation period plates had the medium aspirated and 
were fixed in 100% methanol for 10 minutes. Next plates were stained with 10% Giemsa (10 mL 
Giemsa, 90 mL water). The Giemsa stain was left on the cells for 20 minutes then rinsed in water 
and left to dry. The number of colonies was counted by aid of a light box. 
 
2.5 Irradiation of cell lines  
Cells were irradiated with a gamma source (IBL 437C) containing a source of Caesium 137, with 
a dose rate of 1 Gy / 16.5 seconds. Tubes were placed inside the metal canister, in a plastic 
device to hold the tubes so that they were placed directly in the beam of ionising particles. The lid 
was applied and the canister was placed inside the machine and the door shut. Cell lines were 
irradiated in 2 Gy doses and were irradiated when about 50% confluent and then the medium was 
changed. Cells were never passaged and radiated on the same day. When flasks became 
confluent they were passaged and allowed 48 hours to recover before next radiation treatment. 
 
2.6 Lymphocyte donation, separation, and culturing 
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Anonymous donors generously gave 10 mL of blood with full ethical approval. 10 mLs of 
Histopaque (Sigma UK, 1077 room temp) was pipetted into 50 mL falcon tube and the 10 mL of 
blood was layered on top of the Histopaque so that neither mixed together but formed 2 separate 
layers. The tubes were centrifuged at 2000 rpm for 20 minutes with the brake off so as not to 
disturb the layers. The lymphocytes (and platelets) formed a layer on top of the Histopaque and 
between the plasma. The lymphocytes were aspirated off gently with a sterile fine tipped Pasteur 
pipette and put into a separate falcon tube and centrifuged at 1500 rpm for 5 minutes. The 
lymphocytes formed a pellet and the supernatant containing platelets was discarded. Medium 
(RPMI 1640) was added to the cells and a single suspension was prepared and counted. A stock 
of 1 x 10
6
 cells / mL (= 1 x 10
5
 cells / 100 μL) was prepared and 100 μL was added to wells in 96 
well plate. Phytohemagglutinin (PHA Biostat UK, 08E2701) was added to the wells to promote 
proliferation. Stock of 90 μL was added to 2.910 mL medium and 100 μL was added to wells (final 
conc. = 3 μL / mL). 
 
2.7 Strawberry extract preparation 
Freeze dried total, anthocyanin, and elligatannin polyphenol extract from strawberries was kindly 
prepared for us by Scottish Crop Research Institute, Dundee (Ross, et al., 2007 for full method).. 
Briefly, strawberries were homogenised and filtered so that all vitamin C, organic acids, and free 
sugars were removed and only the polyphenol content remained. Total polyphenol extract was 
further separated to give anthocyanin and elligatannin extracts (Ross, et al., 2007). All polyphenol 
extracts were freeze dried and transported over on dry ice. The extracts were checked for purity 
in Dundee and filtered for sterility in St Andrews University. When vials were needed they were 
taken from the -70 °C freezer and rehydrated by addition of 500 μL / vial of sterile PBS. Extract 
was filtered through 0.22 μm filter to produce sterile extract. Phenol concentration was measured 
using a modified Folin-Ciocalteu method (Singleton, et al., 1965). 10 μL of sterile filtrate was 
added to 240 μL sterile water in a sterile 1 mL cuvette and mixed. 250 μL of sterile 50% Folin-
Ciocalteu reagent (Sigma UK, F9252) was pipetted into the cuvette and the solution was left to 
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stand for 3 mins. 500 μL of filtered saturated sodium carbonate (VWR UK, VW8928-1) was 
pipetted into the cuvette and the samples were left to stand for 1 hour. The samples were read on 
a spectrometer at absorbance 750 nm. The values were entered into the following calculation to 
obtain phenol concentrations μg / mL:  
 
Phenol concentrations μg / ml = spec reading / 0.03072 / 0.01 / 4 
 
(Where y=mx + c standard curve m = 0.03072 and c = 0) 
 
Six samples were done for each filtrate and the phenol concentrations were averaged.  
A range of phenol concentrations were diluted down from 550 μg / mL – 1 μg / mL. 
 
Polyphenols were added to prostate and lymphocyte cells 24 hours after the cells were plated in 
96 well plates. 10 μL of doses 550 μg / mL – 16.5 μg / mL was added to wells. Blanks of medium 
and strawberry extract were added for each dose. Extract was applied to cells 24 hours after 
plating and plates were read after 3 days incubation. 10 μL Dojindo kit was added to every well 
including blanks and plates were incubated in the absence of light for 3 hours. Plates were read 
at absorbance 450 nm and readings for medium and extract were subtracted from the cell values. 
Cell growth without extract was taken as 100% and cell survival rates were calculated 
respectively.  
 
2.8 Micronuclei assay 
2.8.1 Slide preparation 
Prostate cells were trypsinised and a single cell suspension was prepared and 2 mL / flat bottom 
tube was added on day 0. Two tubes were set up so one was 0 Gy control and one was 3.5 Gy 
test. Tubes were radiated at 0 Gy and 3.5 Gy on day 1 by aid of the Gamma Source, Bute 
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Medical School, St Andrews University. After radiation, medium on the cells was changed to 2 mL 
normal prostate medium. Tubes were incubated until day 2 when cytochalasin B (Sigma UK, 
C6762) was added to stop cells at the end of mitosis from dividing. 100 μL of stock (2 mg / mL) 
was added to 900 μL of medium and 20 μL was added to the tubes containing 2 mL (final conc. = 
2 μg / mL), and tubes were incubated for 48 hours. Day 4 tubes were trypsinised and centrifuged. 
Cells were resuspended in 1 mL and 500 μL of cell suspension was added to cytospin buckets / 
slides. Slides were centrifuged in cytospin machine 800 rpm 10 minutes. Slides were allowed to 
dry and then fixed in 100% methanol for 10 minutes. Slides were then stained with 10% Giemsa 
(10 mL Giemsa, 90 mL Water) for 20 minutes then rinsed in water and allowed to dry. Cover slips 
were mounted onto the slides when dry using DePeX fixing agent and allowed to set.  
 
2.8.2 Counting procedure 
Slides were visualised under 10X and 40X objective. Cells that had two separately stained nuclei 
within one cell were counted as binucleate cells. Cells with two separate nuclei in one cell but 
including a separate small collection of nuclear material were counted as binucleate cells with 
micronuclei. The number of binucleate cells within a population gave an indication of how healthy 
the cells were by recording the number of cell divisions. The number of binucleate cells with 
micronuclei served as an index of chromosome breaks and mitotic spindle apparatus dysfunction. 
The number of binucleate cells per 1000 cells and the number of micronuclei cells per 1000 cells 
were counted in triplicate.  
 
2.8.3 Statistics 
To determine if there was a significant diference between results statistic anaylsis was 
undertaken. The paired student T Test was used as the results were related as they were the 
same population of cells before and after treatment with either radiation or strawberry extract. 
Results were entered into Microsoft Office Excel and the equation command used was “T 
Jennifer Weaver 
  69 
TEST(cell range for 1
st
 set of results , cell range for 2
nd
 set of results, tails type, test type) 
dependent on the values being anaylised. P values were quoted in the text along with the 
relevant significance. 
2.9 Metaphase spreading 
Cells were incubated in the presence of colcemid. 75 µL of stock (10 µg / mL) was added to 5 mL 
medium and incubated on the cells for 4 hours. Cells were trypsinsed and spun down to pellet 
cells (800 rpm, 5 minutes, 20 °C). The medium was removed from the cells and 5 mL of 75 mM 
KCl (Sigma UK, P5405) was added to the tubes and incubated at room temperature for 10 
minutes to lyse the cells. The fixative was prepared with a 3:1 ratio of methanol to acetic acid. 
After the 10 minutes incubation, the cells were centrifuged (800 rpm, 20 °C) for 5 minutes and the 
supernatant removed. 3 mL of fixative was pipetted into the tube while it was on the vortex. Once 
the fixative was added the tubes were given a final vortex. The cells were incubated overnight at -
4 °C. The slides were prepared by soaking them in 100% ethanol for 1 hour then wiped dry. Cells 
were centrifuged (800 rpm, 20 °C) for 5 minutes and the supernatant was discarded. 3 mL of 
fixative was added on the vortex and the tubes were incubated at 20 °C for 10 minutes. This was 
repeated and the cells were resuspended in fixative (200 µL per 5 x 10
5 
cells). 10 µL was pipetted 
onto the prepared slides and left to air dry. Once dry, the slides were stained with 10% Giemsa, 
washed and left to dry. The chromosomes of the cells that had been blocked in metaphase were 
counted. This was repeated several times so an accurate average could be calculated.  
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2.10 Supplier Addresses 
 
BDH: Supplied by VWR. 
 
Beckman Coulter: Beckman Coulter Ltd, Buckinhamshire, UK. 
 
Becton Dickinson: BD Bioscience, Oxfordshire, UK. 
 
Bio-stat: Biostat Laboratories, Inverness, UK 
 
DAKO: Cambridge House, Ely Cambridgeshire, UK. 
 
DIFCO: supplied by Becton Dickinson. 
 
Dojindo: Molecular Technologies, Rockville, USA. 
 
GE Healthcare Ltd: Amersham Place, Buckinghamshire, UK.  
 
Gibco: Supplied by Invitrogen. 
 
Globepharm: Esher, Surry, UK. 
 
GURR: Supplied by VWR. 
 
Invitrogen: Invitrogen, Paisley, UK.  
 
Kodak: Kodak UK Ltd, Hemel Hempstead, UK. 
 
Lonza: Slough, UK. 
 
PALL corporation: Europa House, Portsmouth, Hampshire, UK. 
 
Promocell: GmbH Sickingenstr, Heidelberg, Germany. 
 
Sigma: Sigma Aldrich, Dorset, UK. 
 
Jennifer Weaver 
  71 
Vector Laboratories: Vector Laboratories Ltd, Peterborough, UK. 
 
VWR: VWR International, Leicestershire, UK. 
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Chapter 3 
 
Establishment of Immortalised Cell Lines 
from the Prostate for in vitro 
Transformation Studies 
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3.1 Introduction 
As previously discussed, there are no good reliable in vitro cell models of normal human prostate 
and tumourigenic cell models which share the same parent donor. Here I report successful 
immortalisation to create cell lines and transform them with radiation. The first cell line model 
derived from the same patient and from different regions of the prostate.  
 
3.2 AIM: - to take human prostate cells and immortalise them by transducing them with two 
non-viral genes cdk4, and hTERT. These genes are normally expressed in human cells in relation 
to cell cycle regulation and maintenance of telomere length in specific cell types.  
 
3.3 Establishment of cell lines 
3.3.1 Procedure 
Transurethral resected (TUR) chips were collected from Ninewells Hospital and treated with 
collagenase and the epithelial cells were separated out and plated so that primary epithelial cell 
cultures were established, (See Chapter 2). Once healthy cells formed a sub-confluent layer they 
were transduced with the first gene, cdk4. This was done by applying a retroviral supernatant 
containing the plasmid which contained the cdk4 gene and an antibiotic resistance gene on to the 
cells. The cells were treated with an antibiotic to select out the cells that had successfully taken 
up and were expressing the genes in the plasmid. The cells were allowed to recover and then 
were transduced with the second gene, hTERT, and then subsequently treated with a different 
antibiotic to select out the cells that expressed the second gene, (See Chapter 2). 
 
This was performed for a number of TUR samples from 7 different patients.  
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3.3.2 Results 
3.3.2.1 Establishment of prostate P21s and P21d cell lines 
Patient P21 cells from the superficial and deep region were the only cells to be successfully 
immortalised with cdk4 and hTERT, Table 3.1. This was seen as both cells lines P21s and P21d 
were able to continue growing after the respective selection pressures were applied. The other 
cell lines were difficult to immortalise as the cells often died following G418 treatment after 
exposure to the cdk4 construct, Table 3.1.  It was also difficult to establish good monolayer 
cultures to be able to treat with the constructs before they senescesed at passage 5. Flash frozen 
viral supernatants seemed to be less effective than fresh viral supernatants.  
 
P21 Successfully immortalised with cdk4 and hTERT. 
P22 S – Got to P3 then stopped growing and discontinued. 
D – Got to P2 then stopped growing and discontinued. 
P23 D – Survived cdk4 and G418. Treated with hTERT and puromycin. Poor growth and 
discontinued at P3. 
S – Survived cdk4 and G418 but grew very slowly. 
P24 D – Successfully immortalised with cdk4 and survived selection. Treated with 
hTERT and puromycin but then stopped growing and discontinued at P3. 
P25 D –Treated with cdk4 and G418. Treated with hTERT and puromycin but did not 
grow well afterwards and discontinued at P4. 
S – Treated with cdk4 and G418 but did not grow well afterwards. Got  to P4. 
P26 Died after selection of G418 after cdk4 treatment at P3.  
P27 No S or D. Just epithelial cells. Treated with cdk4 and G148 and stopped growing. 
 
Table 3.1 - Patient prostate samples and immortalisation results 
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3.4 Properties of cell lines P21s and P21d 
3.4.1 Procedure 
The cells were grown and then stocks were frozen down at roughly every 20 passages. The 
properties of the cell lines were initially characterised. Growth curves were defined by plating out 
at cell doses from 500 to 6000 cells per well (5 wells per dose, 96 well plate) and plates were set 
up so that one could be read at two day intervals. Blanks were set up of just medium at the same 
time as plating the cells. Results were read by addition of MTT (3, (4, 5-Dimethylthiazol-2-yl)-2, 
5– diphentyltetrazolium bromide) solution and the plates incubated in the absence of light. DMSO 
and Sorensen‟s Buffer were added and then read at 590 nm in enzyme-linked immunosorbent 
assay plate reader (ELISA). 
 
Similarly, anchorage independent colony formation was assessed. A single cell suspension of 
250,000 cells / mL was prepared. A 5% base layer of 5% agar and medium was poured and left 
to set. A top layer consisting of a mixture of cells, 3% agar and medium was poured on top of the 
5% layer and left to set, See Chapter 2. The final dose of cells was 50,000 cells per dish. The 
plates were left to incubate for 3 weeks and then checked for colonies.  
 
Morphology was also characterised. Cells were maintained in monolayer culture at below 90% 
confluency. Photomicrographs were taken with a Nikon Coolpix camera through an inverted 
microscope to visualise the cells morphology. 
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3.4.2 Results 
3.4.2.1 Anchorage independent colony formation 
P21s 0Gy cells never produced anchorage independent colonies at any passage number up to 
80 passages studied. P21d 0Gy started producing colonies after passage 9 but only few in 
number. After passage 20 the number of colonies rapidly increased, typically 20-30 colonies were 
produced per 10
3
 cells plated, Figure 3.1a and 3.1b. This experiment was repeated with three 
different repeats by defrosting the immortalised P21d passage 5 cells which were grown up to 
passage 40 and the same colony formation pattern was seen. In addition primary P21d cells were 
grown up and re immortalised with the two genes, and the same anchorage independent growth 
trend was observed. Every repeat experiment consisted of four plates and the average was 
calculated from them. One of these colonies was picked and a cloned cell line was grown up and 
characterised, defined as P21d 0Gy (clone-a). The cells grew slowly with an average of four days 
between passage number. 
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Figure 3.1a - Number of anchorage independent colonies at different passage number for the 
P21d and P21s cell lines 
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Figure 3.1b. – Photomicrographs of P21d (passage 40) anchorage independent colonies in agar 
 
Photomicrographs were taken of the colonies produced in agar from the cells from the P21d cell 
line. Colonies have been stained with Iodonitrotetrazolium chloride (p-Iodonitrotetrazolium Violet, 
2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT).  
 
 
P21d late passage A. I. 
colonies 
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3.4.2.2 Morphology 
P21s differed in morphology from the P21d and P21d 0Gy clone cells. The P21s cells were 
rounded and cobblestone in appearance and grew in single or clumped together colonies. P21d 
cells were flatter and exhibited larger nuclei than P21s and grew in flat clustered colonies. P21d 
clone cells differed again from its parent P21d line. The cells were smaller than P21d and more 
rounder in appearance than P21d. These cells were smaller than P21s and grew in clustered 
colonies, Figure 3.2. 
 
 
 
 
P21s 
 
 
P21d early passage 
 
 
P21d 0Gy (clone-a) 
 
 
P21d late passage 
 
Figure 3.2 - Photomicrographs of the established cell P21 lines from s and d 
100 µm 
50 µm 50 µm 
50 µm 
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3.4.2.3 Growth rates 
Here it can be seen that the P21s cell line grows at a slower rate than the P21d or P21d 0Gy 
clone line, Figure 3.3. The P21s cell line grows at a slow rate after 3 days of seeding but after day 
4 grows faster with an absorbance 0.2 at day 4, an absorbance of 0.4 at day 5, and an 
absorbance of 0.8 at day 6. P21d grows at a faster rate initially up to day 3 than P21s, but then 
the growth rate slows down a little and peaks at an absorbance of 0.6 after 5 days growth and the 
growth rate slows and decreases. P21d 0Gy (clone-a) has an over all faster growth rate than 
P21s or P21d but initially grew at a slower rate than P21d in the first 2 days of growth. P21d 0Gy 
(clone-a) cells had an absorbance of 0.18 after 2 days growth and rapidly increased to 0.8 in two 
days. After day 4 the P21d and P21d 0Gy (clone-a) cells did not grow any more and decreased in 
number, Figure 3.3. 
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Figure 3.3 - Growth curves of cells from the P21s, P21d and P21d 0Gy (clone-a) cell lines 
measured using the MTT assay 
 
Cells were plated at varying doses and the absorbance read after 2, 4, and 6 days incubation. A 
cell dose of 3000 cells was chosen for this graph and the absorbance for each cell line at the 
specific day after incubation was taken and plotted.  
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3.5 Derivation of P21d plastic-attached clones 
3.5.1 Procedure 
P21d cells from passage 5 were defrosted, grown up and plated out at 625, 1250, 2500, 5000 
cells per 90 mm Petri dish. The dishes were incubated for 10 days at 37 °C 5% CO2 with medium 
changed every 3 days. Attached colonies grown from single cells were selected, cloning rings 
placed over them and the colony was trypsined and the cells were transferred into flasks. Seven 
clones were thus generated. They were defined as P21d (plastic) clone a – g. 
 
Cloned lines were characterised by anchorage independent growth, growth curves, 
immunocytochemistry, invasion through a Matrigel porous membrane, and number of 
chromosomes per cell in metaphase.  
 
Cloned lines were set up in 3% agar medium mixture and plated on a 5% agar medium layer. 
Various cell doses were set from 50,000 cells to 65,000 cells / plate. The plates were incubated 
for 3 weeks and the anchorage independent colony number was counted and equated to 100,000 
cells.  
 
Growth curves were set up for all cloned lines at doses of 500-5000 cells / well in 96 well plates. 
Plates were incubated and read at day 2, 4, 6 days after plating on ELISA at 450 nm. Results 
were acquisitioned by addition of 10 µL of Dojindo reagent. 
 
Cells were plated in invasion chambers at doses 2.5 x 10
4
 cells. They were incubated for 23 
hours then stained and the number of cells that passed through the Matrigel membrane and 
control were counted.  
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To count the number of chromosomes per metaphase cell metaphase spreads were prepared. 
The chromosomes of the cells blocked in metaphase were counted. This was repeated for 
several cells so that an accurate average could be calculated. 
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3.5.2 Results 
3.5.2.1 Summary of cloned cell lines characteristics 
Cloned lines from P21d early passage cell line, derived from low plating on plastic, all showed 
anchorage independent growth. All cloned lines exhibited negative staining for c-Myc and positive 
for cytokeratin 18 and cytokeratin 5. All of cloned lines exhibited invasion through a Matrigel 
porous membrane.  The average number of chromosomes of cells in metaphase showed that all 
cell lines had an increase in copy number of chromosomes per cell, Table 3.2. 
 
P21d cloned cell 
lines 
No. A I 
colonies / 
100,000 cells 
plated 
ICC c-Myc CK18 and 
CK5 
% Invasion No. 
chromosomes / 
cell (metaphase 
spread) 
A 1.5 ± 0.5 Negative Positive 3.8 70 
B 20 ± 0.5 Negative Positive 2.7 70 
C 11 ± 0.5 Negative Positive 1.3 75 
D 27 ± 0.5 Negative Positive 3.5 74 
E 20 ± 0.5 Negative Positive 4.5 64 
F 8 ± 0.5 Negative Positive 3.7 72 
G 7 ± 0.5 Negative Positive 1.1 62 
 
Table 3.2 - P21d plastic cloned cell lines characterisation by anchorage independent colony 
formation, immunocytochemistry for cytokeratin 18 and 5, invasion results and number of 
chromosomes per cell in metaphase 
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3.5.2.2 Photomicrographs of P21d plastic cloned cell lines metaphase spreads 
P21d clone b cell line had an average of 70 chromosomes per cell and P21d clone c had an 
average of 75 chromosomes per cell in metaphase, Figure 3.4. 
 
 
 
 
 
 
 
Clone b 
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Figure 3.4 - Photomicrographs of P21d cloned cell lines metaphase spreads (oil 1000X) 
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3.5.2.3 Growth rates 
Cloned line d grew the fastest of all cloned lines after four days growth, Figure 3.5. Cloned line f 
was the slowest growing cell line. Cloned lines d, e, c and b grew out with the media and space 
conditions after 6 days growth, whereas cloned lines a, f, and g all were still dividing after 6 days 
growth, Figure 3.5.  
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Figure 3.5 - Growth curve of cells from P21d plastic cloned cell lines measured using the Dojindo 
assay 
 
A cell dose of 3000 cells was chosen for this graph and the absorbance for each cell line at the 
specific day after incubation was taken and plotted.  
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3.6 Transformation studies 
3.6.1 Procedure 
To transform the cell lines into tumourigenic cells, they were irradiated with 2 Gy fractions over 
weeks to accumulate a dose of 40 Gy. After doses of 10 Gy, 20 Gy, 30 Gy, and 40 Gy cells were 
screened for anchorage independent growth in agar. Only P21s was treated with radiation to 
transform as P21d already produced colonies in agar. The cells produced colonies in agar after 
radiation treatment and the colonies were picked and grown up so that a cloned cell line could be 
created. This cell line was characterised with growth curves. Single cell suspensions were 
prepared and cells were plated in 96 well plates. Cells were grown at doses from 500 – 6000 cells 
/ well. At 2 day intervals plates were read by addition of 10 µL of Dojindo Kit at an absorbance of 
450 nm.  
 
Before the cells were exposed to irradiation treatment they were characterised for their sensitivity 
to the radiation. This was done by a survival assay using both the MTT and colony assays. For 
the survival assay single cell suspensions were prepared at optimal doses for a 4 day assay (data 
derived from the growth assays). Cell suspensions were irradiated at 0 Gy, 2 Gy, 8 Gy, 10 Gy, 
and 12 Gy. At the higher doses of radiation due to the resulting cell loss (10 Gy and 12 Gy) the 
cell dose plated was increased. Once cells had been irradiated 100 µL of cell suspension was 
plated into 5 wells for each dose. The plates were incubated and read after 4 days at 590 nm 
following MTT addition. In calculating percentage cell survival the 0 Gy growth was taken as 
100%. If the cell dose was increased for the higher radiation doses then the absorbance values 
were normalised to the same cell dose as the 0 Gy control reading. 
 
Colony assays for plastic attached colonies were also set up. Cell suspensions of 150 cells / mL 
were exposed to 0 Gy, 2.5 Gy, 5 Gy, 8 Gy gamma irradiation. 1 mL of cells were plated in 90 mm 
dishes and 9 mL medium was added. Plates were incubated for 2-3 weeks, fixed, stained and 
counted. 
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3.6.2 Results 
3.6.2.1 4 day radiation survival assay 
The P21s cell line was the most sensitive to the radiation and showed a significant decrease in 
cell survival with increase dose of radiation, Figure 3.6. 4 Gy caused a 50% reduction in cell 
survival and increasing the dose of radiation resulted in a decreased cell survival. But increasing 
the dose from 8 Gy to 12 Gy only resulted in 10% reduction in cell survival, Figure 3.6. 
 
2 Gy dose of radiation caused P21d to grow better than the control of no radiation (0 Gy) with a 
resulting 120% cell survival, Figure 3.6. 4 Gy dose also caused the cells to grow better than the 0 
Gy control but not as well as 2 Gy resulting in only 110% cell survival. The cell survival did not 
decrease by much and a 12 Gy dose only reduced the cell growth by 10% giving a 90% cell 
survival, Figure 3.6.  
 
P21d 0Gy (clone-a) was more resistant to radiation than P21s but 2 Gy and 4 Gy irradiation dose 
did not affect the cells at all with the cell survival at 100%, Figure 3.6. Higher doses of 8 Gy to 12 
Gy did have an effect on the cell survival but only caused the cell survival rate to drop to 80%, 
Figure 3.6. 
 
 
 
 
 
 
 
 
 
 
Jennifer Weaver 
  88 
 
 
 
 
 
 
0 5 10 15
10
100
1000
P21s
P21d
P21d 0Gy clone a
Radiation Dose (Gy)
%
 C
e
ll
 S
u
rv
iv
a
l
 
Figure 3.6 - Survival curves of cells from P21s, P21d, and P21d 0Gy (clone-a) cell lines 
measured after different doses of gamma radiation exposure using the MTT assay 
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3.6.2.2 7 day radiation survival assay 
The P21d cell line showed a greater reduction in cell survival if the cells were incubated for longer 
after the radiation treatment with 10 Gy causing a 90% reduction in cell survival, Figure 3.7. The 
Do value for the P21d cell line was Do (3.6 ± 0.5) Gy. 
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Figure 3.7 - Survival curves of cells from P21d cell line measured after different doses of gamma 
radiation exposure using the MTT assay 
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3.6.2.3 Colony radiation survival assay 
From 0 – 2 Gy there is a shoulder as the percent cell survival is still high then there is a sharp 
drop in cell survival with increased dose of radiation, Figure 3.8. P21s was the most affected cell 
line compared to P21d and P21d 0Gy clone with 3 Gy causing 50% reduction in cell survival. The 
Do value for the P21s cell line was Do (1.25 ± 0.5) Gy. The maximum dose (8 Gy) caused a 
marked decrease in cell survival with 4% survival. P21d cell line was more resistant to the 
radiation than P21s, with 5 Gy causing 50% reduction in cell survival. The Do value for the P21d 
cell line was Do (3.0 ± 0.5) Gy. The maximum dose resulted in 21% cell survival. P21d clone line 
was initially more resistant to the effects of radiation with 2.5 Gy only causing 92% cell survival. 
The Do value for the P21d 0 Gy cell line was Do (1.4 ± 0.5) Gy.  However, 4.5 Gy gave 50% 
reduction in cell survival which was similar to P21d. 8 Gy caused a 6% reduction in cell survival 
which was greater than P21d, Figure 3.8. 
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Figure 3.8 - Survival curves of cells from P21s, P21d, and P21d 0Gy (clone-a) cell lines 
measured after different doses of gamma radiation exposure using the colony assay 
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3.6.2.4 Anchorage independent colony assay 
P21s cells were exposed to 2 Gy fractions and after the cells had been exposed to 10 Gy, 20 Gy, 
30 Gy and 40 Gy the cells were screened for anchorage independent growth. 50,000 cells were 
plated in agar and plates were incubated for 3 weeks. After the cells had accumulated 40 Gy 
exposure they produced colonies in agar. (4.0 ± 0.5) colonies per 10
5
 cells plated were seen. One 
of these colonies was picked and a cloned cell line was established – P21s 40Gy (clone-a). This 
cell line produced an average of 138 colonies / plate in agar for 60,000 cells / plate i.e. (1150 ± 
0.5) colonies per 10
5
 cells, Table 3.3 
 
 
Dose (Gy) No. of A.I. Colonies formed in agar/  
50,000 cells plated 
0 0 
10 0 
20 0 
30 0 
40 8-10 
 
Table 3.3 - Number of anchorage independent colony formation after increasing radiation 
treatment in 2Gy fractions for the P21s cell line 
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3.6.2.5 Growth rate assay 
The greater the dose of cells originally plated the faster the growth rate and the higher the final 
absorbance value, Figure 3.9. 500 and 1000 cells doses originally plated both growth curves 
started off slowly and only after day 4 did they grow in a linear fashion, Figure 3.9. 2000 cells 
originally plated growth curve grew faster than the 500 and 1000 cells and after day 2 grew in a 
linear fashion till day 6. If the plated cell number exceeded 2000 then after day 4 of growth the 
cell growth rate slowed down and did not increase but exhibited a plateau, Figure 3.9.  
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Figure 3.9 - Growth curves of cells from the P21s 40Gy (clone-a) cell line at different cell doses 
plated using the Dojindo assay 
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3.7 Discussion 
3.7.1 Immortalisation of the cell lines 
Cells successfully grew out of the TUR chips from patient P21 from both regions after 
collagenase treatment in monolayer culture and the primary cultures were established. The cells 
from the superficial layer and deep layer were transduced with the cdk4 genes and hTERT genes 
and grew in the presence of the selective antibiotic pressure. Cells from patient 21 were the only 
cells to be successfully immortalised with cdk4 and hTERT, Table 3.1. The procedure was difficult 
because it was hard to get good monolayer cultures established preferably at passage 2 as this 
gave enough time to transduce the cells with cdk4 and hTERT before the cells senesced at 
passage 5. As the cells were being grown outside physiological parameters they senesced and 
stopped growing at passage 5. The cells when grown out with physiological conditions become 
stressed due to the increased oxygen concentration in the atmosphere. If cells become stressed 
the p16 gene is switched on and the p16 protein binds to cdk4 and prevents cyclin D1 binding to 
it in the cells cell cycle (Zhang, et al., 2006). If cdk4 cannot bind to cyclin D1, the cell cannot 
normally proceed into S phase and senesces. If the cells are transduced and express the cdk4 
gene this causes more cdk4 protein to be produced by the cell.  This results in it binding to the 
cyclin D1 even though the p16 gene is switched on as there is more cdk4 substrate than p16 
protein. This temporally immortalises the cells and they can proliferate until the telomeric length 
reaches a critical point (Shay, et al., 2001).  
 
The cells were then transduced with the hTERT gene and the cells successfully expressed the 
gene and grew for extended periods compared to the control non-transduced cells. The hTERT 
gene encodes the critical subunit of the telomerase enzyme. As the cells expressed the hTERT 
gene they produced the active subunit of the telomerase enzyme and the telomeres of the cells 
regenerated and never reached a critical short length which triggered senescence (Shay, et al., 
2001). This effectively immortalises the cells completely. 
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This method of immortalisation has been only been performed with bronchial cells so far and 
scientists reported successful immortalisation of the cells to provide cell lines that did not form 
tumours in mice or colonies in agar and exhibited normal epithelial morphology (Ramirez, et al., 
2004). The order of immortalisation with cdk4 or hTERT was not important with the bronchial cells 
but it was important with the prostate cells as they had to have been transduced with cdk4 before 
hTERT to survive. This could be because the prostate cells were becoming stressed due to the 
oxygen levels of in vitro culture and thus preventing the cells from growing. If the prostate cells 
were transduced with hTERT the cells would still senesce due to the oxidative stresses. Possibly 
the bronchial epithelial cells since originating from lining the airway tubes were not so sensitive to 
the oxygen levels of in vitro culture and so could survive longer in culture.  
 
Prostate epithelial cells have been immortalised in culture with over expression of hTERT alone 
(Kogan, et al., 2006; Shao, et al., 2008). The Kogan group took tissue from patients undergoing a 
radical prostatectomy as they had progressive tumours but the tissue used for the experiments 
was classified as normal (Kogan, et al., 2006). Only one of the four cell lines created could be 
propagated in culture for ~200 population doublings and their results showed that the cell line had 
been immortalised by another vector other than the hTERT, concluding that the cell line was not 
only hTERT immortalised.  These cell lines were positive for cytokeratins 8 and 18 which are 
highly expressed in prostate cancer cell lines (DU145, PC3, and LNCaP) but not benign prostate 
epithelial cell lines (Sherwood, et al., 1990). Sherwood et al., (1990) reported differential 
cytokeratin expression of CK18 and CK8 in prostate carcinoma compared to no expression of 
these cytokeratins in cultured benign prostate hyperplasia (BPH) tissue. Expression levels of 
cytokeratins 8/18 in patients with prostate cancer and BPH have been investigated (Wolff, et al., 
1998). They have reported that there is no statistically relevant correlation and the levels cannot 
be used to determine between the two diseases. Another study that found cytokeratin 8 and 18 
fragments could be used as a new tumour marker as they reported differential expression 
between healthy individuals and prostate cancer patients (Silen, et al., 1994).  
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CK18 is a substrate for lethal caspase activation pathway and hence is a marker for cell 
apoptosis and in turn high cell turnover (Sherwood, et al., 1990). Shao et al., (2008) described 
prostate cell lines which were transduced with hTERT. The cell lines grew longer than the 
controls but it was discovered that hTERT over expression alone was not sufficient to immortalise 
and transform the cells. They reported that down regulation of the p16
INK4a 
checkpoint was also 
nessceary to immortalise the cells (Shao, et al., 2008). The prostate cell line exhibited non 
transformed characteristics including a near diploid complement but expressed 9p and 17p 
translocations, were anchorage dependent and did not form tumours in immunosuppressed 
animals (Shao, et al., 2008). This shows that hTERT over expression alone is not sufficient to 
immortalise prostate cells and gives support that with over expression of cdk4, which suppresses 
the p16
INK4a 
stress response, is sufficient to immortalise prostate cells. 
 
Both P21s and P21d cell lines grew well and have been passaged for more than 100 passages 
now. P21d grew faster than P21s as can be seen in Figure 3.3. The control prostate epithelial 
cells that were not transduced with cdk4 and hTERT, senesced after reaching passage 5. The 
parent P21s cell line was tested for anchorage independent growth as it has been reported to be 
a method of screening for transformation and P21s never produced anchorage independent 
colonies in agar, Figure 3.1a (Lichtenberg, et al., 1995). Anchorage independent colony formation 
is used to assess malignant transformation (To-Ho, et al., 2008; Wang, et al., 2008) but it should 
be noted that some cell lines that show anchorage independent growth do not form tumours in 
immunosuppressed mice (Kuettel, et al., 1996). 
 
3.7.2 Morphology 
The P21s and P21d and P21d cloned line all differ in morphology, Figure 3.2. This shows that the 
cell lines are different from each other.  
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3.7.3 Anchorage independent colony formation of P21d cell line 
The cell line immortalised from the cells from the TUR chips from the deep region of the prostate 
produced anchorage independent colonies in agar without radiation manipulation after passage 9, 
(Figure 3.1a, Figure 3.1b). This was observed while undertaking the control experiments when 
irradiating P21d and growing the irradiated cells in agar to see if they had transformed. Frozen 
vials of P21d from passage 5 were grown up and the P21d cell line always produced anchorage 
independent colonies with increasing passage number after passage 9. As the early P21d was 
re-grown a few times and each time anchorage independent colonies were seen with increasing 
passage number it was deduced that the cells contained a latent cancer clone present in the 
population that had been immortalised with cdk4 and hTERT. This is more probable than 
spontaneous transformation for two reasons. One, spontaneous transformation of human cells in 
culture is an extremely rare event (Morales, et al., 2003; Herbert, et al., 2001) and the P21s cell 
line never produced anchorage independent colonies and it was immortalised with over 
expression of the same genes. Spontaneous transformation requires mutations in several genes, 
such as p16, p53, and pRb, and their cellular pathways that are involved in cellular senescence 
(Herbert, et al., 2001). 
 
Two, prostate carcinomas arise from the deep region of the prostate so it is very probable that 
there was a latent clone present, (Long, et al., 2005).  It has been estimated that 80% of males 
over the age of 80 harbour microscopic, undiagnosed, latent foci of prostate cancer (Taichman, et 
al., 2007). Most of these foci never develop into clinically detectable cancer which is consistent 
with the frequent finding of prostate cancer during autopsies of asymptomatic men in whom the 
condition was never diagnosed (Gelmenn, 2008; Stemmermann, et al., 1992). 
 
Generally, transformation of cells in culture is defined by the ability to grow in an anchorage 
independent fashion, the ability to grow in the absence of serum, the ability to grow in soft agar, 
and by the development of tumours in nude mice (Morales, et al., 2003). Many cell lines 
immortalised with hTERT do not exhibit changes typically associated with malignant 
Jennifer Weaver 
  97 
transformation including being able to grow colonies in agar. This has been shown for human 
fibroblasts (Morales, et al., 1999), human oesophageal squamous epithelia cell lines (Morales, et 
al., 2003), and human bronchial epithelial cell lines, (Ramirez, et al., 2004).  
 
Although immortality is a fundamental characteristic of most human cancers, the immortal 
phenotype alone is not sufficient to transform normal cells into their fully malignant counterparts 
(Morales, et al., 2003). As previously discussed, spontaneous transformation is a very rare 
occurrence as seen with hTERT immortalised fibroblasts that grew to over 300 population 
doublings and failed to transform (Morales, et al., 1999).  
 
One of the anchorage independent colonies from P21d cell line was isolated and grown up and 
labelled P21d 0Gy (clone-a) as it was transformed but had not been irradiated. The transformed 
cells were most likely to be prostate epithelial cells and not another cell line infecting the culture 
as the cells grew in the presence of the two combined antibiotics, G418 and Puromycin. No other 
cell lines with this pattern of antibiotic resistance were being maintained in the lab at this time. 
 
3.7.4 Plastic attached derived P21d clones 
The cell line P21s never produced anchorage independent colonies whereas, the P21d cell line 
consistently produced increasing numbers of anchorage independent colonies after passage 9 
with increasing passage number, Figure 3.1a. This tends to suggest that the P21d is a mixed 
culture of abnormal and normal cells and not exhibiting spontaneous transformation but the 
abnormal cells were proliferating faster than the normal cells and becoming the predominant part 
of the cell line (shown by increasing anchorage independent colony formation with increase in 
passage number). Therefore, it would have been anticipated that cloned cell lines from this early 
passage would have exhibited normal characteristics including no anchorage independent colony 
formation.  
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As seen in Figure 3.1a and b, P21d cell line produced anchorage independent colonies. This is a 
characteristic of potential transformed lines as anchorage independent growth is one of the most 
rigorous tests of cellular transformation in vitro and provides the best correlate to tumourigenic 
growth potential (Hamad, et al., 2002). The P21d cell line also exhibited abnormal morphology 
and a faster growth rate, Figure 3.2, 3.3. P21d cell line started showing anchorage independent 
growth at passage 9 and onwards, this suggests that the P21d cell line consisted of a mixture of 
normal and abnormal cells and that the abnormal cell population grew faster and took over the 
culture as the cell line was grown, Figure 3.1a. Therefore, if the early passage P21d cell line was 
plated on plastic dishes and the resulting colonies that grew up could be trypsined and grown up 
as new cloned cell lines. Assuming that P21d cell line is a mixed culture of normal and abnormal 
cells then some of the new cloned cell lines may be normal. This was done and seven cell lines 
were derived and propagated in culture. These cell lines were fully characterised for growth rate, 
screened for anchorage independent growth, c-Myc and cytokeratin expression, chromosome 
number, and percentage invasion across a Matrigel porous membrane, Table 3.2, Figure 3.4 and 
3.5.  
 
The P21d cloned lines from early passage P21d show abnormal characteristics such as 
anchorage independent growth, abnormal number of chromosomes per cell and invasion, Table 
3.2, Figures 3.4 and 3.5. Therefore, they cannot be classed as normal cell lines derived from 
patient P21 prostate deep region but cloned tumour cell lines, Table 3.2. This suggests that all 
seven cell lines are abnormal (Hamad, et al., 2002; Ko, et al., 2003; Gu, et al., 2006). Invasion 
across an in vitro Matrigel porous membrane is a characteristic of cancer cell lines and has been 
used as a tool for predicating the ability of cancer cell lines to metastasise in in vivo conditions 
(Bello, et al., 1997). All of the cell lines showed invasion, Table 3.2. Metaphase spreads showed 
that the average copy number was more than diploid, Figure 3.4, Table 3.2. An abnormal large 
copy number of chromosomes is seen in prostate cancer cell lines and is associated with a 
neoplastic phenotype (Ko, et al., 2003; Gu, et al., 2004; Yasunaga, et al., 2001). 
 
Jennifer Weaver 
  99 
The cloned line g appeared to be the least abnormal of the cloned lines as it exhibited the least 
invasion, produced few anchorage independent colonies in agar and had the lowest abnormal 
number of chromosomes per cell (62 chromosomes), Table 3.2. However, it was not the slowest 
growing cell line, Figure 3.5.  
 
All seven cloned cell lines exhibited abnormal characteristics including anchorage independent 
colony formation. Therefore, it can be concluded that the P21d cell line did not compose of a 
mixture of normal and abnormal cells but is an unstable population of abnormal cells. It thus 
might be possible that the patient P21 had prostatic intraepithelial neoplasia (PIN) in the deep 
region of the prostate and that a PIN region has been immortalised early on and propagated in 
culture, as PIN lesions in human prostates are very common in men with increasing age and 
thought to be the precursor of prostate cancer (Taichman, et al., 2007; Gelmenn, 2008; 
Stemmermann, et al., 1992). 
 
Therefore, it could be concluded that the P21d cell line consists of a mixed population of cells 
from a PIN lesion that have been immortalised and as the cell line has grown up over time the 
more aggressive abnormal cells have dominated the culture shown by increasing anchorage 
independent colony formation. Many repeats all showed anchorage independent colony formation 
beginning at the same moment in culture, all at passage 9. This along with the seven cloned cell 
lines, which all showed abnormal characteristics and supports this hypothesis, shows that the 
anchorage independent colony formation is not a random event nor due to the immortalisation 
process, but a characteristic of the abnormal cells taken from patient P21.  
 
This was an attempt to extract a normal cell line from P21d cell line. At early passage P21d cell 
line was thought to be a mixed culture of more normal than abnormal tumour cells. As the cells 
were plated at low doses the colonies seen were derived from a single cell and hence the 
population of the cloned cell line would all have been homogenous. Even though these cloned 
lines are not normal, but probable latent tumour foci cells that have been immortalised and cloned 
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up to give cloned tumour lines, they can still be used as a novel tool to investigate prostate 
cancer. 
 
3.7.5 Survival characteristics after exposure to radiation of the cell lines 
3.7.5.1 Survival assay reponse with the MTT assay 
The MTT assay is a novel method of quantifying metabolically viable cells through their ability to 
reduce a soluble yellow tetrazolium salt to blue-purple formazan crystals (Price, et al., 1990). The 
crystals are dissolved and quantified by measuring the absorbance of the resultant solution with 
the absorbance being relative to the number of live cells (Price, et al., 1990). P21s cell growth 
decreased after exposure to radiation with decreasing cell survival with increased quantity of 
radiation in a one time exposure, Figure 3.6, 3.7. 4 Gy dose of radiation caused a 50% reduction 
in P21s cell survival after 4 days incubation after radiation exposure, Figure 3.6. However, if this 
dose is increased from 4 Gy to 12 Gy there is only a drop from 50% to 30% cell survival, which 
shows that the cells survival response is not linear, Figure 3.6. However, this is a four day assay 
and a longer assay may show a greater reduction in cell survival with higher doses of radiation. 
 
P21s is more sensitive to radiation than P21d and P21d 0Gy (clone-a), the transformed cell lines, 
Figure 3.6. Whereas 4 Gy gives a 50% reduction in cell survival for P21s doses higher than 12 
Gy are required to cause a 50% reduction in cell survival for the P21d and P21d (clone-a) cell 
lines, Figure 3.6. Doses of 12 Gy caused a reduction of 22% in cell survival for the P21d and 
P21d (clone-a) cell lines. For P21d a 2 Gy dose caused an increase in cell survival which is 
unusual as 2 Gy dose has no effect on cell survival for P21d 0Gy (clone-a) cell line, Figure 3.6 
This shows that the P21s normal immortalised cell line is more sensitive to radiation than its 
transformed sister cell lines. Transformed cell lines are often more resistant to radiation than the 
parent lines (Riches, et al., 2001). 
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The results from the MTT assay were very surprising as it was expected that 12 Gy of radiation 
would have had a substantial cytotoxic effect on the cells. Further investigation showed that the 
cells were still metabolising after four days incubation from the irradiation treatment as the optical 
density was almost the same as the control cells shown by the cells metabolising the MTT 
solution from yellow to blue compounds. Plates were fixed in methanol and stained with Giemsa 
(10%) instead of MTT and the cells were microscopically visible in large numbers showing that 
they were proliferating and taking longer than 4 days to undergo apoptosis. As seen in Figure 3.6 
the P21d cell line shows that the cells are proliferating since they were plated and increasing in 
number. Since cells were irradiated then plated this shows that the P21d cells were not 
undergoing apoptosis but actively proliferating in culture even after being subjected to 12 Gy. This 
result is very unexpected as other cell lines are much more sensitive in this assay. For example, if 
human lung cancer cell lines are exposed to 9 Gy then plated in MTT assay for a 3 day 
incubation it results in 2-3% cell survival (Carmichael, et al., 1987). For the prostate carcinoma 
cell line LNCaP the mean survival at the clinically relevant dose of 2 Gy was 51.2% (Leith, 1994). 
Radiation kills the cells by inducing damage in the DNA and causing lethal mutations or 
chromosomal aberrations leading to apoptosis during mitosis (Zellweger, et al., 2003). However, 
for the P21d cells there appears to be very little radiation induced apoptosis after four days, 
Figure 3.6.  
 
If we compare this to clinical situations, in locally advanced tumour stages the recommended 
treatment is radiotherapy (Hermann, et al., 2008) but although radiation is capable of 
permanently eradicating localised prostate cancer, up to 30% of patients treated with potentially 
curative doses relapse at the sites of the irradiated tumours, (Zellweger, et al., 2003). This 
indicates that there are variations in clonal sensitivity to the lethal effects of radiation within a 
given tumour (Zellweger, et al., 2003). However, this does not explain the irregular result seen for 
P21d cells when exposed to 12 Gy as all cells appear to be immune to the radiation, Figure 3.6. 
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As radiation causes the cells to apoptose by inducing DNA damage so that the cells cannot 
continue mitosis, one option could be that the cells are not dividing fast enough to see any 
detrimental effects after four days of incubation. Hence, the cells are still dividing and successfully 
proliferating as the optical density values for P21d and P21d 0Gy (clone-a) cell lines are almost 
the same as the control 0 Gy, Figure 3.6, which means that these cells even after been exposed 
to up to 12 Gy irradiation were still proliferating at the same rate as the control cells. As the cells 
in this assay were also stained up with Giemsa and shown to be there and not an artefact of the 
assay, this gives further support that the cells are not apoptosing. The same assay was set up for 
the P21d cell line but the cells were incubated for seven days after radiation treatment instead of 
four. Consequently a smaller cell number was plated to make sure the cells were still dividing for 
the seven day period. This seven day MTT assay showed a larger detrimental result on cell 
survival, Figure 3.7. There is the initial shoulder from 0 Gy to 2.5 Gy and then the percentage of 
cell survival drops (10 Gy causing 90% drop in cell survival) showing that if the cells are left for 
longer after radiation treatment then the detrimental effects are seen more clearly, Figure 3.7. 
This shows that the cells are not surviving after larger doses of radiation and are undergoing 
apoptosis and not proliferating. This shows that the four day MTT assay is not adequate for this 
cell line as the cells are exhibiting abortive growth and undergoing apoptosis after the four day 
period as seen with the seven day assay. These results show that prostate cells take longer to 
undergo apoptosis after radiation treatment and have a long abortive growth period. The seven 
day MTT assay gave more accurate results than the four day MTT assay but a longer term assay 
may be more applicable for this cell line.  
 
Normally the clonogenic assay for measuring radiation survival is the preferred method but the 
MTT assay is useful for measuring the survival in cells which do not grow as colonies (Price, et 
al., 1990). However, this assay relies on quantifying the radiation damage in the growth response 
of the cells in short time culture, and was designed at measuring tumour cells responses which 
grow at a faster rate (Price, et al., 1990). One study looked at radio sensitivity of cell lines which 
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had doubling times of 10, 20, and 85 hours and found that the clonogenic assay was more 
accurate than the MTT (Carmichael, et al., 1987).  
 
Since the P21 cell lines had a long doubling time it was decided that this assay was not 
appropriate for this cell line and a longer-term assay would give more accurate results.  
 
3.7.5.2 Survival assay response with the colony assay 
P21s and P21d 0Gy (clone-a) cell lines were the most sensitive cell lines to the radiation damage 
as seen by the Do value (Do (1.25 ± 0.5) Gy and (1.4 ± 0.5) Gy respectively). The Do value is the 
radiation dose which reduces survival by one natural logarithm from 100% to 37% (Reid, et al., 
1981). P21d cell line Do value was (3.0 ± 0.5) Gy. This shows that the P21d cell line was the 
most resistant as it took a greater radiation dose to give a 63% reduction in cell survival.  
 
P21s cells produced fewer colonies after all radiation treatments than the P21d or P21d 0Gy 
(clone-a) line, Figure 3.8. This shows that the P21s cell line is more susceptible to radiation 
damage than the P21d cell lines, which is what is seen in normal prostate cells in respect to 
transformed or prostate cancer cells (Bromfield, et al., 2003). It was documented that normal 
prostate epithelial cells were more susceptible to increasing accumulated radiation exposure (in 2 
Gy fractions) than DU145 prostate carcinoma cells when presented with a colony assay. The 
same results were found after only a 1 x 2 Gy fraction and 1 x 10 Gy fraction, which are the single 
doses given in radiotherapy (Bromfield, et al., 2003). In comparison to other cell lines these 
prostate cell lines are more resistant to radiation damage shown by higher Do values. Human 
skin squamous carcinoma cell lines have a Do value range of (1.31-2.66) Gy (Weichselbaum, et 
al., 1988). In comparison normal human immortalised epidermal keratinocytes have a Do value of 
(2.24) Gy and human fibroblast have a Do value of (1.45) Gy (Kasid, et al., 1987). This shows 
that the P21 cells lines have similar radiation resistance to other normal human epithelial cell 
lines.  
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3 Gy of radiation gave a 50% reduction in cell survival for P21s cells where as 5 Gy of radiation 
gave a 50% reduction in cell survival for P21d and P21d 0Gy (clone-a) cell lines. This assay 
shows a more reliable result in cell survival as it is a longer assay of three weeks and looks at 
colony survival (on plastic) as apposed to cell viability after four days from treatment. The effect of 
X-rays on the reproductive death of cultured normal human mammary epithelial cells was 
examined using a ten day colony assay (Yang, et al., 1983). The results showed exponential cell 
survival with increased X-ray dose exposure and an efficient clonogenic assay suitable for 
measuring radiation survival curves was developed. Now the most frequently measured cellular 
response to radiation is cell death, usually assayed by colony-forming ability (Stary, et al., 1997).  
 
3.7.6 Radiation transformation of P21s cell line 
P21s cells were exposed to 2 Gy fractions of gamma radiation and after the cells had been 
exposed to 40 Gy they produced anchorage independent colonies in agar, Table 3.3. A colony 
was picked and the cell line was propagated from it and labelled P21s 40Gy (clone-a). 
 
P21s produced no colonies whereas the P21s 40Gy radiated cell line produced anchorage 
independent colonies in agar, Table 3.3. The cloned line P21s 40Gy (clone-a) can be taken as 
the suggested transformed sister cell line. This method has been used before to transform human 
prostate cell lines (Kuettel, et al., 1996). Their cells showed anchorage independence and altered 
morphology after 2 x 2 Gy exposures (Prasad, et al., 1996). After the cells had accumulated a 30 
Gy dose of radiation they were fully transformed and exhibited anchorage independent growth in 
agar and in athymic mice (Kuettel, et al., 1996). No p53 or ras mutations were observed but 
frequent translocations on chromosomes 3 and 8 were detected and the first successful 
malignant transformation of human prostate epithelial cells was reported (Kuettel, et al., 1996). 
These prostate cells (SV40-immortalised neonatal human prostate epithelial cells 267B1) only 
took 15 x 2 Gy fractions to transform the cells where as the P21s cell line needed 20 x 2 Gy 
fractions to cause transformation (Kuettel, et al., 1996). Even then the P21s 40Gy cell line 
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produced few anchorage independent colonies after accumulating 40 Gy exposure (4.0± 0.5 
colonies per 10
5
 cells) Table 3.3. This shows that the P21s cell line was difficult to transform. This 
could be related to the fact that it was from tissue derived from the superficial region and prostate 
carcinomas only arise from the deep region (Long, et al., 2005). 
 
P21d 0Gy (clone-a) and P21s 40Gy (clone-a) both grew anchorage independent colonies in agar 
which shows that the cell lines picked from anchorage independent clones suggest that they are 
transformed.  
 
3.7.7 Growth characteristics of prostate P21 cell lines 
P21s 40Gy (clone-a) grew a lot faster in culture than its immortalised parent line P21s 0Gy, 
Figure 3.9. P21s 0Gy after day five was still growing at a steady rate whereas P21s 40Gy (clone-
a) by day five had grown already at a linear rate and reached a plateau showing that the originally 
plated 3000cells had grown out with media and space restrictions.  
 
P21d and P21d 0Gy (clone-a) possibly transformed cell lines both grew faster than P21s, Figure 
3.3. P21s after day five is still growing steady with an absorbance of 0.5 at 590nm. Whereas, 
P21d and P21d 0Gy (clone-a) are 0.6 and 0.8 absorbance at 590 nm respectively after day five 
and the cells have stopped growing and exhibit a plateau as they have exhausted the medium or 
space, Figure 3.3.  
 
P21d 0Gy (clone-a) grows faster than its P21d parent line, Figure 3.3, 3.8. The P21d 0Gy (clone-
a) by day four of growth has peaked with an absorbance of 0.8 (590 nm) and the cells cease to 
grow anymore and actually start dieing off as the absorbance decreases from 0.8 to 0.6 by day 
six, Figure 3.9. P21d by four days growth is still growing steady with an absorbance of 0.5 which 
shows it is growing slower than the cloned line and by day six has reached an absorbance of 0.6, 
Figure 3.3. 
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Transformed lines compared to the parent lines often have an increased growth rate (Riches, et 
al., 2001) and so the P21d and P21d clone would be expected to have a faster growth rate in 
relation to the non-transformed P21s. The growth rate of P21s being much lower also suggests 
that the over expression of cdk4 and hTERT has successfully immortalised it but not transformed 
it. 
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3.8 Conclusion 
All cell lines out grew the control non-immortalised cells and so can be considered to be 
successfully immortalised cell lines by over expression of cdk4 and hTERT.  
 
It can be concluded that P21d was a mixed population of cells of abnormal and latent clone 
(tumourigenic) cells. The tumour cells grew faster in number and as the P21d cell line was 
passaged these cells dominated more of the population as was seen by increasing anchorage 
independent colonies, Figure 3.1a. The P21s cell line did not ever produce anchorage 
independent colonies and was slower in growth and more susceptible to DNA damage from 
radiation than P21d or P21d 0Gy (clone-a) which points to this cell line being normal.  
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Chapter 4 
 
Characterisation of the Prostate Cell 
Lines 
 
 
 
 
 
Jennifer Weaver 
  109 
4.1 Introduction 
Once the P21 cell lines had been derived, it was important to further characterise them for 
markers, chromosome analysis and invasive properties.  
 
4.2 AIM: - To investigate the cytokeratin expression and markers of the cells, to investigate 
the invasiveness of the transformed cells, and investigate the chromosome analysis of the cell 
lines by single nucleotide polymorphism (SNP) and spectral karyotype (SKY) analysis. 
 
4.3 Procedure 
4.3.1 Immunocytochemistry assay 
Single cell suspensions were prepared of 400,000 cells / mL. To see which markers the cells 
were expressing 40,000 cells were cytospun down on to slides and fixed in acetone. Cells were 
probed for CK14, CK5, CK18, Telomerase, p63, p16, PSCA, CD133, CK6, and c-Myc expression, 
see Chapter 2.  
 
4.3.2 Invasion assay 
The invasion assay was performed with the use of a kit (BD Biocoat
TM
 Matrigel
TM
 Invasion 
Chamber 24 well plate 8.0 micron, 354480). Control plates were included in the kit and consisted 
of the same plates with identical inserts except they contained no matrigel and consisted of only a 
porous membrane. The matrigel inserts were pre-treated according to manufactures instructions 
and 5 x 10
4
 cells / mL single cell suspensions were prepared. 2.5 x 10
4
 cells were added to the 
inserts and incubated with a chemoattractant in the well beneath the insert. All non invading cells 
were removed from the insert and the inserts were stained and the cells that had invaded through 
were counted.  
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4.3.3 Spectral karyotype and single nucleotide polymorphism chip 
characterisation 
SKY analysis was kindly carried out by Dr. Horst Zitzelsberger and Dr. Ludwig Hieber at Institute 
of Molecular Radiation Biology, Cytogenetics group, GSF National Research Centre for 
Environment and Health, GmbH, Neuherberg Germany.  
SNP data was kindly carried out by Prof Iggos Lab, St Andrews University. CNAG is the computer 
programme to visualise the results. 
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4.4 Results 
4.4.1 Immunocytochemistry results 
All cell lines tested positive for CK5, CK14, telomerase, CK6 and PSCA, Table 4.1, Figure 4.1.  
All cell lines tested were negative for CD133. P21s was positive for CK5, p63, p16, CK14, 
telomerase, and PSCA. P21s was negative for c-Myc and CK18 where as P21s 40Gy (clone-a) 
was weakly positive for c-Myc and strongly positive for CK18, Table 4.1, Figure 4.1. P21d and 
P21d 0Gy clone were positive for c-Myc and negative for p63 and p16, Table 4.1, Figure 4.1. 
  P21s P21d P21d 0gy 
(clone-a) 
P21s 40Gy 
(clone-a) 
CD133 N N N - 
CK5 Y Y Y Y 
p63 Y N N Y 
p16 Y N N N 
CK14 Y Y Y Y 
Telomerase Y Y Y Y 
CK6 Y Y Y Y 
PSCA Y Y Y Y 
CK18 N Y Y Y 
c-Myc N Y Y Y 
 
Table 4.1 - ICC results for cells from P21s, P21d, P21d 0Gy (clone-a) and P21s 40Gy (clone-a) 
cell lines 
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Figure 4.1 - Photomicrographs of the ICC results from the P21d, P21s, and P21d 0Gy (clone-a) 
cells (magnification X40 except P21d 0Gy clone p16 and p63 X10) 
All immunocytochemistry results were verified independently by two people. 
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4.4.2 Invasion assay results 
P21s cells did not migrate across the Matrigel porous membrane, Figure 4.2. Cells from the P21d 
and P21d 0Gy (clone-a) cell line did migrate through the porous Matrigel membrane. A greater 
number of the P21d 0Gy (clone-a) cells migrated through the Matrigel membrane, Figure 4.2.  
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Figure 4.2 - Invasion assay results for P21s, P21d and P21d 0Gy (clone-a) 
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4.4.3 SNP chip results  
Single nucleotide polymorphism (SNP) chip assay is a good way of detecting if there is increased 
expression or deletion of specific areas of DNA.  
4.4.3.1 P21s cell line 
The data shows that there are no regions of deletions or over expressions on any of the 
chromosomes in the P21s cell line, Figure 4.3. It is normal apart from a region of LOH on part of 
chromosome 4 and the X chromosome, Figure 4.3.  
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Figure 4.3 - P21s SNP data (CNAG) 
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Copy Number Analyzer for Gene-Chip (CNAG) version 2.0 was used to analyse the SNP data. 
CNAG is a software package which allows for the detection of copy number alteration using the 
signal intensities of the probes (http://www.genome.umin.jp) (Jackson, et al., 2007). The output 
from CNAG includes a graphical view of the log2 ratios for each chromosome as well as raw 
output which contains information regarding the SNP IDs, chromosomal location, log2 ratio of the 
signal intensity and LOH scores (Jackson, et al., 2007). The blue bars under chromosome X 
represent suspected loss of heterozygosity (LOH) and the pink bars under chromosome X 
represents „true‟ LOH.  
Jennifer Weaver 
  118 
4.4.3.2 P21d cell line 
SNP data for P21d cell line showed a chromosome 22q amplicon, 10p deletion, 17p deletion. The 
X chromosome has a true LOH region, Figure 4.4. Enlarged SNP traces for chromosome 10, 11, 
17, and 22 of the P21d cell line are exhibited in Figure 4.5. Chromosome 10 shows a region of 
deletion at the beginning of the p arm, no deletion on chromosome 11, a region of LOH on 
chromosomes 17p arm, and a region of amplification on chromosome 22q arm, in the P21d cell 
line, Figure 4.5.  
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Figure 4.4 - P21d SNP data (CNAG) 
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Figure 4.5 - Individual chromosome SNP analysis for P21d cell line 
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4.4.3.3 P21d 0Gy (clone-a) cell line 
SNP data for P21d 0Gy (clone-a) cell line showed a chromosome 22q amplicon, 10p deletion, 
17p deletion, the same as P21d and also an 11p amplicon, Figure 4.6. Enlarged SNP traces for 
chromosome 10, 11, 17, and 22 of the P21d 0Gy (clone-a) cell line are exhibited in Figure 4.7. 
Chromosome 10 shows a region of deletion at the beginning of the p arm, a region of 
amplification on chromosome 11, a region of LOH on chromosomes 17p arm, and a region of 
amplification on chromosome 22q arm, in the P21d 0Gy (clone-a) cell line, Figure 4.7.  
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Figure 4.6 - P21d 0Gy (clone-a) SNP (CNAG) 
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Figure 4.7 - Individual chromosome SNP analysis for P21d 0Gy (clone-a) cell line 
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4.4.3.4 Summary of SNP chips analysis 
The SNP chip results analysed by CNAG program showed the cell lines P21d and P21d 0Gy 
(clone-a) had common regions of deletions on chromosome 10p and 17p and a common region 
of amplification on chromosome 22q. Results also showed that the P21s 0Gy (clone-a) cell line 
had an additional region of chromosome 11p that was amplified, Figure 4.8. 
 
 
P21D 0Gy (clone-a) P13 + P21D P13 
22q amplicon, 10p and 17p deletion 
 
 
 
 
 
 
P21D 0Gy (clone-a) P13 only 
11p amplicon 
 
 
Figure 4.8 - Summary of regions of deletion and amplifications in P21d and P21d 0Gy prostate 
cell lines (CNAG) results 
 
 
 
 
Jennifer Weaver 
  128 
4.4.4 SKY results 
4.4.4.1 P21s cell line 
The P21s cell line appears normal with no large translocations or rearrangements. There are 3 
copies of chromosome 20 and the cell line has an X and a Y chromosome, Figure 4.9. 
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Figure 4.9 - SKY chromosome analysis of cell line P21s  
Jennifer Weaver 
  130 
4.4.4.2 P21d cell line 
P21d cell line has many more copies of chromosomes than normal and all chromosomes are 
duplicated with chromosome 10 having 6 copies, Figure 4.10. Rearrangements include parts of 
chromosomes 8 on two of chromosome 10, part of chromosome 15 on to one of chromosome 11, 
parts of chromosome 20 on two copies of chromosome 17, and parts of chromosome 17 on two 
copies of chromosome 20. 17 and 20 have the same false colour and so the RGB analysis is 
shown below it. There are two copies of chromosomes X and the cell line has lost the Y 
chromosome, Figure 4.10. 
 
SKY analysis for P21d showed the population consisted of 4 sub clones all having abnormal SKY 
karyotypes. Only the most common clone is shown, Figure 4.10.  
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Figure 4.10 - SKY chromosome analysis of cell line P21d  
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4.4.4.3 P21d 0Gy (clone-a) cell line 
P21d 0Gy (clone-a) cell line has many more copies of each chromosome also but the karyotype 
is different to the P21d cell line, Figure 4.11. However there are some similarities with the loss of 
the Y chromosome and 2 copies of the X chromosome and 3 copies of chromosome 1 and 19. 
Rearrangements consisted of a part of chromosome 5 translocated on to chromosome 2, part of 
chromosome 8 onto 10 in two copies, parts of chromosome 5 and 15 on to different 
chromosomes of 11, part of chromosome 17 on to chromosome 12, parts of chromosomes 12 
and 20 on to chromosomes 17, and a part of chromosome 2 on to chromosome 21, Figure 4.11. 
 
The SKY analysis of the P21d 0Gy (clone-a) cell line showed the cell line to also consist of a 
mixed population containing 4 clones. The most common one is shown here, Figure 4.11.  
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Figure 4.11 - SKY chromosome analysis of cell line P21d 0Gy (clone-a) 
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4.4.4.4 P21s 40Gy (clone-a) cell line 
The P21s 40Gy (clone-a) cell line has an average chromosome number of 49 chromsomes per 
cell including an X and Y chromosome. The complememt contains an additional chromosome 5, 
9, and 20. There is a deletion region on chromosome 2p. Rearrangements consisted of a part of 
chromosome 15 and 2 translocated on to chromosome 7, a part of chromosome 7 translocated 
on to chromosome 15, and both copies of chromosome 21 having parts of chromosome 7 and 15, 
Figure 4.12.  
 
SKY analysis of the P21s 40Gy (clone-a) cell line showed the cell line to also consist of a sub 
clone population. Its‟ karyotype is 49 chromosomes per cell including an X and Y, with an 
additional 5, 8, 9, and 20 chromosomes. There is the same deletion region on chromosome 2 and 
same translocation regions on chromosome 7 and 15. This clone has in addition a trisomy 8 and 
is missing the translocation of chromosome 7 on to 21. 
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Figure 4.12 - SKY chromosome analysis of cell line P21s 40Gy (clone-a) 
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4.4.4.5 P21d plastic derived cloned cell line 
P21d plastic derived clones C and D were also sent for anaylsis. Clone C has an average number 
of 69 chromosomes and the modal chromosome number is near triploid. Clone D has an average 
number of 64 chromosomes and is also near triploid. 
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4.5 Discussion 
4.5.1 Immunocytochemistry results of P21s, P21s 40Gy (clone-a), P21d and 
P21d 0Gy (clone-a) 
In all aspects there is evidence to show that the P21s, P21s 40Gy (clone-a), P21d, P21d 0Gy 
(clone-a) cell lines are very different from each other. The growth and morphology were the first 
evidence for this, Chapter 3. The immunocytochemistry results show that the cells of the lines are 
expressing basal cell markers CK14 and CK5 so therefore can be assumed to be of basal origin 
from both regions superficial and deep, Table 4.1 (Collins, et al., 2001).  
All cell lines were positive for stem cell precursor markers cytokeratin 6 (CK6) and prostate stem 
cell antigen (PSCA). CK6 is a stem cell marker in normal human prostate tissue (Schmelz, et al., 
2005). PSCA messenger ribonucleic acid (mRNA) and protein expression has been localised to 
the basal cell epithelium in normal prostate (Reiter, et al., 1998; Watabe, et al., 2002) and the 
stem cell compartment (Collins, et al., 2001). However PSCA expression is highly up-regulated in 
prostate intraepithelial neoplasia (PIN) and prostate cancer (Watabe et al., 2002; Reiter, et al., 
1998). Therefore expression of stem cell markers cannot be used to distinguish between normal 
and cancer phenotypes. CD133 has also been identified as a human prostate stem cell marker 
(Miki, et al., 2007). Prostate stem cells have been identified to be CD133+/ α2β1
hi
/CD44+ cells, 
(Richardson, et al., 2004; Collins, et al., 2001). In benign prostate CD133 is also expressed within 
the α2β1
hi
 cell population which has been found to be expressed in less than 1% of the basal 
cells (Shepherd, et al., 2008). The prostate cell lines in the current study showed a negative result 
for CD133 expression, Table 4.1. However, the CD133 positive population accounts for 1% of the 
total cell population (Richardson, et al., 2004). Since the number of cells on the slide for 
immunocytochemistry was 20,000 – 40,000 cells, it is thus likely that the number of CD133+ cells 
would be very small and the negative result show be read with caution. 
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P21s was negative for the proto-oncogene c-Myc where as P21d and P21d 0Gy (clone-a) had 
very positive nuclear staining and P21s 40Gy (clone-a) had weakly positive staining, Figure 4.1. 
This is evidence that P21s was a normal cell line and P21s 40Gy (clone-a), P21d, P21d 0Gy 
(clone-a) were not normal and indicative of prostate cancer phenotypes as c-Myc expression is 
seen to be up-regulated in prostate cancer (Williams, et al., 2005; Yang, et al., 2005). In the 
prostate, there is compelling evidence that deregulation of c-Myc gene is involved in 
tumourigenesis and amplification was identified in 30-50% or prostate carcinoma specimens 
(Yang, et al., 2005). Up-regulation of c-Myc gene in prostate epithelia is sufficient to induce 
carcinogenesis (Williams, et al., 2005). c-Myc is seen to be overexpressed in LNCaP, DU145 and 
PC-3 prostate cancer cell lines (Nag, et al., 1989; Uslu, et al., 1997; Sinha, et al., 1995). 
 
P21s cell line was also negative for cytokeratin 18 (CK18) where as P21s 40Gy (clone-a), P21d 
and P21d 0Gy (clone-a) were very positive. CK18 is a substrate for lethal caspase activation 
pathway and hence is a marker for cell apoptosis and in turn high cell turnover. It is highly 
expressed in tumourigenic cancer cell lines such as PC3, LNCAP and DU145 (Sherwood, et al., 
1990) and a majority of prostate carcinomas (Chu, et al., 2002). This shows that P21s is a cell 
line that is slow growing with slow turn over of population which is indicative of a normal cell line. 
P21s 40Gy (clone-a), P21d and P21d 0Gy (clone-a) have a fast growth rate as shown in chapter 
3, and expressing CK18 is a suggestion that these cell lines have a small doubling time 
characteristic of tumour cells. CK18 expression was found in prostate cells lines immortalised 
with SV40 large T antigen (Daly-Burns, et al., 2007), HPV-18 (Bello, et al., 1997), and with over 
expression of telomerase (Li, et al., 2008; Miki, et al., 2007).  
 
All cell lines were positive for telomerase as is expected as over expression of the hTERT gene 
causes transcription and activation of the telomerase enzyme, which lengthens the telomeres so 
the cells can divide indefinitely. Other prostate cell lines immortalised by transduction using a 
retroviral vector expressing the human telomerase catalytic subunit hTERT exhibited high levels 
of telomerase (Yasunaga, et al., 2001).  
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p63 is a member of the p53 gene family and encodes proteins that interact with p53 proteins. It is 
expressed in healthy prostate tissue as it is required for normal development of prostate tissue 
(Signoretti, et al., 2005). Loss of expression of p63 is recorded in most invasive cancers (Urist, et 
al., 2002) and is required for cellular apoptosis in response to DNA damage (Flores, et al., 2002). 
P21s and P21s 40Gy (clone-a) were positive for p63 expression and P21d and P21d 0Gy (clone-
a) were negative, giving further support that P21d and P21d 0Gy (clone-a) were transformed and 
possibly tumourigenic lines. Li, et al., (2008) also found p63 expression in the hTERT 
immortalised prostate cell lines.  
 
The p16
INK4a
 gene is a tumour suppressor and encodes p16 protein in mammalian cells (Zhang, 
et al., 2006). p16 protein is often expressed in cells in culture and indicates a normal RB pathway 
but expression is lost in many cancers including prostate cancer (Chakravarti, et al., 2003). If 
p16
INK4a
 gene expression is lost then p16 protein is no longer produced and there is no inhibitory 
pathway to prevent the cells from going into apoptosis when they are stressed. P21s was positive 
for p16 expression as would be expected as the cells were stressed as growing out with 
physiological conditions, but as cdk4 is being over expressed there is higher levels of cdk4 to 
bind to cyclin D1 than there is p16 protein binding to cdk4 to inhibit it and cause the cell to go into 
apoptosis. P21s 40Gy (clone-a), P21d and P21d 0Gy (clone-a) were not positive for p16 
expression and therefore have lost a checkpoint to control cell division. This is further support that 
P21s 40Gy (clone-a), P21d and P21d 0Gy (clone-a) are possibly tumourigenic lines. In contrast, 
tumour derived prostate cancer cell lines described by Gu, et al., (2004), Ko, et al., (2003) were 
found to be expressing p16. 
 
4.5 2 Invasion Assay Results of P21s, P21d and P21d 0Gy (clone-a) 
Invasion assays are an easy, fast, and cheap way of measuring invasiveness properties of cell 
lines without using animal models. Figure 4.2 shows that P21s was non-invasive whereas, P21d 
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and P21d 0Gy (clone-a) were more than 50% invasive. This assay has been used to show that it 
is a good model to investigate cells invasiveness properties and selecting tumour cells 
(Terranova, et al., 1986; Albini, et al., 1987). This is very good evidence that P21d and more so 
P21d 0Gy (clone-a) would invade other tissues if injected into animals and another piece of 
evidence that they are possibly tumourigenic models. The prostatic carcinoma cell lines PC-3, 
LNCaP and DU145 all invade a Matrigel porous membrane (Nagakawa, et al., 1998; Goto, et al., 
1999; Geldof, et al., 1997) and they form tumours in immuno-compromised mice (Kaighn, et al., 
1979; Horoszewicz, et al., 1983; Platica, et al., 2001). RWEP-1 (immortalised with HPV-18) and 
RWEP-2 (immortalised with HPV-18 and transformed with v-Ki-ras) prostate cell lines showed no 
invasive and invasive properties respectively (Bello, et al., 1997). RWEP-1 cells did not produce 
tumours when injected into nude mice where as the RWEP-2 transformed cells did (Bello, et al., 
1997). These results for the RWEP-1 and RWEP-2 prostate cell lines suggest that the invasion 
assay results correlate with tumourigenicity in nude mice.  
 
4.5.3 SNP chip analysis of P21s, P21d and P21d 0Gy (clone-a) 
The SNP data shows that P21s has no regions of deletion or amplification, Figure 4.3. This is the 
first evidence that the P21s cell line has normal DNA makeup. SKY analysis will confirm this 
though. The SNP data for the P21d and P21d 0Gy (clone-a) cell lines show that they are related 
as they have the same regions of deletions and amplification on chromosome 10, 17 and 22 
respectively Figure 4.4, 4.5, 4.6 and 4.7. P21d 0Gy (clone-a) had the same genetic make up with 
an additional 11p amplicon and chromosome Xp deletion. This is further support that P21d and 
P21d 0Gy (clone-a) are related and are not normal.  
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4.5.3.1 Genes that are up-regulated in prostate cancer on chromosome 22q amplicon 
(q11.21-12.1) 
Amplifications of this region have been reported for prostate cancer (Joos, et al., 1995). This 
region 22q11.21-12.1 is a common region of DNA amplification of head and neck squamous 
carcinoma, malignant glioma, and B-cell lymphoma (Matsumura, et al., 2000). This strongly 
suggests that this region of 22q contains an oncogene. Mitogen activated protein kinase 1 (MKP1 
or MAP kinase) maps within this region and has been established to function as an important 
mediator of signal transduction by growth factor receptors (Matsumura, et al., 2000). It has also 
been reported to be activated and over expressed in various types of cancers including breast 
cancer (Matsumura, et al., 2000; Wang, et al., 2002). Recently it has been reported that activation 
of mitogen-activated protein kinase is associated with prostate cancer progression (Gioeli, et al., 
1999). High levels of activated MAP kinase were observed in high-grade and advanced-stage 
prostate tumors (Gioeli, et al., 1999). MAP kinase activation in prostate cancer is linked to cell 
proliferation (Gioeli, et al., 1999). It was also suggested that increasing levels of activated MAP 
kinase was linked to development of androgen independent growth (Gioeli, et al., 1999). P21d 
and P21d 0Gy (clone-a) cell lines both expressed a 22q amplicon, Figure 4.4, 4.5, 4.6, 4.7, 4.8 so 
this might explain their anchorage independent growth characteristics and more evidence that 
they may be tumour cell lines.  
 
4.5.3.2 Genes that are up-regulated in prostate cancer on chromosome 10p deletion (p15.3-
11.21) 
Deletions in this region of 10p have been recorded in prostate cancer suggesting there is a 
possible tumour suppressor gene located here (Trybus, et al., 1996; Komiya, et al., 1996). There 
is also evidence for the presence of a tumour suppressor gene on chromosome 10p15 in human 
prostate cancers (Fukuhara, et al., 2001). Loss of heterozygosity on 10p has been reported much 
more frequently in advanced prostate cancers than in clinically localised tumours (Ittman, 1996; 
Fukuhara, et al., 2001). This finding suggests that a putative suppressor gene on 10p15 is 
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involved in the progression of prostate cancers (Fukuhara, et al., 2001). To attack it from the 
other side, if the chromosomal fragment 10p including 10p15 is introduced into human prostate 
cancer cell lines it is seen to suppress the tumourigenicity of the cancer cell lines (Sanchez, et al., 
1996; Murakami, et al., 1996). In light of this evidence there seems to suggest the presence of 
two tumour suppressor genes on 10p at loci 10p11.2 and 10p15. P21d and P21d 0Gy (clone-a) 
had deletions in this region, Figure 4.4, 4.5, 4.6, 4.7, 4.8, and exhibit tumour characteristics 
(anchorage independent growth, positive for c-Myc and CK18 expression, and invasion across 
Matrigel porous membrane, Chapter 3 and Table 4.1, Figure 4.1, 4.2).  Therefore, deletion of this 
region on chromosome 10 which report to possibly contain tumour suppressor genes may explain 
why P21d and P21d 0Gy (clone-a) cell lines are exhibiting tumourigenic characteristics. 
 
4.5.3.3 Genes that are up-regulated in prostate cancer on chromosome 17p deletion (p13.3-
p12) 
The p53 gene is mapped to chromosome 17p13.1 and has been shown to be mutated in prostate 
(Carroll, et al., 1993), renal (Contractor, et al., 1997), colon, lung, esophagus, breast, liver, brain, 
reticuloendothelial tissues, and hemopoietic tissues (Hollstein, et al., 1991). The p53 protein is a 
cellular gatekeeper and protects the genome against genotoxic and other types of stresses 
(Griewe, et al., 2003). Numerous studies have evaluated the status of the p53 alterations in 
prostate cancer (Griewe, et al., 2003). Mutations of the p53 tumour suppressor gene are a 
frequent genetic event in prostate cancer and can be detected in up to 94% of cases (Downing, et 
al., 2001). p53 mutations have been reported to be associated with acquisition of androgen 
independence and metastasis in prostate cancer (Downing, et al., 2001). P21d and P21d 0Gy 
(clone-a) cell lines have a deletion in 17p13.3-12 and therefore have LOH for p53 expression, 
Figure 4.4, 4.5, 4.6, 4.7, 4.8. Mutations in p53 leading to a reduction in expression of the p53 
gene cause prostate cells to gain the characteristics of aggressive prostate cancer and therefore 
it can be concluded that the P21d and P21d 0Gy (clone-a) cell lines are cell models of prostate 
cancer.  
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4.5.3.4 Genes that are up-regulated in prostate cancer on chromosome 11p amplicon 
(p15.2-p11.2) 
Gain of chromosomal 11p was a frequent aberration in lung adenocarcinoma tumours of male 
smokers (Yen, et al., 2007). A gene, lactate dehydrogenase C (LDH-C), is located at 11p15.1 and 
an increase in the average transcript level of LDH-C with the gain of 11p was found amplified in 
cases of lung adenocarcinoma (Yen, et al., 2007). It has been reported that LDH-C is up-
regulated alongside increased 11p number in many other cancers including prostate (Koslowski, 
et al., 2002). LDH-C codes for an isoform of the lactate dehydrogenase family and is normally 
only expressed in germ cells (Koslowski, et al., 2002).LDH-C enzyme catalyses lactate into ATP 
in the glycolysis pathway and thus LDH-C activation in cancer may provide a metabolic rescue 
pathway in tumour cells by exploiting lactate for ATP delivery (Koslowski, et al., 2002). It was 
noted that the cell line P21d 0Gy (clone-a) had a significant 11p amlicon from the SNP data, 
Figure 4.6, 4.7, 4.8.  
 
4.5.4 SKY analysis of prostate P21 cell lines 
The SNP data confirms with the SKY chromosome analysis and shows amplifications in regions 
that can be identified and matched with the SKY data for P21s, P21d and P21d 0Gy prostate cell 
lines. 
 
4.5.4.1 P21s cell line 
P21s cell line has an almost correct copy number of chromosomes per cell and is normal except 
for 3 copies of chromosome 20 which is apparently very common in immortalised prostate cells, 
Figure 4.9 (Yasunaga, et al., 2001; Macoska, et al., 2000). 
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4.5.4.2 P21d cell line 
The P21d cell line has many chromosome aberrations including 6 copies of chromosome 10 and 
two of which have lost the p arm, Figure 4.10. This matches the SNP data which shows a 10p 
deletion, which the programme would have read as to the 6 copies there were only 4 copies of 
the p arm, Figure 4.4, 4.5, 4.8. hTERT immortalised prostate cancer cell lines also exhibit loss of 
10p arm (Yasunaga, et al., 2001). As discussed above the loss of 10p has been recorded in 
prostate carcinomas suggesting there is a possible tumour suppressor gene located here 
(Trybus, et al., 1996; Komiya, et al., 1996). 
 
The SKY analysis shows that two pieces of chromosome 8 were spliced on to the top of 
chromosome 10 where chromosome 10 had lost the p arms, Figure 4.11. The SKY analysis also 
shows that P21d cell line had four copies of chromosome 17 and two of which have lost the p arm 
which corresponds to the SNP data, Figure 4.10 and 4.4, 4.5, 4.8. Pieces of chromosome 20 
have been spliced on to the tops of chromosome 17 and correspondingly pieces of chromosome 
17 have been spliced on to chromosome 20, Figure 4.10. 17p deletions have been reported in 
hTERT immortalised prostate cancer cell lines (Yasunaga, et al., 2001; Gu, et al., 2004), HPV16 
immortalised prostate cancer cell lines (Ko, et al., 2003), and radiation transformed prostate cell 
lines (Kuettel, et al., 1996). As discussed above the p53 tumour suppressor gene is located on 
17p and is shown to be mutated in many cancers including prostate (Hollstein, et al., 1991; 
Carroll, et al., 1993). The loss of 17p in prostate cancer cell lines immortalised by either hTERT, 
HPV-16 or transduced with radiation, shows that it is a common occurrence and gives further 
support for the p53 tumour suppressor gene being deleted as being a step towards the cells 
becoming cancerous.  
 
The SNP data also showed a 22q amplicon for the P21d cell line and the SKY analysis shows 
corresponding data for the P21d and P21d 0Gy (clone-a) cell lines. There are three copies of 
chromosome 22 and all three are abnormally large if compared to the P21s cells chromosome 22, 
Figure 4.10, 4.9. There is no report of 22q amplifications in the other immortalised prostate 
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cancer cell lines (Ko, et al., 2003; Yasunaga, et al., 2001; Gu, et al., 2004; Kuettel, et al., 1996). 
However, it has been reported a common occurrence in many cancers including prostate (Joos, 
et al., 1995; Matsumura, et al., 2000) which suggests there is a possible tumour suppressor gene 
in this region but may not be vital to prostate cancer progression. 
 
4.5.4.3 P21d 0Gy (clone-a) cell line 
The SKY analysis showed that there were three copies of chromosome 10, instead of two, two of 
which had lost the p arm, Figure 4.11. This corresponds to the SNP data which showed a 10p 
arm deletion, Figure 4.6, 4.7, 4.8. 10p arm deletions are common in prostate cancer, as 
discussed above (Trybus, et al., 1996;Komiya, et al., 1996). SKY analysis of the P2d 0Gy (clone-
a) cell line also illustrated that there were 5 copies of chromosome 17 and one of which had a p 
arm deletion which corresponded to the SNP data. Pieces of chromosome 20 and 12 had spliced 
onto pieces of chromosome 17, Figure 4.11. Four copies of chromosome 11 were detected for 
P21d and P21d 0Gy (clone-a) by SKY but only one copy in the P21d 0Gy (clone-a) cell line had 
an abnormally large p arm, Figure 4.10, 4.11. This corresponds to the SNP data for the 11p 
amplicon, Figure 4.6, 4.7, 4.8. As previously discussed gain of 11p is frequent event in prostate 
cancer and hence might explain why this cell line is behaving with characteristics distinctive of 
cancer cell lines. 
 
The P21d 0Gy (clone-a) cell line had more abnormalities than the P21d cell line as detected by 
SKY analysis, Figure 4.10, 4.11 This includes abnormal numbers of chromosomes 2, 10, 12 and 
21 with spices of chromosome 5, 8, 17, and 2 respectively, Figure 4.11. 
 
P21d and P21d 0Gy (clone-a) cell lines have extensive chromosome aberrations including many 
translocations, including the loss of the Y chromosome and gain of an X chromosome, Figure 
4.10, 4.11. Loss of the Y chromosome has been seen before in prostate cancer cell lines 
immortalised with hTERT over expression (Gu, et al., 2004; Yasunaga, et al., 2001). The loss of 
the Y chromosome is often seen in prostate cancer and specific loss of two genes on the Y 
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chromosome SRY and BPY2 genes have been recorded in more aggressive prostate cancer 
(Perinchery, et al., 2000). In one study of forty-six prostate carcinoma specimens the Y 
chromosome was the most frequently lost chromosome (Konig, et al., 1996). Another study that 
added a tagged Y chromosome to the prostate carcinoma PC-3 cell line and assessed its 
tumourigenicity in vivo, found that the addition suppressed tumor formation by PC-3 in athymic 
nude mice (Vijayakumar, et al., 2005). This supports the presence of tumour suppressor genes 
important for prostate tumourigenesis on the Y chromosome.  
 
4.5.4.4 P21s 40Gy (clone-a) cell line 
The SKY anaylsis shows that there are different regions deleted, increased in number and 
rearranged than the P21d and P21d 0Gy (clone-a) abnormal cell lines, Figure 4.10-4.12. The only 
major deletion is on chromosome 2p. Loss of 2p was observed in hTERT immortalised primary 
human prostate cancer clonal cell line (Gu, et al., 2004). Loss of 2p was also observed in a 
neoplastic tumour derived human prostate cell line immortalised with E6 and E7 genes of HPV-16 
genome (Ko, et al., 2003). These cell lines were derived from the tumours and so were already 
transformed. However a radiation transformed prostate human cell line had an abnormal 
chromosome karyotype with lots of extra copies of chromosomes but did not express a loss in 2p 
regions (Kuettel, et al., 1996). 
 
There were extra copies of chromosome 5, 9 and 20 in the main karyotype of P21s 40Gy (clone-
a) cell line and an extra copy of 8 in the subclone. As previously mentioned trisomey 20 is very 
common in immortalised prostate cell lines. Extra copies of chromosomes have been reported in 
the literature for prostate tumour cell lines. For a primary tumour derived cell line chromosomes 7 
and 20 were increased in number (Ko, et al., 2003), a radiation induced transformed prostate cell 
line had multiple copies of many chromosomes (Kuettel, et al., 1996), and hTERT immortalised 
tumour cell lines had extra copies of chromosomes 16 and 20 (Yasunaga, et al., 2001). 
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The SKY anaylsis showed that the cell line had a lower chromosome number complement than 
the P21d and P21d 0Gy (clone-a) abnormal cell lines, Figure 4.10-4.12. However this cell line 
showed abnormal characteristics such as increased growth rates, loss in p16 expression, 
increase in c-Myc expression, and anchorage independent growth. This is compared to the non-
irradiated P21s cell line which exhibited slower growth, p16 expression and undetectable c-Myc 
levels and no anchorage independent colony formation. These abnormal characteristics of the 
P21s 40Gy (clone-a) cell line along with an abnormal chromosome complement suggests that 
this cell line had been transformed by exposure to ionising radiation.  
 
 
4.5.4.5 P21d plastic derived cloned line 
SKY anaylsis was incomplete for the P21d plastic derived cloned cell lines clone C and D. 
However the anaylsis did conclude that the two cell lines were abnormal with near triploid 
chromosome complements. This along with the data that they produce anchorage independent 
colonies and were invasive through a Matrigel porous membrane suggests that these cell lines 
were abnormal and cannot be used as a normal cell line for the deep region of patient P21. This 
also supports the idea that the tissue from the deep region of patient P21 conatined a PIN lesion 
and the abnormal cells once immortalised dominated the culture as seen by increased anchorage 
independent colony number with increased passages.  
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4.6 Conclusion 
This DNA analysis strongly supports the view that P21s is a normal cell model as it has a near 
diploid phenotype and shows no major amplification or deletions. P21d and P21d 0Gy (clone-a) 
cell lines can be taken as abnormal and express many characteristics of transformed 
tumourigenic cell lines, including invasion and polydiploid phenotype. The P21s 40Gy (clone-a) 
cell line demonstrates abnormal charateristics also including anchorage independent growth, c-
Myc expression and an abnormal chromosome complement. These normal and abnormal cell 
lines from the same patient are a novel and good model to study prostate cancer.  
 
4.7 Further experiments 
 Replate P21d 0Gy (clone-a) in agar and pick an anchorage independent clone and try 
again to get a cloned cell line.  
 RT-PCR up regions highlighted by SNP to confirm analysis. 
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Chapter 5 
 
The Effects of Plant-Derived Polyphenols 
on Normal and Malignant Human 
Prostate Cell Lines 
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5.1 Introduction 
Polyphenol extract from fruit is obtained by blending up the whole fruit and applying it to a C18 
solid phase extraction column, which separates out the organic acids, vitamin C and free sugars, 
(Ross, et al., 2007). The whole polyphenol extract contains a mixture of ellagitannins and 
anthocyanins and there is controversy in the literature as to which compound is acitve (Ross, et 
al., 2007; Ye, et al., 1999). Polyphenols are natural antioxidants and have been known to exhibit 
anti-bacterial, anti-viral, anti-inflammatory, anti-allergic and vasodilatory actions (Ye, et al., 1999). 
 
Polyphenol rich diets also appear to be protective against brain ageing and Alzheimer‟s (Rossi, et 
al., 2008), DNA damage from carcinogens (Srinivasan, et al., 2008) and radiation (Chaudhary, et 
al., 2006; Orsolic, et al., 2007). However, this could be a result of the antioxidant properties of the 
polyphenols modifying the damaging free radicals and preventing damage. 
 
5.2 AIM: - We will use the P21 cell lines as a model to see if strawberry polyphenol extract has 
differential effects between cancer and normal cells and to see if the polyphenol extract has a 
protective effect against DNA damage caused by a radiation insult. 
 
5.3 Procedure 
5.3.1 Cell viability assays 
The cell lines used were P21s, P21s 40Gy (clone-a), P21d, P21d 0Gy (clone-a), P21d plastic 
derived cloned cell lines. The effects of the polyphenol rich extracts were also tested on the 
prostate cell line P20 and its‟ irradiated cloned cell line P20 30Gy (clone-a), which were derived 
from prostate tissue and immortalised with E7 and hTERT overexpression. LNCaP and PC-3 
established prostate carcinoma cell lines were also studied. 
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Prostate cells were trypsinised and 2000 cells / well were plated at day 0 at in 96 well plates. 
Total strawberry polyphenol, anthocyanin and ellagitannin rich fraction extracts were rehydrated 
in 500 μL PBS / vial and filtered. Varying concentrations of whole extract were applied to the wells 
on day 1 varying from 50 μg / mL to 1.5 μg / mL. For each test and control concentration 5 wells 
were set up. Control wells of extract and media were also set up for each dilution. Plates were 
incubated for 3 days at 37 °C 5% CO2 and read on day 3. To obtain the results 10 μL of Dojindo 
reagent was added to all wells and incubated in the dark for 3 hours then read at absorbance 450 
nm. Data was entered into a spread sheet and cells growing without extract were used as 100% 
survival. Each experiment was set up in duplicate or triplicate (3 x 96 well plates / cell line / day) 
and was repeated on 3 or 4 different occasions. Each concentration tested was set up for 5 wells 
/ plate. The results for each value are an average of 3-11 replicate plates from the sum of each 
experiment carried out on 3- 4 different days ± standard error. 
 
For the P21d plastic derived cloned cell lines, each experiment for whole extract was set up in 
triplicate (3 x 96 well plates / cell line / day). Each concentration tested was set up for 5 wells / 
plate. The results for each value are an average of 15 replicate values from the sum of each 
experiment ± standard error. 
 
The separate extracts on LNCaP cell line experiment were set up in doublet and each 
concentration tested was set up for 5 wells / plate. The results for each value are an average of 5 
– 10 replicate plates from the sum of each experiment carried out ± standard error. 
 
Blood was taken from human subjects (with full ethical approval) and the lymphocytes were 
separated out from the sample. The cells were washed and the cell number was measured. 1 
x10
5
 cells / well at day 0 were plated out in 96 well plates and phytohemagglutinin (PHA) was 
added, see Chapter 2. The cells were incubated for 24 hours at 37 °C 5% CO2. On day 1 
polyphenol whole, anthocyanin and ellagitannin rich fractions were rehydrated in 500 μL PBS / 
vial and filtered. The polyphenol concentrations were calculated and 10 μL of each dilution 
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applied to 5 wells of the cells for each concentration. Control wells of extract and media were also 
set up for each dilution. The plates were incubated at 37 °C 5% CO2 for 3 days then read by 
addition of 10 μL of Dojindo reagent and incubated in absence of light for 3 hours. Plates were 
read at absorbance 450 nm. Each experiment was set up in duplicate (2 x 96 well plates / cell line 
/ day) and was repeated on 3 different occasions on five different individuals‟ blood cells. Each 
concentration tested was set up for 5 wells / plate. The results for each value are an average of 
15 replicate values from the sum of each experiment carried out on 3 different days ± standard 
error. 
 
Cells were plated in 25 cm
3
 culture flasks in PREBM medium and cultured so that they never 
became 100% confluent. Whole crude strawberry extract was incubated on the cells for 3 days at 
concentrations of 25 μg / mL, 5 μg / mL and control 0 μg / mL. The cells were washed with 2 mL 
PBS and fixed with 100% methanol for 10 minutes. The cells were stained with 10% Giemsa for 
20 minutes and washed with water and left to dry. Photomicrographs were taken on Nikon coolpix 
camera using an inverted microscope.  
 
5.3.2 Micronuclei studies 
Prostate cells were cultured below confluency, trypsinised and counted. A concentration of 2 x 
10
4
 cells / mL was prepared and 2 mL were plated in flat bottomed tubes at day 0. On day 1 
strawberry whole extract was rehydrated in 500 μL PBS / vial and filtered. The polyphenol 
concentration was measured and concentrations of 5 μg / mL and 1 μg / mL were prepared.  
 
 Experiment 1 – Extract was added to the cells 3 hours before and during irradiation. The 
medium on all tubes was removed and 3ml of 5 μg / mL, 1 μg / mL or 0 μg / mL was 
added to the tubes and lids reapplied. The tubes were incubated for 3 hours then the 
experiment tubes were irradiated at 3.5 Gy and control tubes were not irradiated.  
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 Experiment 2 – Extract was added to the cells 3 hours before irradiation. 3 hours before 
irradiation the medium on all tubes was removed and 3 mL of 5 μg / mL, 1 μg / mL or 0 
μg / mL was added to the tubes. After 3 hours the medium was taken off the cells and 5 
mL of fresh medium was applied and the experiment tubes were irradiated at 3.5 Gy. 
 Experiment 3 – Extract was added to the cells during irradiation. The medium on all tubes 
was removed and 5 mL of 5 μg / mL, 1 μg / mL or 0 μg / mL was added to the tubes and 
lids reapplied. The experiment tubes were irradiated at 3.5 Gy and control tubes were not 
irradiated.  
 
All tubes had medium removed and 2 mL fresh medium was applied. Day 2, cytochalasin B was 
added to the tubes at a final concentration of 2 μg / mL. The tubes were put back in the incubator 
and left for 48 hours. After 48 hours the cells were trypsinised, resuspended in 1 mL medium and 
0.5 mL / slide spun down on to slides. Cells were fixed in 100% methanol and stained with 10% 
Giemsa and left to dry. Once dry, cover-slips were fixed onto the slides using DPX mountant and 
left to dry and cells with micronuclei were counted the next day.  
 
The assay was set up for one tube per condition and 3 slides were prepared from each tube and 
each slide was scored twice. The experiment was repeated 3 times. The results are the sum of 
the triplicate experiments of 9 slides per condition scored twice ± standard error. 
 
Cell viability assay of cells with incubation of low concentrations of extract for 3 hours 
On day 0 a single cell solution of 30,000 cells / mL was prepared of the cell line P21s. 100 μL of 
cells were pipetted into wells of 96 well plates and incubated at 37 °C 5% CO2. Day 2, 50 μg / mL 
and 10 μg / mL and 0 μg / mL of strawberry polyphenol extract dilutions were prepared. 10 μL of 
either 50 μg / mL or 10 μg / mL or 0 μg / mL dilution was pipetted onto the respective cells and 
the plates were incubated for three hours, After 3 hours, 10 μL of Dojindo reagent was pipetted 
onto the cells and the plates were incubated in the absence of light for 3 hours. Plates were read 
on the ELISA spectrometer at an absorbance of 450 nm. 0 µg / mL was taken as a control and 
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taken as a 100% cell survival. The readings for the 1 µg / mL and 5 µg / mL concentrations were 
taken as a percentage of the control. 
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5.4 Results 
5.4.1 Cell viability assays 
5.4.1.1 Effects of whole extract on the cell survival of prostate cell lines  
All the P21 cell lines showed exponential decline in cell viability with increased polyphenol 
concentration with >10 μg / mL giving a 50% cell survival, Figure 5.1.  
 
The P20 cell line exhibited less cytotoxicity to the whole polyphenol extract than the P21 cell 
lines, Figure 5.1. The P20 prostate cell line was less sensitive to polyphenol treatment compared 
to its irradiated cloned cell line P20 30Gy (clone-a), Figure 5.1. P20 cell line was the most 
resistant to the cytotoxic effects with 15 μg / mL required to cause 50% reduction in cell survival, 
Table 5.1. At concentrations below 6 μg / mL there was an increase in cell survival above the 
control after treatment with whole crude polyphenol extract in all cell lines except P21s, Figure 
5.1. 
Cell Line Concentration 
 ( µg / mL ) 
P21s 8 
P21s 40Gy (clone-a) 8 
P21d 8 
P21d 0Gy (clone-a) 8 
P20 15 
P20 30Gy (clone-a) 6 
 
Table 5.1 - Concentrations of whole extract to cause 50% reduction in cell survival in P21 and 
P20 cell lines 
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Figure 5.1 - Cell survival response following treatment with whole polyphenol extract on prostate 
cell lines P21s, P21s 40Gy (clone-a), P21d, P21d 0Gy (clone-a), P20, P20 30Gy (clone-a) 
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5.4.1.2 Effects of anthocyanin and ellagitannin rich extract on the cell survival of prostate 
cell lines  
The anthocyanin rich extract had the same effect on P21s and P21d (clone-a). The anthocyanin 
extract at concentrations up to 25 – 30 μg / mL exhibited limited cytotoxicity. At the maximum 
concentration of 50 μg / mL studied 50% reduction in cell survival was observed. The anthocyanin 
rich extract seemed to have little effect on the P21d cell line, and the P20 prostate cell lines, 
Figure 5.2, Table 5.2. 
 
In contrast the ellagitannin rich extract had a marked cytotoxic effect on all the cell lines with as 
little as 5 μg / mL giving a 50% reduction in cell growth rate, Figure 5.2, Table 5.2. 
 
At concentrations below 6 μg / mL there was an increase in cell survival above the control after 
treatment with the anthocyanin or ellagitannin rich polyphenol extracts in all cell lines, Figure 5.2. 
 
 
 
Cell Line Anthocyanin  
( µg / mL ) 
Ellagitannin 
 ( µg / mL ) 
P21s 50 8 
P21s 40Gy (clone-a) 40 8 
P21d > 50 8 
P21d 0Gy (clone-a) > 50 6 
P20 > 50 3 
P20 30Gy (clone-a) > 50 8 
 
Table 5.2 - Concentrations of anthocyanin and ellagitannin rich extracts to cause 50% reduction 
in cell survival in P21 and P20 cell lines 
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Figure 5.2 - Cell survival response following treatment with anthocyanin and ellagitannin rich 
extracts on prostate cell lines P21s, P21s 40Gy (clone-a), P21d, P21d 0Gy (clone-a), P20 and 
P20 30Gy (clone-a) 
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5.4.1.3 Effects of whole, anthocyanin and ellagitannin rich extract on the cell survival of 
prostate carcinoma cell lines  
The total polyphenol extract had a cytotoxic effect on the established cell lines. The PC-3 and 
LNCaP prostate carcinoma cell lines exhibited similar responses to the extract. These cell lines 
show that a concentration of ~40 µg / mL is required to give a 50% reduction in cell survival. At 
low concentrations there is an increase in cell survival above the control for both prostate cancer 
cell lines, Figure 5.3. 
 
The anthocyanin rich extract fraction was less cytotoxic than the ellagitannin fraction on the 
LNCaP cell line, Figure 5.3. The anthocyanin extract caused at most 20% reduction in cell 
survival. The ellagitannin extract caused a decrease in cell survival with increase of extract 
concentration with ~30 µg / mL causing 50% reduction in cell survival, Figure 5.3, Table 5.3. 
 
At low concentrations of whole, anthocyanin and ellagitannin extracts there was an increase in 
cell survival above the control in PC-3 and LNCaP cell lines, Figure 5.3. 
 
 
Cell Line Whole 
( µg / mL ) 
Anthocyanin  
( µg / mL ) 
Ellagitannin 
 ( µg / mL ) 
PC-3 40 Not tested Not tested 
LNCaP 50 > 50 25-40 
 
Table 5.3 - Concentrations of whole, anthocyanin and ellagitannin rich extracts to cause 50% 
reduction in cell survival in PC-3 and LNCaP carcinoma cell lines 
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Figure 5.3 - Cell survival response following treatment with whole and separated anthocyanin and 
ellagitannin rich strawberry extract fractions on human prostate cancer cell lines 
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5.4.1.4 Effects of whole extract on the cell survival of prostate plastic derived cloned cell 
lines  
The total polyphenol extract is cytotoxic to all the cell lines with increasing concentration causing 
a reduction in cell survival. All seven cloned cell lines showed a similar response to the total 
polyphenol extract with ~20 µg / mL causing 50% reduction in cell survival, Figure 5.4, Table 5.4. 
 
All cloned cell lines showed an increase in cell survival above the control at concentrations below 
6 µg / mL, Figure 5.4.  
 
 
Cell Line Concentration 
 ( µg / mL ) 
a 18 
b 20 
c 18 
d 20 
e 28 
f 22 
g 16 
 
Table 5.4 - Concentrations of whole extract to cause 50% reduction in cell survival in P21d plastic 
derived cloned cell lines 
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Figure 5.4 - Cell survival response following treatment with whole polyphenol extract on prostate 
cell lines P21d plastic derived cloned lines a-g 
Jennifer Weaver 
  163 
5.4.1.5 Effects of anthocyanin and ellagitannin rich extract on the cell survival of prostate 
plastic derived cloned cell lines  
The anthocyanin rich extract fraction exhibited a less cytotoxic effect than the ellagitannin rich 
extract fraction on all five cloned cell lines tested, Figure 5.5. However, the cells still exhibited a 
decrease in cell survival with increasing anthocyanin concentration. ~30 µg / mL of anthocyanin 
extract fraction caused a 50% reduction in cell survival, Table 5.5. The ellagitannin fraction was 
more cytotoxic to the cells with 10 µg / mL of extract causing a 50% reduction in cell survival, 
Figure 5.5, Table 5.5. 
 
All cloned cell lines showed an increase in cell survival above the control at concentrations below 
6 µg / mL for anthocyanin and ellagitannin rich extracts, Figure 5.5.  
 
 
Cell Line Anthocyanin 
( µg / mL ) 
Ellagitannin 
 ( µg / mL ) 
a 24 6 
b 25 10 
c 25 10 
d 32 10 
f 35 10 
 
Table 5.5 - Concentrations of anthocyanin and ellagitannin rich extract to cause 50% reduction in 
cell survival in P21d plastic derived cloned cell lines 
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Figure 5.5 - Cell survival response following treatment with  anthocyanin and ellagitannin rich 
extracts on prostate cell lines P21d plastic derived cloned lines a-d and f 
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5.4.1.6 Effects of whole, anthocyanin and ellagitannin rich extracts on the cell survival of 
human lymphocytes 
The whole extract had a linear effect on reducing cell survival with increasing concentration of 
extract. The lymphocytes were more resistant to the extract than the prostate cells as a larger 
concentration of 30 μg / mL caused a 50% reduction in cell survival, Table 5.6. 
 
The anthocyanin rich extract did not seem to affect the lymphocytes growth in a dramatic way. 
Small concentrations of the extract caused a dip in lymphocyte cell growth but reached a plateau 
after 10 μg / mL and any further increase in concentration resulted in no further change in 
decrease of cell growth. This effect was seen on all three subjects‟ cells. 
 
The ellagitannin rich extract affected the lymphocyte cell growth in a more sensitive manner with 
increasing concentration resulting in a more noticeable decrease in cell growth. This was the 
most toxic of the three extracts with concentrations of 20-35 μg / mL giving a 50% reduction in 
cell survival, Figure 5.6. 
 
Whole, anthocyanin and ellagitannin rich extracts all had a positive effect on cell survival at 
concentrations below 6 μg / mL, Figure 5.6. 
Subject Whole 
( µg / mL ) 
Anthocyanin  
( µg / mL ) 
Ellagitannin 
 ( µg / mL ) 
1 32 > 50 28 
2 37 > 50 20 
3 > 50 > 50 12 
4 > 50 > 50 22 
 
Table 5.6 - Concentrations of whole, anthocyanin and ellagitannin rich extracts to cause 50% 
reduction in cell survival in human blood lymphocytes stimulated with PHA 
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Figure 5.6 - Cell survival response following treatment with whole and separated extracts on 
human lymphocytes stimulated with PHA 
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5.4.1.7 Effects of whole, anthocyanin and ellagitannin rich extracts on cell survival of P21s, 
P21d, and P21d 0Gy (clone-a) prostate cell lines 
After 3 day incubation with 5 μg / mL concentration of whole extract caused a noticeable 
decrease in viable cells, Figure 5.7. At higher concentrations of 25 μg / mL incubation of extract, 
there were no viable cells left and only cell debris was stained. 5 μg / mL concentrations of whole 
extract resulted in 50% reduction in cell survival and 25 μg / mL resulted in no viable cells which 
correlates with the cell proliferation assay, Figure 5.1, Table 5.1. 
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Figure 5.7 Photomicrographs to show the effect of the extract on the cells 
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5.4.2 Micronuclei Assays 
5.4.2.1 Micronucleus response of P21s prostatic cell line treated with whole polyphenol 
extract for 3 hours before and during irradiation 
The number of cells with micronuclei per 100 binucleate cells was recorded. It was found that 
cells that were not irradiated had no micronuclei per 100 binucleate cells indicating that there was 
no DNA damage if the cells were incubated with the polyphenol extract for 3 hours. There was a 
significant decrease in the number of micronuclei per 100 binuclear cells within the samples that 
were incubated with polyphenol extract, Table 5.7. The cells incubated with a higher 
concentration of 5 μg / mL polyphenols showed a lower number of binuclear cells with 
micronuclei. Following exposure to 3.5 Gy and no polyphenol extract 23 micronuclei per 100 
binucleate cells were observed whereas, following 3.5 Gy and treatment with 5 μg / mL extract 
only 10 micronuclei per 100 binucleate cells were observed.  
 
Binucleate index is an indication of how much the cells are proliferating. The cells that were not 
irradiated had a higher binucleate index than the cells that were irradiated. The binucleate index 
was similar between the 0 Gy cells that were incubated with or without the extract. The 3.5 Gy 
cells all had lower binucleate indices than the 0 Gy cells, Table 5.7. The irradiated cells treated 
with extract had a slightly higher binucleate index than the irradiated cells that were not treated 
with the extract, Figure 5.8. 
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Test between P value Significance 
3.5 Gy 0 μg / mL and 3.5 Gy 1 
μg / mL 
p ≤ 0.00001 significant 
3.5 Gy 0 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.00001 significant 
3.5 Gy 1 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.1 Not significant 
 
Table 5.7 - T-Test statistics of the number of micronuclei cells / 100 binucleate cells if extract was 
incubated with the cells before and during irradiation 
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Figure 5.8 - Micronuclei response at 3.5 Gy irradiation of P21s prostate cells treated with 
polyphenol extract 3 hours before and during irradiation 
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5.4.2.2 Micronuclei response of P21s prostatic cell line treated with whole extract for 3 
hours before irradiation 
In all 0 Gy cells (treated or untreated with extract) there were no binuclear cells containing 
micronuclei in contrast to all 3.5 Gy cells which contained between 9 – 20 micronuclei per 100 
binuclear cells, Figure 5.9. In the 3.5 Gy cells 0 µg / mL the number of micronuclei per 100 
binucleate cells was double that of the 3.5 Gy 5 µg / mL cells, Figure 5.9.  The 3.5 Gy cells 0 µg / 
mL had a significantly higher number of micronuclei per 100 binuclear cells compared to the 3.5 
Gy cells which had been treated with extract, Table 5.8.  
 
The binuclear indices for the treated and untreated 0 Gy cells were very similar. The binuclear 
indices for the treated and untreated 3.5 Gy cells were also very similar. The binuclear index 
between the untreated 0 Gy and the untreated 3.5 Gy showed a marked difference (p ≤ 0.001) 
Figure 5.9. 
 
 
Test between P value Significance 
3.5 Gy 0 μg / mL and 3.5 Gy 1 
μg / mL 
p ≤ 0.0005 significant 
3.5 Gy 0 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.0005 significant 
3.5 Gy 1 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.001 significant 
 
Table 5.8 - T-Test statistics of the number of micronuclei cells / 100 binucleate cells if extract was 
incubated with the cells before irradiation 
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Figure 5.9 - Micronuclei response at 3.5 Gy irradiation of P21s prostate cells treated with 
polyphenol extract 3 hours before irradiation 
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5.4.2.3 Micronuclei response of P21s prostatic cell line treated with whole extract during 
irradiation only 
The 0 Gy cells (with and without extract) all exhibited a zero micronuclei value. The 3.5 Gy cells 
all exhibited binucleate cells containing micronuclei, Figure 5.10. The 3.5 Gy 0 μg / mL cells had a 
higher number of micronuclei per 100 binuclear cells than the 3.5 Gy 1 μg / mL and 5 μg / mL 
cells, Figure 5.10. The 3.5 Gy cells treated with extract during irradiation exhibited fewer number 
of micronuclei per 100 binuclear cells compared to the 3.5 Gy cells not treated with extract, 
Figure 3.10. There is a significant decrease in the number of micronuclei per 100 binuclear cells 
in the samples that were incubated with polyphenol extract, Table 5.9. 
 
The binuclear index for the 0 Gy cells not treated with extract was smaller than the 0 Gy cells 
treated with extract. The binuclear index for the 3.5 Gy cells with and without extract was not 
significantly different (p ≤ 0.5), Figure 5.10. 
 
Test between P value Significance 
3.5 Gy 0 μg / mL and 3.5 Gy 1 
μg / mL 
p ≤ 0.01 significant 
3.5 Gy 0 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.001 significant 
3.5 Gy 1 μg / mL and 3.5 Gy 5 
μg / mL 
p ≤ 0.01 significant 
 
Table 5.9 - T-Test statistics of the number of micronuclei cells / 100 binucleate cells if extract was 
incubated with the cells during irradiation 
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Figure 5.10 - Micronuclei response at 3.5 Gy irradiation of P21s prostate cells treated with 
polyphenol extract during irradiation only 
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5.4.2.4 Effect of 3 hour incubation of whole extract on the cell survival of P21s cells 
Incubation of the cells for 3 hours with polyphenol whole extract had no measurable effect on cell 
survival, Figure 5.11. The 5 μg / mL caused an increase in cell survival which shows that this 
concentration of extract increases cell proliferation after 3 hours exposure (p ≤ 0.005), Figure 
5.11. 
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Figure 5.11 - Cell survival response after 3 hours incubation with polyphenol extract 
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5.5 Discussion 
5.5.1 Effect of whole strawberry polyphenol extract on cells from human 
prostate cell lines  
The whole polyphenol strawberry extract is cytotoxic to the prostate cells with ~10 µg / mL giving 
50% reduction in cell survival for P21 cell lines, Figure 5.1 and 5.4. The P20 prostate cell lines 
were prostate cells immortalised with E7 and hTERT and exhibited similar cytotoxic effects when 
the whole polyphenol extract was applied to the cells, Figure 5.1. The whole polyphenol extract 
for the LNCaP and PC-3 prostate carcinoma prostate cell lines is less cytotoxic than the P21 cell 
lines with 45 – 50 µg / mL giving 50% reduction in cell survival, Figure 5.3.  The P21d plastic 
clones were slightly more resistant to the whole extract compared to the other P21 cell lines, with 
~20 µg / mL giving 50% reduction in cell survival, Figure 5.4. However, the P21d plastic clones 
were more sensitive than the prostate cancer cell lines LNCaP and PC-3.  
 
So far these results show that the strawberry total polyphenol extract did not have differential 
effects of killing cancer cells over normal cells over four days incubation with the extract. The 
visual results show that the normal and abnormal cells are indeed under going apoptosis and 
dying rather than just going into quiescence and match the Dojindo reagent assay results with 5 
µg / mL resulting in 50% cell death, Figure 5.7. This has been confirmed by post thesis 
preliminary immunocytochemistry results looking at expression of apoptotic markers M30 and 
caspase 3. The extract is affecting the cells in a way that is faster than the radiation survival 
assays. The radiation survival assays, which were also a four day assay, were measuring percent 
cell survival also. The radiation caused DNA damage which was not seen until after 7 days 
whereas, the damage caused by the extract is seen within 4 days incubation. Therefore the 
extract is more cytotoxic than the radiation and must be causing apoptosis in a more direct 
manner.  
 
Jennifer Weaver 
  177 
All prostate cell lines studied showed no differential cytotoxic effect between normal and cancer 
cell lines with the crude polyphenolic extract, Figure 5.1, 5.3 and 5.4. If anything the prostate 
cancer cell lines LNCaP and PC-3 are more resistant to the crude extract, Figure 5.3. However, 
unlike the P21 cell lines, these cell lines require to be cultured in 10% fetal calf serum which will 
influence the availability of certain polyphenol components as the polyphenol components bind to 
the serum and become unavailable to the cells (Ross, et al., 2007). Thus, the dose response 
curves between serum free and serum added experiments cannot be directly compared.  
 
Other extracts that have been studied include grape seed polyphenol effects on the DU145 
prostate cancer cell line (Agarwal, et al., 2000), blackberry, black raspberry, blueberry, cranberry, 
and red raspberry effects on the LNCaP prostate cancer cell line (Seeram, et al., 2006) all 
exhibited marked cytotoxicity at similar concentrations. The extracts had irreversible growth 
inhibitory effects on all the cell lines and reportedly caused this effect via mitogenic signalling and 
induction of cell cycle G1 arrest. Further research looked at the effect of the polyphenolic 
compounds on human prostate cancer cells in an environment mimicking the body. Pomegranate 
juice extracts, including ellagic acid, were reported to inhibit the invasion of the human prostate 
cancer cell line PC-3 in vitro across a Matrigel 
TM
 membrane but the mechanism is unknown 
(Lansky, et al., 2005). However, no control was run alongside nor was it considered  if the that the 
extract could have been so cytotoxic that it was killing the cells which prevented the invasion.  
 
Previous work has reported that polyphenolic compounds have a cancer cell specific effect using 
a rapidly proliferating cell line such as HeLa for the tumour model and a slower growing 
premalignant cell line such as HaCat in comparison (Aparico-Fernandez, et al., 2006). They 
reported that the polyphenolic compounds were inducing an inhibitory growth effect and inducing 
apoptosis to a greater effect in the HeLa cancer cells than the slower growing HaCaT cells. They 
reported that the polyphenol extracts were causing apoptosis in a cell cycle dependent manner. 
However, no work has been completed with normal prostate cells in comparison to prostate 
cancer cells.  
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It would be expected that the extract would affect the more rapidly proliferating cells according to 
Aparico-Fernandez, et al., 2006 study. This suggests that the polyphenolic compounds are 
affecting the cells by preventing them from completing the cell cycle and forcing them into 
apoptosis at concentrations above 6 µg / mL which has also been reported (Boivin, et al., 2007; 
Wu, et al., 2007). However, these concentrations above 6 µg / mL are higher than physiologically 
attainable values. 
 
The human prostate cancer cell line DU145 was shown to undergo cell cycle G1 arrest and levels 
of cdk4 were decreased by 90% after treatment with grape seed polyphenolic extract, (Agarwal, 
et al., 2000). As well as down regulation of cdk4, it was also found that prostate cancer cells after 
treatment with strawberry polyphenolic extract, expressed a down regulation of cdk6, cyclin D1 
and cyclin D3 (Biovin, et al., 2007). This suggests that the polyphenolic compounds are causing 
an up-regulation of p21
WAF1
 that is in turn inhibiting the cdk4 and cdk6 binding their respective 
cyclin D1 and cyclin D3 and preventing the cells from progressing from G1 into S phase and 
instead undergoing apoptosis. However, the levels of p21
WAF1 
have to be high enough to inhibit 
the cdk4 and cdk6 as a low base line of expression enables the cdk4 and cdk6 to bind their 
respective cyclins and cells can progress through the cell cycle. Hence, p21
WAF1 
has a negative 
and positive effect on G1 progression through the cell cycle (Weinberg, et al., 2002).  
 
However, the p21
WAF1
pathway maybe a mechanism by which the extract is causing the cells to 
apoptose and is not why the polyphenols could be selective at killing the cancer over normal 
cells. The results showed that the polyphenol extract was not prostate cancer cell specific as it 
caused cell death irrespective of normal, abnormal and cancer cells. 
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5.5.2 Effect of anthocyanin and ellagitannin strawberry polyphenol extract 
on cells from human prostate cell lines  
Studies that investigated the effects of strawberry polyphenol extract reported that all 
polyphenolic compounds inhibited the growth of DU145 and LNCaP prostate cancer cell lines at 
concentrations ranging from 25 – 250 µg / mL for 48 hours incubation (Zhang, et al., 2008; Boivin, 
et al., 2007; Seeram, et al., 2006; Chen, et al., 2004). The crude polyphenol extract was 
separated into ten compounds and ellagic acid was one of the most toxic compounds (Zhang, et 
al., 2008). Ellagic acid was found to be selectively cytotoxic to a range of cultured cancer cell 
lines including prostate compared to normal human embryonic lung fibroblast HEL 299 cells 
(Losso, et al., 2004). Ellagic acid is found in the ellagitannin rich fraction of the strawberry extract 
(Ross, et al., 2007) and was shown to be the more toxic than the anthocyanin rich extract in P21, 
P20, LNCaP prostate cell lines and lymphocytes, Figure 5.2, 5.3, 5.5. 5.6. The results are 
consistent with the Ross, et al., (2007) study which also found that anthocyanins have little 
cytotoxic effect on HeLa cells. It has been reported that ellagic acid induces apoptosis via the 
intrinsic mitochondrial pathway (Ross, et al., 2007; Miura, et al., 2008).  
 
Grape seed proanthocyanidin extract (which contains ellagic acid) has a positive effect on normal 
human gastric mucosal cells and J774A murine macrophage cells and enhances their growth and 
viability (Ye, et al., 1999). This was also observed at very low concentrations of crude extract for 
the P21s 40Gy (clone-a), P21d 0Gy (clone-a), LNCaP, PC-3, P20, P20 30Gy (clone-a), P21d 
plastic cloned cell lines and lymphocytes, Figure 5.1, 5.3, 5.4, 5.6. 
 
One study has reported that the anthocyanin and ellagitannin rich fractions have equal cytotoxicty 
to LNCaP prostate cancer cells (Zhang, et al., 2008). The LNCaP results of this study contradict 
Zhang, et al., (2008) study results but the Zhang study used higher concentrations with longer 
incubation times of 72 hours. This could lead to increased cytotoxicity and hence no differential 
results would have been seen. 
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Crude extract, anthocyanin, and ellagitannin levels below 6 µg / mL all showed an increase in cell 
survival including normal P21s, and abnormal P21d, P21d 0Gy (clone-a), P21d plastic derived 
cloned and cancer cell lines LNCaP and PC-3, Figure 5.1- 5.5. This is relevant as physiological 
levels of polyphenols are below 6 µg / mL and all other work has been reporting anticancer 
activities of polyphenol extracts at concentrations ranging from 25-250 µg / mL (Zhang, et al., 
2008; Boivin, et al., 2007; Seeram, et al., 2006; Chen, et al., 2004; Han, et al., 2005; Ye, et al., 
1999).  
 
Han, et al., (2005) reported blackraspberry polyphenol fractions having differential cytotoxic 
effects on human pre and malignant oral cell lines but not normal human oral epithelial cells 
obtained from cheek swabs. The results showed that RO-ET fraction (ethanol fraction) had 
inhibited the pre and malignant cell lines at 200 μg / mL by 45% and 27% respectively but did not 
inhibit the growth of the normal cells at the same concentration (Han, et al., 2005). However, at 
lower concentrations the differential effect was lost and malignant cells were only inhibited by 5% 
and normal cells by 3%. Cytotoxic effects were only observed at 200 μg / mL which are above 
attainable physiological values. 
 
Studies have reported that anthocyanins are less absorbed than ellagitannin fractions in plasma 
when fruit is ingested (Manach, et al., 2005; Hollands, et al., 2008). Anthocyanins are therefore 
poorly bioavaliable with low nanomolar levels being detected in blood plasma (Hollands, et al., 
2008; McDougall, et al., 2005). However a new study has reported that an increase in fruit (up to 
400 g) causes a linear relationship to detection in the urine but plasma levels still only reached 
10-50 nmol/L in human subjects (Hollands, et al., 2008).  The same has been found with 
ellagitannin fractions (Seeram, et al., 2004; Manach, et al., 2005). Although they are absorbed 
more readily, the physiological values in blood plasma are nanomolar and hence the 
concentrations of strawberry tested (50 – 1.5 μg / mL) would never reach prostate cells. 
Pomegranate studies showed that ellagic acid (main component of ellagitannin rich fraction) was 
detected in human plasma at a maximum concentration (31.9 ng / mL) after 1 hour post-ingestion 
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but was rapidly eliminated by 4 hours (Seeram, et al., 2004). This highlights another important 
point that these polyphenols have very short half lives therefore, to affect cancer cells there would 
have to be high concentrations required over a long period of time.  
 
The results above showed that at concentrations below 6 μg / mL the polyphenols enhanced 
cancer cell growth, Figures 5.1 – 5.5. If these polyphenol extracts enhance the growth of cancer 
cells at physiological concentrations then all studies reporting anticancer properties need re-
thinking and more investigation is needed into physiological levels of polyphenols on normal and 
cancer cell growth.  
 
5.5.3 Effect of whole, anthocyanin and ellagitannin strawberry polyphenol 
extract on cells from human lymphocytes 
Lymphocytes were investigated because if polyphenol compounds had an anti-cancer effect then 
they would be absorbed into the blood and come into direct contact with blood cells including 
lymphocytes. If the polyphenol extracts were differentially killing the prostate cancer cells and 
were toxic to lymphocytes but not normal prostate cells. This would markedly reduce their 
effectiveness. 
 
The lymphocytes were more resistant to the crude extract than the P21 and P20 prostate cell 
lines with 30 µg / mL required to give 50% reduction in cell survival, Figure 5.6. The ellagitannin 
rich extract was the more potent than the anthocyanin rich extract with 10 – 25 µg / mL causing a 
50% drop in cell survival. Low concentrations of anthocyanin rich fraction caused an initial drop in 
cell survival then any further increase above 10 µg / mL did not cause any further drop in cell 
survival. The lymphocytes were cultured in 10% fetal calf serum, which may influence the 
availability of polyphenols (Ross, et al., 2007). It is notable that the lymphocytes were as sensitive 
to the strawberry extract as the established prostate cancer lines (LNCaP and PC-3, Figure 5.3). 
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Other studies using human haematopoietic cells found that two polyphenol compounds showed 
no differential cytotoxic effects when applied to normal CD34+ haematopoietic progenitor cells 
and acute myeloid leukemic cells (Liesveld, et al., 2003). Studies using black raspberry extracts 
did demonstrate a differential effect on pre and malignant oral epithelial cells as compared to 
normal human oral epithelial cells as discussed above (Han, et al., 2005). Similarly cocoa 
extracts had a differential effect on metastatic DU145 and non-metastatic 22Rv1 prostate cancer 
cell lines compared to a non-tumourigenic prostate epithelial cell line immortalised with HPV-18 
(Jourdain, et al., 2006). Du145 and 22Rv1 cells exhibited 50% inhibition to cell growth when 
0.01% extract was applied whereas, 0.01% and 0.1% inhibited 70% cell growth on the normal 
cells. However, at the concentrations above 0.1% the cancer cells exhibited 90% inhibition and 
the normal cells showed no inhibition. Therefore, at the higher concentrations used there was a 
differential effect exhibited. Therefore ,the differential effect was noted at high concentrations of 
cocoa extract only.  
 
Human breast cancer and normal cell lines treated with red wine polyphenols (Hakimuddin, et al., 
2006) and colon cancer and normal gastric mucosal cells treated with gallotannin and 
proanthocyanidin extracts (Al-Ayyoubi, et al., 2007; Ye, et al., 1999) both exhibit differential 
cytotoxicity.  Thus the responses of tumour cells compared to normal cells depends on the tissue 
system being investigated. 
 
There have been a number of in vivo studies where rats have been fed a control or fruit phenol 
diet and noticed the effects when esophageal or colon cancer is induced (Kresty, et al., 2001; 
Harris, et al., 2001). Lyophilised black raspberries were found to cause significant reductions in 
the formation of preneoplastic esophageal lesions, decreased tumor incidence and multiplicity in 
short and long term assays (Kresty, et al., 2001). This study started the fruit diets before and 
during chemically induced carcinogenesis.  The colon study initiated the chemical carcinogenesis 
then started the diet of lyophilised black raspberries (Harris, et al., 2001). Although the 
adenocarcinoma multiplicity decreased in a correlating fashion with increased concentration of 
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black raspberries in the diet, it was to a lesser extent than the Kresty, et al., 2001 study. This 
points to the polyphenol compounds may having a preventative effect if present before the 
carcinogen.  
 
5.5.4 Micronuclei data 
So far the results clearly showed no differential effect of killing prostate cancer cells over normal 
cells of the same tissue origin. To further investigate the polyphenol compounds effects, the cells 
were exposed to ionising radiation in the presence of the polyphenol compounds and with 
incubation of the extract 3 hours before irradiation treatment. 
 
5.5.4.1 Effect of incubation with whole extract on cells before and during ionising radiation  
The number of cells with micronuclei per 100 binucleate cells is a value that represents the DNA 
damage. Micronuclei are small, extra-nuclear bodies that are formed in mitosis from acentric 
chromosomal fragments or chromosomes that are not included in each daughter nucleus (Chung, 
et al., 2002). The larger the number of cells with micronuclei per 100 binucleate cells the greater 
the DNA damage experienced by the cells (Schweikl, et al., 2001). As can be seen in Figure 5.8, 
the number of cells with micronuclei in 100 binucleate cells is zero for the non-irradiated cells with 
and without extract showing that the control cells are unaffected by the strawberry whole 
polyphenol extract concentration alone. The 3.5 Gy irradiated cells have high micronuclei values 
with and without extract presence which shows that the cells exposed to ionising radiation have 
experienced DNA damage, Figure 5.8. The presence of extract 3 hours before and during 
radiation treatment causes the micronuclei value to decrease showing that the extract presence 
before and during γ-ray treatment helps decrease the DNA damage to the cells, Figure 5.8. The 1 
µg / mL and 5 µg / mL extract concentrations are not significantly different, Table 5.7, Figure 5.8. 
These results show that there is a protective effect exerted on the cells by the polyphenol 
compounds when incubated before and during the radiation treatment. 
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The binucleate index is a percentage of the proportion of the cells that have two nuclei and it 
determines how many number of cells that have gone through one cell cycle. This is because the 
cytochalasin B added blocks cytokinesis thus producing two daughter nuclei in the same 
cytoplasm which therefore allows cells that have completed one cell cycle to be distinguished by 
their binucleated appearance (Chung, et al., 2002). The 0 Gy cells with and without extract exhibit 
high values for the binucleate index, Figure 5.8. The presence of the polyphenol at 1 µg / mL and 
5 µg / mL cause the binucleate index to increase which shows that the presence to the extract at 
these concentrations for 3 hours and during the radiation treatment is not cytotoxic. The 
binucleate index for the 3.5 Gy with and without extract exhibit lower values than the 0 Gy 
controls which shows that 3.5 Gy affects the cells ability to replicate which is expected, Figure 
5.8. However, the binucleate index values are not too low that the micronuclei data is not 
significant as the micronuclei can only be expressed in cells that have completed nuclear division 
as the DNA is damaged during the cell division (Fenech, 2008). 
 
However, to determine when the extract is protecting during or before the irradiation separate 
experiments were set up. These included incubating the cells 3 hours before the radiation 
treatment with extract and only having the extract present during the radiation treatment. 
 
5.5.4.2 Effect of incubation with whole extract on cells before ionising radiation  
The 0 Gy controls showed a zero value for the number of cells with micronuclei per 100 
binucleate cells which shows that the extract is not cytotoxic to the cells by causing DNA damage 
during cell division after 3 hours incubation with the extract. As can be seen in Figure 5.9, 
incubation with the extract 3 hours before radiation treatment has a reducing effect on the number 
of cells with micronuclei per 100 binucleate cells in the irradiated cells. This shows that the 3 
hours incubation with extract alone before irradiation has a protective effect from the ionising 
radiation which causes DNA damage. Other studies have looked at protective effect of ellagic 
acid which is in the ellagitannin rich extract fraction (Thresiamma, et al., 1998). They have 
reported protective effects from radiation in bone marrow cells and lymphocytes of mice that were 
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fed the antioxidant before radiation treatment (Thresiamma, et al., 1998). It was reported that the 
antioxidant inhibited the DNA strand breaks produced upon radiation treatment. Ellagic acid has 
been shown to be also protective to rat peripheral blood lymphocytes from nicotine induced DNA 
damage at concentrations of 10, 50, 100, 150 and 300 μM with the micronuclei assay (Sudheer, 
et al., 2007). Nicotine when broken down produced reactive oxygen species that damaged the 
cells DNA and damage to DNA may lead to mutations, initiation of cancer cells and cancer 
progression (Sudheer, et al., 2007). Phenolic compounds can act as free radical scavengers by 
virtue of their hydrogen donating ability and existing reports have shown that polyphenols exhibit 
anti-oxidative effects both in vitro and in vivo conditions (Sudheer, et al., 2007).  
 
Gallic acid, found in ellagitannin rich fractions, has been shown to be one of the anti-carcinogenic 
polyphenols present in green tea and in vitro and in vivo studies have shown that it protects DNA 
against ionizing gamma radiation (Gandhi, et al., 2005). Investigations found that plasmid DNA in 
the presence of gallic acid and whole mice exposed to gallic acid before radiation exhibited lower 
DNA damage and hence were protected (Gandhi, et al., 2005).  
 
Gamma radiation is known to damage the cells DNA through the free radicals generated in the 
aqueous milieu in the cell. Exposure to ionizing radiation produces a variety of lesions in DNA 
such as single strand breaks, double strand breaks, DNA–DNA and DNA protein cross-links 
together with damage to nucleotide bases (Gandhi, et al., 2005). The presence of the gallic acid 
reduced the DNA damage as it absorbed the reactive oxidative species formed in the cell by the 
radiation hence, protecting the DNA of the cells.  
 
The oxygen effect is important in the case of sparsely ionizing radiation such as low dose of 
gamma irradiation, e.g. 3.5 Gy (Hall, 1994). To observe the oxygen effect, oxygen must be 
present during or within microseconds after the radiation exposure (Hall, 1994). Radiation is 
absorbed by the cells which leads to the production of fast charged particles (Hall, 1994). The fast 
charged particles then pass through the cell material producing ion pairs which have a short life 
Jennifer Weaver 
  186 
span of 10
-10
 of a second. The ion pairs produce free radicals which have an un-paired valence 
electron and are hence very reactive. The half life of the free radical is 10
-5
 of a second. Hence, 
the oxygen effect time scale is very short due to the short half life of the free radicals generated 
by the ionizing radiation. As cells consist of mostly water the ion pairs ionize the water and cause 
free radicals in this way. Therefore the oxygen molecules interfere with the free radicals and 
cause more damaging reactive species to be formed. This therefore increases the number of 
damaging free radicals and hence leads to more damage. This can be observed as anoxic 
tissues are less damaged by the same dose of ionizing gamma radiation than oxygenated tissues 
(Hall, 1994). The increased availability of oxygen in the cell amplifies the ROS and results in 
greater damage. However, this response is extremely quick. 
 
The free radical reactive oxygen species are generated during irradiation and cause the DNA 
damage immediately (Leach, et al., 2001). Therefore, the polyphenols have to be present at the 
time of irradiation to prevent DNA damage as the reactive oxygen species once created by the 
ionizing radiation have an extremely short half life and cause immediate damage. In this assay 
the polyphenols were incubated on the cells for 3 hours then washed off before irradiation. A 
protective effect was still observed with both concentrations of polyphenol being incubated on the 
cells 3 hours before irradiation compared to cells incubated with no extract, Figure 5.9. Therefore, 
the polyphenol compounds must be taken up by the cells and retained in the cells during 
irradiation to exert a protective effect. 
 
The binucleate index values show the extract alone has no negative effect on the 0 Gy cells cycle 
progression and the 3.5 Gy cells with and without extract exhibit lower values with a drop in the 
binucleate index and are lower than the 3 hours and during binucleate values, Figure 5.9. This 
shows that the 3.5 Gy cells with only 3 hours incubation before the radiation are taking longer to 
progress through a cell cycle. 
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5.5.4.3 Effect of incubation with whole extract on cells during ionising radiation  
The micronuclei data for this experiment show a significant reduction in the number of cells with 
micronuclei per 100 binucleate cells with incubation of extract during ionising radiation treatment, 
Figure 5.10, Table 5.9. Following exposure to 3.5 Gy and no polyphenol extract 17 micronuclei 
per 100 binucleate cells were observed where as following 3.5 Gy and treatment with 1 µg / mL 
extract only 10 micronuclei per 100 binucleate cells were observed, Figure 5.10. This shows that 
if polyphenol compounds are present during ionising radiation of 3.5 Gy it has a protective effect. 
This could be explained by the polyphenol compounds acting as free radical scavengers (Masaki, 
et al., 1995). Masaki et al., (1995) showed that hamamelitannin (a polyphenol component of 
Hamamelis virginiana L.) has a protective effect on skin fibroblasts damaged by UVB irradiation 
by modifying the reactive oxygen species.  
 
It is expected that if the polyphenol extract is on the cells during radiation there would be a 
protective effect observed. This is because the ionizing radiation creates the reactive oxidizing 
species and they cause immediate damage then disappear as they have very short half lives 
(Leach, et al., 2001). If the polyphenols are present when the reactive oxidizing species are 
formed the DNA damage is minimized as they have ability to neutralize the reactive oxidizing 
species.  
 
The binucleate values for all conditions are not below the 0 Gy 0 µg / mL control value which 
shows that if the extract is present during radiation treatment then the cells are protected to the 
extent where the cells progression through the cell cycle is not affected by the ionising radiation, 
Figure 5.10.  
 
To check that the cells were not affected with the strawberry extract on them for 3 hours a cell 
viability assay was set up, Figure 5.11. The results showed that if the extract was incubated on 
the cells for 3 hours at concentrations of 1 µg / mL and 5 µg / mL there was no reduction in cell 
survival, Figure 5.11. Interestingly, there was a slight increase for the 5 µg / mL concentration 
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which is seen for low concentrations of total extract in the cell viability assays earlier on in this 
chapter.  
 
The micronuclei data show that the strawberry total polyphenol compounds have a protective 
effect from ionising radiation. If the extract is present during the radiation only then the cells have 
the lowest number of micronuclei per 100 binucleate cells compared to if the extract is present for 
3 hours before radiation treatment. However, if the polyphenol extract is incubated on the cells for 
3 hours before radiation treatment there is still a slight protective effect. This could explain why 
maintaining a constant level of fruit and vegetables in the diet is shown to be advantageous in 
epidemiological studies. Epidemiological and experimental data suggest that an increased intake 
of fruit and vegetables can reduce the risk of cancer (Briviba, et al., 2007). In in vitro experiments, 
phenolic compounds have been shown to inactivate reactive oxygen and nitrogen species, which 
are able to generate DNA strand breaks and to oxidize DNA bases that can lead to the formation 
of mutations, hyperproliferation, and cancer (Briviba, et al., 2007).  To further investigate this in 
humans an experiment was undertaken to assess the effect of consumption of apples on 
antioxidant activity and DNA damage in human lymphocytes (Briviba, et al., 2007).  The 
polyphenol content was 308 – 321 μg / g fresh weight and a protective effect was noted if eaten 
24 hours prior to DNA induced oxidative damage by iron chloride. Polyphenol compounds are 
known to be able to interact with transition metal ions such as copper and iron, which can induce 
oxidative processes and DNA damage in vitro (Briviba, et al., 2007).   
 
The results from this study could explain why the polyphenol compounds present in these foods 
appear to have a protective effect from the ionising radiation and ionising radiation (including 
reactive oxidising species) can damage the DNA and in turn cause cancer.  
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5.6 Conclusion 
The results show that polyphenolic compounds from fruit are not prostate cancer cell specific and 
that the mechanism behind polyphenol modulation of cell cycle signalling is very complex and 
needs more thorough investigation.  
 
Further work needs to be carried out to investigate the up-regulation and down-regulation of cell 
cycle genes to see if the strawberry polyphenolic extract is causing apoptosis in the p21 pathway 
and why the established cell lines LNCaP and PC-3 are more resistant.  
 
The polyphenol-rich strawberry extract had significant cytotoxic effects on normal and 
tumourigenic prostate but there was little evidence for differential cytotoxicity at the 
concentrations used. As the serum bioavailability of many berry polyphenols is much lower than 
the levels required for inhibition of cell proliferation in this study, it is very unlikely that prostate 
cancer cells would ever be exposed to these levels in vivo through normal diets (Williamson, et 
al., 2005). 
 
The micronuclei data showed that the concentrations of 1 µg / mL and 5 µg / mL of total 
polyphenol strawberry extract has a protective effect if exposed to the cells for a short period 
before ionising radiation treatment. This is encouraging data but these concentrations are lethal 
to the cells if exposed to a longer period of 4 days at very high levels (shown by the Dojindo 
reagent cell viability assays).  
 
Epidemiological studies have shown that a constant low level of polyphenol antioxidants 
chemicals prevents cancer (Briviba, et al., 2007). Hence, studies into physiological levels of 
polyphenols on prostate tissue over a longer period and then administering the radiation 
treatment may be advantageous.  
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Chapter 6 
Molecular Characterisation of a Novel 
Complex of Metabolic Enzymes in 
Normal and Tumour Cell Lines derived 
from the Prostate 
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6.1 Introduction 
In non-cancerous cells LDH-B is associated with NDPK-B which uses ATP to generate GTP and 
results in G-protein activity being up-regulated. CK2 is bound to AMPK/NDPK-A and has an 
inhibitory effect on NDPK-A. ATP production in this complex is then repressed. In stressed and 
cancer cells, LDH-B is switched for LDH-A on NDPK-B which augments CK2 alpha in the NDPK-
B complex and the result blocks ATP dependent GTP production. c-Myc is ejected from this 
NDPK-B/LDH-A complex and is hypothesised to translocate to the nucleus and activate 
downstream c-Myc targets. ATP is no longer used to generate GTP for G- protein processes and 
G-protein activity is repressed. ATP is instead being manually over-produced by the NDPK-A / 
AMPK complex by direct effect of LDH-A upregulating AMPK activity, and phosphorylating ACC 
and hence ATP mass production, and no inhibitory effect or control via CK2 alpha as it has 
translocated to NDPK-B.  
 
The activity of LDH isoform expression is a direct link to the NAD
+
/NADH ratio (redox status) of 
the cell which is directly linked to oxidative stress to how the cells generate ATP via glycolysis. 
This is true under normal conditions but in cancer cells, anaerobic glycolysis is favoured as 
described by the Warburg Effect, (Warburg, 1956). 
 
 
6.2 AIM – We will test whether the mechanism of LDH exchange and LDH-dependent c-Myc 
association with NDPK-B is conserved across three prostate cell lines as reported in breast and 
RPE cell normal and cancer cell models (Campbell personal communication). 
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6.3 Procedure 
6.3.1 Cell lines  
Human prostate cell lines immortalised by transduction with cdk4 and hTERT genes, were used 
for these experiments. P21s is a normal cell line derived from the superficial region of the 
prostate. P21d was derived from the same patient from the deep peripheral region of the prostate 
where all malignant prostate carcinomas occur. P21d is a cell line that has a mixed 
heterogeneous population of abnormal and possibly cancer cells. P21d 0Gy (clone-a) is a cloned 
cell line derived from an anchorage independent clone of P21d and is a population of abnormal 
and possibly cancer cells all derived from the same parent cell. 
 
6.3.2 NDPK A/ B western blot analysis 
Cytosol extracts from the cell lines were prepared as described in Cytosolic protein extraction, 
Chapter 2. NDPK-A and NDPK-B were precipitated out of the cytosol extract taken from P21s, 
P21d and P21d 0Gy (clone-a) cells using 3 μL of goat anti-NDPK-A and goat anti-NDPK-B 
antibody, see Immunoprecipitation, Chapter 2. Bradford analysis was carried out on the cytosol 
extracts so that the same protein concentration was loaded onto the gel. The extract was ran on 
prepared 10% SDS-PAGE utilising the Laemmli protocol and transferred to nitrocellulose 
membrane, see Laemmli protocol, Chapter 2, and probed for CK2 alpha using a primary 1 / 1000 
dilution goat anti-CK2 alpha antibody and secondary 1 / 5000 anti-goat antibody, see Western 
Blot Analysis Chapter 2. The membrane was treated with ECL and the film was exposed to the 
membrane for three minutes and developed, see developing the film, Chapter 2.  
 
6.3.3 Two dimensional western blot analysis 
Cytosol extracts were prepared as described in Cytosolic protein extraction, Chapter 2, from 
P21s, P21d and P21d 0Gy (clone-a) cells cytosol. To determine which isoform of LDH was 
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associated with NDPK-A, NDPK-B, and c-Myc in the cell cytosol, samples were prepared using 3 
μL of respective anti-NDPK-A goat, anti-NDPK-B goat, anti-c-Myc mouse antibody, see 
Immunoprecipitation, Chapter 2. Bradford analysis was carried out on the cytosol extracts so that 
the same protein concentration was loaded onto the gel. The extracts were ran on a precast 
Isoelectric Focus (IEF) pH 3 – 10 gel and individual lanes were cut out and transferred to a 
second precast Tris-Glycine 4-12 % separation gel and ran according to molecular weight and 
transferred to a nitrocellulose membrane, See SDS PAGE for Precast gels for 2 D gel separation, 
Chapter 2. The membrane was probed for LDH using a primary 1 / 1000 dilution of goat anti-LDH 
antibody and secondary anti-goat 1 / 5000 dilution and results were visualised with addition of 
Enhanced Chemiluminescent (ECL) reagent see Western Blot Analysis, Chapter 2. Kodak film 
was exposed to the membrane for 3 minutes and developed in the dark room, see developing the 
film, Chapter 2.  
 
6.3.4 Immunocytochemistry analysis 
Cells from P21s, P21d and P21d 0Gy (clone-a) were trypsinised, washed and resuspended in 
PREBM as described in Epithelial cell culture, Chapter 2. Single cell suspensions were counted 
via the Coulter counter and stock of 400,000 cells / mL was prepared and 100 μL (40,000 cells) 
was applied to slides and fixed in 100% ice cold acetone, See Immunocytochemistry, Chapter 2. 
Slides were stained for c-Myc expression using primary 1 / 150 dilution of commercial mouse c-
Myc antibody. Slides were stained using biotinylated method and counter stained with 
haematoxylin, see Immunocytochemistry Chapter 2. Photomicrographs of the slides were taken 
with a Nikon coolpix camera on the microscope.  
 
6.3.5 c-Myc western blot analysis  
To determine the cellular cytosol c-Myc association with NDPK-B, immunoprecipitates were 
prepared using 5 μL anti-NDPK-B rabbit antibody and cell cytosol from P21s, P21d and P21d 
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0Gy (clone-a), see Immunoprecipitation, Chapter 2. Bradford analysis was carried out on the 
cytosol extracts so that the same protein concentration was loaded onto the gel. These samples 
were ran on a pre cast 4-12 % separation Tris-Glycine gel and separated by molecular weight 
and transferred to nitrocellulose membrane and probed for c-Myc, using primary 1/ 1000 dilution 
of mouse anti-c-Myc antibody and secondary 1 / 5000 dilution of anti-mouse antibody.  
 
To see if there was an up-regulation of expression of c-Myc in the nucleus, levels of downstream 
c-Myc targets were investigated. 20 μL of total extract from P21s, P21d and P21d 0Gy (clone-a) 
cells was ran on a 4-12 % SDS-PAGE Tris-Glycine gel and transferred to a nitrocellulose 
membrane and probed for a known c-Myc target LDH. Antibody dilutions used were 1 / 1000 anti-
LDH goat antibody and secondary 1 / 5000 dilution of anti-goat antibody. 
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6.4 Results 
6.4.1 Analysis to investigate the interaction of of NDPK A and B with CK2 α 
Precipitation with NDPK-A from the cell cytosol extracts and probed for CK2 alpha association 
showed that CK2 alpha associated with NDPK-A in the cell cytosol in all normal, and abnormal 
cell lines, as shown in Figure 6.1. CK2 alpha associated with NDPK-B in P21d and P21d 0Gy 
(clone-a) only, Figure 6.1. 
 
There is a greater association of CK2 alpha with NDPK-A in the abnormal P21d 0Gy (clone-a) 
cell line compared to the P21s cell line. For NDPK-B there is significant elevated association 
between CK2 alpha and NDPK-B in P21d 0Gy (clone-a) abnormal cells compared to P21s, 
normal cells, Figure 6.1. 
 
For this assay 20 μg of cytosolic extract from human prostate epithelial cells were precipitated 
using an excess of either NDPK-A or NDPK-B antibodies. 
 
 S= Superficial, P21s cell line 
 D= Deep, P21d cell line (mixture of abnormal cells) 
 C= Cloned cell line of D, P21d 0Gy (clone-a) 
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NDPK-A IP
S D C
CK2
(45 kDa)
NDPK-B IP
Probed 1/1000 
CK2 antibody
S D C
11 kDa
75 kDa
 
Figure 6.1 - NDPK protein immunoprecipitated from cell cytosol from P21s, P21d and P21d 0Gy 
(clone-a) cell lines and probed for CK2α 
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6.4.2 2D analysis to investigate the interaction of NDPK-A with LDH-A or B 
Precipitating with NDPK-A and probing with LDH in P21s cell line cytosol showed the LDH-A 
isoform associated with NDPK-A in normal cells cytosol, Figure 6.2. P21d and P21d 0Gy (clone-
a) cells showed LDH-A also associating with NDPK-A in the cell cytosol. 
 
 
 
 
 
Figure 6.2- NDPK-A protein immunoprecipitated from cell cytosol from P21s, P21d and P21d 0Gy 
(clone-a) cell lines and ran on 2D gel and probed for LDH-A or B isoform 
 
 
Normal, abnormal, clone 
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NDPK-A IP 
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6.4.3 2D analysis investigate the interaction of NDPK-B with LDH-A or B 
Precipitation with NDPK-B in P21s cell cytosol and probing for LDH showed the LDH-B isoform 
associated with NDPK-B in normal P21s cells. In P21d and P21d 0Gy (clone-a) cell extracts, 
NDPK-B associates with LDH-A, Figure 6.3. 
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Figure 6.3- NDPK-B protein immunoprecipitated from cell cytosol from P21s, P21d and P21d 0Gy 
(clone-a) cell lines and ran on 2D gel and probed for LDH-A or B isoform 
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6.4.4 2D analysis investigate the interaction of c-Myc and LDH-A or B 
Precipitation with c-Myc in P21s cell cytosol and probed for LDH showed that LDH-A isoform 
associates with c-Myc in P21s cell cytosol. In P21d and P21d 0Gy (clone-a) cell extracts, c-Myc is 
not observed to associate with either LDH-A or LDH-B, Figure 6.4. 
 
 
 
 
 
Figure 6.4 - c-Myc protein immunoprecipitated from cell cytosol from P21s, P21d and P21d 0Gy 
(clone-a) cell lines and ran on 2D gel and probed for LDH-A or B isoform 
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6.4.5 Analysis to investigate the expression of c-Myc and the interaction 
with NDPK-B and down stream effects 
Using immunocytochemistry, cells were probed for c-Myc expression in P21s, P21d and P21d 
0Gy (clone-a) cells, Figure 6.5a. As can be seen c-Myc was undetectable in normal cells. P21d 
0Gy (clone-a) abnormal cells exhibited extremely strong expression of c-Myc within the nuclei of 
the cells, Figure 6.5a. P21d as mentioned earlier is a mixed population and shows increased 
expression of c-Myc than P21s normal cells but has mixed expression levels within the cell 
population.  
 
c-Myc association with NDPK-B in the cell cytosol was investigated and Figure 6.5b shows that in 
normal cell cytosol (P21s) there is an association. This association is lost in P21d and P21d 0Gy 
(clone-a) cells suggesting that c-Myc is no longer bound to NDPK-B in the cytoplasm. The c-Myc 
IPs showed the same result but as it was not a denaturing gel the naturally occurring hexamer of 
NDPK-B was picked up instead of the monomer. 
 
To determine if increased expression of c-Myc in the nuclei of the P21d 0Gy (clone-a) cells was 
significant, levels of downstream targets of c-Myc in total cell extracts was investigated. Increased 
expression of LDH (a known downstream target of c-Myc) are up-regulated in the P21d 0Gy 
(clone-a) and P21d cells, Figure 6.5c. Levels of LDH are undetectably low in P21s, Figure 6.5c.  
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Figure 6.5a- Immunocytochemistry response after P21s, P21d and P21d 0Gy (clone-a) probed 
for c-Myc 
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Figure 6.5b - NDPK-B and c-Myc protein immunoprecipitated from cell cytosol from P21s, P21d 
and P21d 0Gy (clone-a) cell lines and probed for c-Myc and NDPK-B respectively 
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Figure 6.5c –Total cell cytosol probed for LDH protein concentrations from cell cytosol from P21s, 
P21d and P21d 0Gy (clone-a) prostate cell lines 
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6.5 Discussion 
Studies in our lab have investigated this complex of metabolic enzymes in normal and cloned 
breast and retinal pigment cells. The parent cell lines were immortalised with over expression of 
hTERT gene and are characterised as normal cells. The parent cells lines have been irradiated to 
produce tumourigenic cells and anchorage independent colonies were picked and cloned cell 
lines propagated from them. The breast cell lines were designated, parent B42 and B42 clone 16, 
the RPE parent line and RPE clone (Riches, et al., 2001).  
 
6.5.1 CK2 alpha localisation on NDPK-A and NDPK-B in wild-type and 
cancer prostate cell lines 
CK2 is a pleiotropic serine / theronine protein kinase that primarily exists as an alpha 2 beta 2 
tetramer where the alpha and beta subunits are catalytic and regulatory subunits respectively. 
CK2 phosphorylates a wide array of substrates in vitro (Martel, et al., 2001). Other studies in our 
labs have demonstrated that CK2 alpha will bind exclusively to NDPK-A in the wild type cells and 
exclusively NDPK-B in the tumour cells from the breast (B42) and RPE cell lines (Campbell 
personal communication). This supports their model that CK2 alpha binding on the complex 
switches between wild-type and cancer, possibly having a synergistic effect. Other studies in our 
lab have reported that CK2 alpha translocates between NDPK-A and NDPK-B between wild-type 
and cancer cells respectively, in RPE and breast tissues (Campbell personal communication). 
The effect of the movement of CK2 alpha from NDPK-A to NDPK-B means it no longer has an 
inhibitory effect on NDPK-A and substrate channeling of ATP production, levels are able to rise 
(Jovanovich, et al., 2007). If CK2 alpha is located on NDPK-B it has an inhibitory effect on the 
kinase and prevents its function of converting ATP to GTP (a supply of GTP for G-protein 
activities) and thus ATP levels are conserved for other uses in cancer cells.  
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Here we find slightly different results in prostate cell lines. Figure 6.1 shows that CK2 alpha is 
bound to NDPK-A, irrespective of whether the wild-type or cancer prostate cells are analysed. 
However, even though it is bound to both NDPK-A in normal and cancer cells, it may not always 
phosphorylate NDPK-A all of the time and it may be present in the complex in an off state, as it is 
very unlikely that NDPK-A are constantly being inhibited (a theory supported by the observations 
made in Jovanovich et al., 2007). If NDPK-A was constantly inhibited; 
 NDPK-A would not be converting GTP to ATP to maintain ATP stores, and ATP 
expensive processes like fatty acid synthesis would be constantly un-regulated 
and using up the ATP stores. 
 The cells would be insensitive to the cells environment i.e. NAD
+
/NADH redox 
and oxygen stresses and be unable to switch between aerobic and anaerobic 
metabolism respective of external pressures. 
 
This can be investigated further by looking at the other proteins in the complex and will be 
discussed later. This mechanism of action would seem to imply something else is regulating CK2 
alpha‟s inhibitory effect on NDPK-A. This is different from what was reported by Campbell 
(personal communication), where they showed that if CK2 was in the complex it was having an 
inhibitory affect on the NDPK isoform in respective of which one it was bound to.  
 
The NDPK-B results are similar to the work by Campbell study where CK2 alpha is bound to 
NDPK-B exclusively in cancer cells compared to not in normal cells (personal communication).  
 
However, it should be noted that in prostate cells, CK2 alpha was preferentially bound to NDPK-A 
in cancer cells which is not what was found in the Campbell study, and preferentially bound to 
NDPK-B in cancer as what was found by Campbell (personal communication). As just discussed 
this could mean that something else is regulating CK2 alpha‟s inhibitory effect. In prostate cancer 
cells it was found that CK2 alpha was bound to NDPK-B and we noted that CK2 alpha 
association with NDPK-B in cancer was significantly higher than in normal prostate cells, Figure 
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6.1. This is in agreement with the findings with other groups work (Campbell personal 
communication) where in cancer cells CK2 alpha and NDPK-B association is significantly higher 
than normal. The significance of this result shows that CK2 alpha is preferentially binding to 
NDPK-B over NDPK-A in cancer cells. As a result of this binding, it is hypothesised that CK2 
alpha is phosphorylating NDPK-B and inhibiting its function to generate ATP to GTP, thus 
conserving ATP for other consumption in cancer cells, Figure 6.6. 
 
 
6.5.2 LDH isoform associated with NDPK-A in wild type and cancer prostate 
cell lines 
Lactate dehydrogenase is an important enzyme in regulating ATP production in mammalian cells 
in response to oxidative stress (Warburg, 1956). The two isoforms catalyse opposite sides of the 
LDH reaction. The equilibrium of pyruvate + NADH to lactate + NAD
+
 is also changed depending 
on the oxygen concentration within the cells. If oxygen is low, cells undergo anaerobic glycolysis 
using lactate and NAD
+
, but if oxygen is in plentiful supply, pyruvate and NADH are used in 
oxidative phosphorylation. LDH-A equilibrium catalyses the reaction in anaerobic conditions 
where as LDH-B equilibrium catalyses the reaction in aerobic conditions except in cancer cells 
where LDH-A is active independent of the oxygen concentration (Warburg Effect). Other work in 
our lab has shown that this is true in many cancer cell lines and have characterised the 
mechanism (personal communication). 
 
Figure 6.2 shows that LDH-A is bound to NDPK-A in wild type cells and cancer cells. This agrees 
with the Campbell study (personal communication). When the cell is in a resting (un-stressed) 
state, LDH-A is bound in the NDPK-A / AMPK complex. CK2 alpha activity is enhanced by LDH-A 
activity, and thus phosphorylates NDPK-A, repressing its action of converting ADP + GTP to ATP 
(Jovanovich, et al., 2007). If NDPK-A is not channeling ATP to AMPK then this has a knock on 
effect on AMPK ability to phosphorylate ACC and therefore ACC is active and catalysing its 
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critical step in Fatty Acid (FA) synthesis. Fatty acid synthesis is an expensive process in terms of 
ATP performed when the cell has high stocks of ATP available, and therefore it doesn‟t need to 
generate ATP via substrate channeling and shut down ATP consuming processes as a 
mechanism for ATP conservation, Figure 6.6. 
 
Campbell, et al., explain that in stressed cells LDH-A is up-regulated due to oxidative stress 
pushing the cell to proceed with anaerobic metabolism using lactate and NAD
+
, which LDH-A 
catalyses, and so the redox status of the cell becomes altered which can constitute a stress to the 
cell. Low levels of ATP in the cell, noted by the increased AMP levels, activate AMPK to 
phosphroylate NDPK-A which causes a conformational change and removes CK2 alpha from the 
complex and thus it no longer inhibits NDPK-A, which results in ACC becoming phosphorylated 
and inhibited (therefore shutting down fatty acid synthesis). LDH-A fits into this as it can up 
regulate AMPK and start the substrate channeling reaction, Figure 6.6. Thus, when cells go into 
oxidative stress there are two points to activate substrate channeling; rising levels in AMP, and 
LDH-A levels rising due to lowering oxygen levels. In cancer cells even though there is no 
oxidative stress, LDH-A still associates with NDPK-A even though the cells are not in stress 
(Warburg effect). Therefore in cancer cells LDH-A is up-regulated and is activating AMPK. As a 
result, substrate channeling is switched on and ATP levels are conserved via this mechanism. 
We hypothesise that prostate cancer cells are undergoing this process because they want to 
generate as much ATP as possible to compete with surrounding cells for survival. 
 
6.5.3 LDH isoform associated with NDPK-B in wild type and cancer prostate 
cell lines 
Campbell (personal communication) found in unstressed / wild type cells that LDH-B is 
associated with NDPK-B and that NDPK-B is active and generating GTP from ATP sources 
(personal communication). Figure 6.3 shows that in wild type prostate cells, LDH-B also 
associates with NDPK-B, therefore it would be sensible to assume that NDPK-B is active in 
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prostate wild type cells and NDPK-B is doing its normal job of keeping levels of GTP high to 
supply G-protein processes. Hippe et al., (2006) showed that NDPK-B forms a complex with the 
G beta-gamma dimmers and NDPK-B acts as a histidine kinase and phosphroylates G beta at 
His 266. The phosphate is transferred to GDP in the dimmer complex to form GTP and the GTP 
goes on to bind with the G- protein alpha subunit and thus activating the respective G-protein 
(Hippe et al., 2006).  
 
The effects of LDH-B binding to NDPK-B are twofold. LDH-B has an inhibitory effect on CK2alpha 
(which is bound to the complex in normal cells but in a speculative off state Figure 6.1). If CK2 
alpha is inhibited it cannot itself inhibit NDPK-B and ATP is thus used to generate GTP (LDH 
acting as a regulator of CK2 and AMPK activities, Jovanovich, et al., 2007). Also importantly c-
Myc binds to LDH-B (Campbell personal communication). The role of c-Myc is discussed later in 
this chapter.  
 
Figure 6.3 shows that in prostate cancer cells, it is LDH-A that associates with NDPK-B. 
Campbell (personal communication) observed the same phenomena in a variety of different 
cancer cells derived from different tissues. LDH-A is up-regulated in the cancer cells irrespective 
of whether the cells are stressed or have a poor oxygen availability (Warburg Effect). Campbell 
(personal communication) found that if LDH-A was bound to NDPK-B, it had a positive regulatory 
effect on CK2 alpha which in turn inhibited NDPK-B from making GTP, and therefore ATP levels 
are conserved for the cancer cells to use. The same rationale can be applied for the prostate 
cancer cells, Figure 6.3. LDH-A binds to NDPK-B, this results in NDPK-B having a positive 
regulatory effect on CK2 alpha and thus inhibited NDPK-B from catalysing GTP production. LDH-
A levels are increased as the cancer cells want to generate/conserve ATP and down regulate 
ATP consuming pathway such as fatty acid synthesis and G-protein activates (the cell sees these 
as less critical to short term cell survival).  
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An illustrative analogy would like this mechanism to a bank robber master mind. He wants a lot of 
money fast and doesn‟t care about where it comes from or the bad side effects and bad things 
that have to be done to get it. They are thinking about number one and want that villa on a remote 
beautiful island to live his days on. His henchmen are LDH-A and CK2 alpha that cause the cell to 
make a lot of ATP for the cancer cells own purpose and don‟t care about the fact that G-protein 
synthesis suffers.  
 
As a result, cancer cells are over expressing LDH-A to regulate the expensive ATP functions 
(GTP production) by binding to NDPK-B inhibiting its activity via Ck2 alpha activation. This would 
also explain why CK2 alpha is over expressed in the prostate cloned possibly cancer cells, Figure 
6.1. 
 
6.5.4 LDH isoform association with c-Myc in prostate normal and cancer 
cell cytosol 
These experiments were not undertaken in the Campbell study, and were interesting as they did 
not conform exactly to the Campbell model (personal communication), Figure 6.4. Figure 6.4 
shows that in normal prostate cells c-Myc associates with LDH-A in the cytosol, and in cancer 
cells there is no association between c-Myc and LDH.  
 
Campbell study showed that in normal cells, LDH-B was associated with c-Myc in the NDPK-B 
complex. Therefore in prostate cancer cells, c-Myc is bound to either the NDPK-A / AMPK 
complex or it is associated with LDH-A in a completely different complex. More investigations 
would need to be undertaken to see how and where c-Myc is bound. 
 
Interestingly what Figure 6.4 does show is a lack of association of c-Myc with either LDH isoform 
in cancer cells, which agrees with the data in the Campbell study (personal communication). They 
found that in normal cells c-Myc is bound to NDPK-B and is thus inactive but in cancer cells when 
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LDH-B is switched for LDH-A, c-Myc was ejected from the complex. This observation correlates 
with our findings, as no association of either LDH isoform is seen associated with c-Myc in the 
abnormal prostate cells. 
 
6.5.5 c-Myc localisation with prostate normal and cancer cells and cytosolic 
c-Myc association with NDPK-B in prostate normal and cancer cells 
Immunocytochemistry results show c-Myc localisation within the cell and comparable expression 
levels within the cells, Figure 6.5a. As seen in Figure 6.5a it can be seen that there is no c-Myc 
localisation with the normal wild type P21s cells. In P21d there is a mixture of cells expressing c-
Myc and colonies of cells that are not expressing c-Myc at all. This can be explained by P21d 
being a mixed population of cancer and wild type cells, so it would be expected to see 
heterogenous results reflecting the two populations present.  
 
The P21d 0Gy (clone-a) abnormal and possibly cancer cell line shows the highest expression of 
c-Myc and all expression is observed in the nuclei of the cells. We hypothesise that c-Myc is 
being up-regulated and over expressed in cancer cells whilst being located in the nuclei, in 
agreement with the accepted c-Myc literature (Gil, et al., 2005; Yang, et al., 2005). 
 
To investigate intracellular c-Myc location in normal and cancer cells and whether it is held 
inactive in the NDPK-B complex as reported by Campbell (personal communication), experiments 
were done on P21s, P21d and P21d 0Gy (clone-a) cells, Figure 6.5b.  
 
As expected, c-Myc was found in the cytoplasm of the normal prostate cells P21s and bound to 
NDPK-B in the NDPK-B complex, Figure 6.5b. There was no association detectable in the P21d 
or cancer P21d 0Gy (clone-a) cells. This indicates that c-Myc has been removed from the NDPK-
B complex in cancer cells. Suspiciously, c-Myc levels in the nucleus increase in cancer cells so it 
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would be logical to assume that the c-Myc is translocating to the nucleus and further investigation 
is being done to test this hypothesis.  
 
Campbell (personal communication) hypothesise that the binding of LDH-A to NDPK-B in cancer 
cells is a direct cause of c-Myc being removed from the complex. This theory is backed up by our 
observation of the c-Myc LDH isoform dependent association in prostate cancer cells, Figure 6.4. 
Therefore with the evidence of c-Myc not bound to NDPK-B in the cancer cell cytosol, Figure 
6.5b, the lack of c-Myc being associated with LDH- A/B, Figure 6.4, and the over expression seen 
in the nuclei of cancer cells, it is safe to assume that c-Myc that is bound to NDPK-B in normal 
cells, Figure 6.5b, and removed from the NDPK-B complex in cancer cells and might translocate 
to the nuclei of cancer cells. 
 
6.5.6 Downstream targets of c-Myc expression in prostate normal and 
cancer cells 
To investigate if c-Myc is being up regulated in the nuclei of cancer cells, expression levels of two 
c-Myc downstream targets were investigated, Figure 6.5c. As expected a key downstream target 
of c-Myc, LDH-A (Lewis, et al., 2000), expression were up-regulated in cancer cells, Figure 6.5c. 
 
Total cell cytosolic LDH levels were significantly up-regulated in both the P21d and the P21d 0Gy 
(clone-a) cell lines compared to low levels in wild type P21s, Figure 6.5c. Since the antibody 
cannot differentiate between LDH-A and B isoforms, we can only report that LDH levels are 
increased in agreement with the literature (Lewis, et al., 2000) where others have shown that 
LDH-A is a downstream target of c-Myc and not LDH-B. Further analysis by 2D IEF gel analysis 
would confirm that it was LDH-A which is up regulated as opposed to LDH-B.  
 
Increased expression of LDH-A in cancer cells as a result of increased c-Myc expression would 
theoretically constitute a positive feed forward loop by favoring LDH-A presence on the NDPK-B 
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complex which we have shown correlates with enhanced c-Myc expression. As a result c-Myc 
which has been dislodged from NDPK-B (as a result of LDH-A binding) would translocate to the 
nucleus and cause an up-regulation of transcription of LDH-A gene and then more LDH-A protein 
would be synthesised in the cell and the new LDH-A would bind to AMPK / NDPK-A complex and 
NDPK-B complex and increase ATP production via substrate channeling which down regulates 
ATP expensive fatty acid sythensis and increase ATP conservation levels from expensive 
wasteful GTP production and save it all for growth and survival (for that remote beautiful island, 
bank robber analogy). 
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Figure 6.6 - Speculative diagram to show how the metabolic enzymes associate in prostate 
normal and cancer cell cytosol 
 
 CK2 alpha is associated with NDPK-A irrespective to prostate normal or cancer 
cells. 
 CK2 alpha is associated with NDPK-B in cancer cells only. 
 LDH-A isoform is associated with NDPK-A, LDH-B is associated with NDPK-B in 
prostate normal cells. 
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 LDH-A isoform is associated with NDPK-A and NDK-B in cancer and P21d 0Gy 
(clone-a) cells. 
 c-Myc is bound to NDPK-B in normal prostate cells but not cancer cells. 
 
These associations are shown in the diagram. However it is speculated that CK2 alpha is able to 
exist in a regulated off/on state and it has not been proved that fatty acid synthesis is down 
regulated in prostate cancer cells, nor that NDPK-B is being inhibited in cancer cells by CK2 
alpha. It is shown that LDH is associated with AMPK α1, (and NDPK-A, NDPK-B) in normal liver 
cell cytosol and so is predicted to associated with AMPK α1 also in prostate cells (Jovanovich et 
al., 2008). Nevertheless this mechanism has been shown to be expressed this way in breast and 
RPE normal parental and cloned cells therefore it is predicted that this mechanism is arranged 
this way in prostate cells. 
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 Campbell (personal 
communication)– B42 Breast 
and RPE wild type and 
cancer cell lines 
 Prostate wild type and 
cancer cell lines 
CK2 alpha binding to NDPK-
A or NDPK-B in cytosol 
respective to wild type and 
cancer 
CK2 alpha exclusively bound to 
NDPK-A in wild type 
CK2 alpha exclusively bound to 
NDPK-B in cancer 
Ck2 alpha basally associated 
with NDPK-A in wild-type and 
cancer 
CK2 alpha exclusively bound to 
NDPK-B in cancer 
2D IEF Gel to determine 
which LDH isoform A/B was 
binding to NDPK-A and 
NDPK-B cell cytosol in wild 
type and cancer 
LDH A bound to NDPK A in 
wild type 
LDH B bound to NDPK B in 
wild type 
LDH A bound to NDPK A and B 
in cancer 
LDH A bound to NDPK A in 
wild type 
LDH B bound to NDPK B in 
wild type 
LDH A bound to NDPK A and 
B in cancer 
2D IEF Gel to determine c-
Myc association with LDH 
isoform in cell cytosol 
  LDH A bound to c-Myc in wild 
type 
No binding of LDH A or LDH B 
to c-Myc in cancer 
c-Myc localisation in nucleus 
using immunocytochemistry 
  No c-Myc expression seen in 
wild type nucleus or cytosol 
Abundant c-Myc expression 
seen in nuclei of cancer 
Cytosolic association with c-
Myc and NDPK-B 
Strong binding of c-Myc to 
NDPK-B in wild type 
No binding seen in cancer 
Strong binding of c-Myc to 
NDPK-B in wild type 
No binding seen in cancer 
Total extract expression of 
known c-Myc downstream 
targets – LDH 
Low expression of LDH in wild 
type 
Highly increased expression of 
LDH in cancer 
low expression of LDH in wild 
type 
High expression of LDH in 
cancer 
 
Table 6.1 - Correlation between results of Campbell study (personal communication) and this 
study 
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6.6 Conclusion 
This preliminary study has shown that cell metabolism is organised differently in prostate cancer 
and normal cells in association with CK2 alpha vs NDPK-A/B but conserved with LDH isoform vs 
NDPK-A/B. At a molecular level in the cell cytosol it seems LDH-A is a key player, as it 
phosphroylates AMPK at the start of the substrate channeling pathway and also binds to NDPK-B 
which removes c-Myc from the NDPK-B complex. If it would be possible to manipulate this 
mechanism by exchanging LDH-A for LDH-B on NDPK-B in cancer cells it would be possible to 
stop c-Myc expression, which causes oncogenic down stream effects, and change the cells 
metabolism to using aerobic metabolism via LDH-B and oxidative phosphorylation they thus 
would be more sensitive to radiation damage in the aerobic state. This would help as cells that 
are exposed to higher concentration of oxygen are more susceptible to being killed with drug 
manipulation or radiation (Hall, 1994).  
 
 
 
6.7 Further experiments 
 ATP tracking to watch in real time when synthesised by NDPK-A to see if substrate 
channeling mechanism seen in breast and RPE cells is conserved in prostate cells. 
 c-Myc tracking to see if it really translocates to the nucleus of the cell when removed from 
the NDPK-B complex in cancer cells. 
 Use mice in vivo models and tissue from tumours from patients to see if mechanism is 
not an artifact of growing cells in vitro. 
 Looking into the c-Myc and LDH-A association in normal cell cytosol. 
 Grow cell systems in more physiological oxygen conditions. 
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Chapter 7 
 
Final Conclusions 
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7.1 Introduction 
The aim of this study was to derive prostate cell lines without use of viral genes, from two 
different regions of the prostate from the same patient. The regions were important as the 
peripheral region near the capsule is where aggressive prostate cancer usually occurs and the 
peri-urethral region is where the benign disease usually occurs. These cell models would aid the 
further study of progression of prostate cancer in humans. 
 
Here we report successful immortalisation with two non-viral genes, cyclin dependent kinase 4 
(cdk4) and human telomerase (hTERT) to derive prostate cell lines from two different regions of 
the prostate from the same patient. The P21s cell line derived from the superficial peri-urethral 
region and P21d derived from the peripheral capsule region (P21s and P21d). Interestingly, the 
P21d cell line transformed in culture and upon further investigation was composed of a mixture of 
abnormal cells, most likely as a PIN lesion had been immortalised in the primary culture. The 
occurrences of PIN lesions in elderly men are very frequent and increase in probability with age. 
However, these PIN are dormant tumour cells that may turn into malignant prostate carcinoma, 
however many remain dormant. 
 
7.2 A summary of cell lines 
7.2.1 P21s cell line from central, peri-urethral region of prostate 
 Immortalised with cdk4 and hTERT transduction. 
 SKY analysis showed an almost complete chromosome complement including an X and 
Y chromosome and an extra copy of chromosome 20. 
 The SNP analysis confirmed the SKY analysis. 
 Immunocytochemistry results showed positive staining for CK5, CK14, CK6, PSCA, p63, 
p16, and telomerase and negative staining for c-Myc, CK18, and CD133. 
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 P21s cells did not invade through a Matrigel porous membrane. 
 Did not produce anchorage independent colonies. 
 
7.2.2 P21d cell line from capsule, peripheral region of prostate 
 Immortalised with cdk4 and hTERT transduction. 
 SKY analysis showed all chromosomes were duplicated including two copies of 
chromosomes X and the cell line had lost the Y chromosome. Many rearrangements 
were also observed. 
 The SNP analysis correlated with the SKY analysis showing an 22q amplicon, 10p and 
17p deletion. 
 Immunocytochemistry results showed positive staining for CK5, CK14, CK6, PSCA, 
CK18, telomerase and c-Myc and negative staining for CD133, p63 and p16. 
 P21d cells did invade through a Matrigel porous membrane. 
 Did produce anchorage independent colonies. 
 
7.3 Attempting to get a normal P21d cell line 
P21d cell line produced anchorage independent colonies after passage 9 with increasing 
numbers of colonies with increasing passage number. The same trend was observed when the 
experiment was repeated using the immortalised P21d primaries and defrosted passage 5 cells. 
Plastic derived cloned cells lines were derived by plating early passage number at low density 
then picking off colonies formed from a single cell.  
 All seven cell lines were abnormal also, as produced anchorage independent colonies. 
 All seven cell lines all had an abnormal chromosome complement. 
 All seven cell lines were invasive through a Matrigel porous membrane. 
Jennifer Weaver 
  220 
 It was concluded that P21d was a mixed population of abnormal cells derived from 
immortalising a PIN lesion.  
 
Two of the anchorage independent colonies were picked and cloned cell lines were derived – 
P21d 0Gy (clone- a) and (clone- b). Both cell lines produced anchorage independent colonies but 
only P21d 0Gy (clone-a) was fully characterised.  
 P21d 0Gy (clone-a) was highly invasive (more so than P21d) through a Matrigel porous 
membrane. 
 Exhibited the similar immunocytochemistry results as P21d. 
 SKY analysis of P21d 0Gy (clone-a) was very similar to P21d to the extent that it could 
be deduced that they were related cell lines.  
 SNP analysis could be correlated to the SKY analysis.  
 All results point to P21d and P21d 0Gy (clone-a) being transformed cell lines. To confirm 
that they were indeed transformed the cells would have to be grown in immuno-
compromised animals.  
 
7.4 Radiation transformation studies 
Fractionated doses of gamma radiation up to an accumulated dose of 40Gy resulted in P21s 
producing anchorage independent colonies. One of these colonies was picked and a cloned cell 
line was derived.  
 P21s 40Gy clone was positive for CK5, p63, CK14, telomerase, CK6, PSCA, CK18 
including being positive for c-Myc expression a known oncogene, which correlate with an 
abnormal cell line. 
 Produced anchorage independent colonies. 
 The SKY analysis also showed abnormal chromosome complement including extra 
copies of chromosome 5, 8, 9, and 20. 
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 Therefore, it can be postulated that P21s 40Gy (clone-a) is a transformed cell line derived 
from P21s. To confirm transformation the cells would have to be grown in immuno-
compromised animals. 
 
7.5 Using cell lines as models for polyphenol and metabolic 
enzyme experiments 
7.5.1 A summary of the P21 cell lines responses after incubation with 
strawberry polyphenols 
The cell lines were used as a model to investigate if fruit polyphenols have differential effect at 
killing cancer cells as apposed to normal cells. However, most previous reports in the literature 
have not included controls from the same tissue of the same patient origin. This study has shown 
that strawberry polyphenols:- 
 Do not exert differential cytotoxic effects on cancer and normal cells and that the 
polyphenols are exceptionally cytotoxic with doses much lower than reported causing 
50% reduction in cell survival.  
 In fact low doses below 6 µg / mL caused an increase in cell proliferation which is 
alarming as this is not far from physiological values. However, more tests would have to 
be run at physiological values to deduce if it would have an increase in cell survival of 
cancer cells.  
 The polyphenols had a less cytotoxic effect on established prostate cancer cell lines 
LNCaP and PC-3 and human lymphocytes stimulated with PHA. These two cell lines and 
lymphocytes were required to be grown in 10% FCS and it is known that serum binds the 
polyphenols and decreases the availability to the cells. This could explain why higher 
concentrations of polyphenols were required to cause the same cytotoxic effect. Further 
investigations with growing these cells in serum free media would make this clearer.  
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In contrast to the investigation of the direct effect on tumours, polyphenols exhibited a protective 
effect on radiation induced damage.  
 It was noted that the polyphenols had a protective effect if incubated on the cells for 3 
hours before ionising gamma radiation with micronuclei assays. The polyphenols were 
washed from the cells before irradiation and replaced with new medium. Therefore the 
polyphenols must be retained within the cells membranes as the antioxidants have to be 
there when the free radical and ROS are created for there to be an effect. 
 A higher protective effect is observed if the polyphenols were applied to the cells just 
prior to irradiation treatment but this is to be expected as the polyphenols are fresh and 
present during the formation of the free radicals and ROS.  
 A lower protective response was observed if the polyphenols were incubated on the cells 
for 3 hours and left on the cells during irradiation treatment compared to just during 
irradiation treatment. This could be because the polyphenols are being slightly broken 
down by the cells and so the concentration is slightly less just before irradiation.  
 However, if the polyphenols are incubated before and during irradiation the protective 
response is about the same as 3 hours before incubation only. This shows that even after 
washing the cells after 3 hours incubation with the polyphenols, they must have retained 
all available polyphenols within the cells to have the same protective response.  
 
 
7.5.2 A summary of the P21s, P21d and P21d 0Gy (clone-a) cell line 
metabolic enzyme association 
7.5.2.1 CK2 alpha association with NDPK-A / NDPK-B 
 It was deduced that CK2 alpha was associated with NDPK-A in normal P21s cells and 
with NDPK-A and NDPK-B in cancer P21d cell line cells. In P21s cells it was 
hypothesised that the CK2 alpha was having an inhibitory effect on NDPK-As ability to 
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synthesise ATP from ADP and GTP. This new source of ATP would then have been used 
by AMPK to phosphorylate ACC. ACC would then be inhibited and fatty acid synthesis 
would stop. As NDPK-A is inhibited by CK2 alpha fatty acid synthesis is predicted to 
occur as normal in P21s normal cells.  
 
 As there is no association with CK2 alpha with NDPK-B it is assumed that NDPK-B is not 
being inhibited and it can continue to use ATP to generate GTP for G-protein services in 
the cell in normal and P21s cells.  
 
 In the abnormal P21d and P21d 0Gy (clone-a) cells CK2 alpha is associated with NDPK-
A and NDPK-B complexes. CK2 alpha when bound to NDPK-B has an inhibitory effect on 
its ability to generate GTP from ATP stores. When CK2 alpha is bound to NDPK-A it has 
an inhibitory effect on its ability to generate ATP as discussed above.  
 
7.5.2.2 LDH isoform association with NDPK-A, NDPK-B and c-Myc 
 In normal cells it has been reported that LDH isoform expression regulates the cells 
respiration aerobically or anaerobically. It was found in P21s cells, LDH-A bound to 
NDPK-A and LDH-B bound to NDPK-B. It has been reported that LDH-B has a negative 
effect on CK2 alpha binding to NDPK-B and LDH-A bound to NDPK-A encourages CK2 
alpha to bind.  
 
 LDH-A is found to associate with NDPK-A in hypoxic cells, as in normal cells, but in 
hypoxic cells it is hypothesised that LDH-A activates AMPK and causes it to use ATP to 
phosphorylate ACC to prevent fatty acid synthesis (an ATP expensive process) to 
conserve ATP. In cancer cells this same metabolic enzyme set up is hypothesised to 
exist to conserve ATP for growth only. Cancer cells also only express LDH-A isoform and 
respire anaerobically preferably (Warburg Effect).  
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 LDH-A being only expressed in hypoxic and cancer cells means that LDH-A binds to 
NDPK-B preferentially and inhibits it from using ATP to generate GTP and decreases G-
protein activities. A side effect of LDH-A and CK2 alpha binding to NDPK-B and inhibiting 
this enzyme is that c-Myc is removed from the NDPK-B complex. This could be because 
CK2 alpha binding and inhibiting it may change the structural conformation and hence 
cause c-Myc to no longer bind. This has been reported in cancer cells and was found in 
the P21d and P21d 0Gy (clone-a) cells.  
 
 It would be interesting to mark the c-Myc and record where it moves to as in cancer cells 
and observed in P21d and P21d 0Gy (clone-a) cells there is an up-regulation in c-Myc 
expression in the nucleus and an increase in expression of down stream targets. It could 
be interesting to see if c-Myc translocates to the nucleus and binds the DNA and results 
in it causing an up-regulation of its target genes. 
 
 
7.6 Conclusion 
In conclusion the P21s and P21d prostate cell lines have been successfully immortalised with 
over expression of cdk4 and hTERT genes and have been fully characterised. For the superficial 
region P21s is a normal cell model with almost complete chromosome complement with a sister 
and abnormal most likely transformed cancer cell line P21s 40Gy (clone-a). For the deep region 
P21d and P21d 0Gy (clone-a) are abnormal most likely transformed cancer cell lines. All cell lines 
were derived from the same patient and therefore any experiments done with them can be fully 
comparable.  
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